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ABSTRACT OF THE DISSERTATION 
Exploring the Global Virome and deciphering the role of phages in Cystic Fibrosis 
by 
Ana Georgina Cobián Güemes 
Doctor of Philosophy in Biology 
University of California San Diego, 2019 
San Diego State University, 2019 
Professor Forest Rohwer, Chair 
Viruses are the most abundant and diverse life form on Earth. In Chapter 1 of this 
dissertation, a global census of the number of viral particles showed that 6.03 x 1031 viral 
particles are distributed across almost every ecosystem. The global census results showed that 
most viruses are in soils and sediments, two unexplored biomes for viral diversity. Accurate 
and fast bioinformatics methods to explore viral and bacterial composition in metagenomes 
are presented in Chapter 2 as “Fragment Recruitment Assembly Purification.”  
v 
Phages are viruses that infect bacteria, their role in polymicrobial infections such as 
Cystic Fibrosis is explored. Cystic Fibrosis is a genetic disease in which the lung phenotype 
promotes mucus accumulation and microbial colonization. A multi-omics strategy to explore 
changes in the lung microbial community during acute pulmonary exacerbations is presented 
in Chapter 3 as “Cystic Fibrosis Rapid Response: Translating Multi-omics data into Clinically 
Relevant Information.” In Chapter 4, eight acute exacerbations were studied, and a trend of 
loss of diversity and viral lytic lifestyle was observed. Two Cystic Fibrosis patients studied in 
Chapter 4 were colonized by antibiotic resistant bacteria from the genera Achromobacter. 
Both patients suffered fatal exacerbations. This motivated the isolation and characterization of 
lytic phages to be used as antimicrobials against bacterial infections.
1 
Chapter 1 : Viruses as Winners in the Game of Life 
Abstract 
Viruses are the most abundant and the most diverse life form. Their global abundance 
was previously estimated as 1031, but their abundance remains uncertain and their global 
distribution vague. In this meta-analysis we estimated that there are 4.80 × 1031 phages on 
Earth. Further, 97% of them are in soil and sediments—two underinvestigated biomes that 
combined account for only ~2.5% of publicly available viral metagenomes. The majority of 
the most abundant phage sequences from all biomes are novel. Our analysis drawing on all 
publicly available viral metagenomes predicted a mere 257, 679 phage genotypes on Earth—
an unrealistically low number— which attests to the current paucity of metagenomic data. 
Further advances in viral ecology and diversity call for a shift of attention to previously 
ignored major biomes and careful application of verified methods for viral metagenomic 
analysis.  
J.B.S. Haldane observed, “God has an inordinate fondness for stars and beetles.” 
To which we would add, “…and viruses.” 
How many viruses? 
Until the 1970s, viruses were of import only insofar as they were found to cause 
disease in us, our domesticates, and other eukaryotes of economic value. Bacteriophages —
viruses that infect bacteria— were proving themselves to be eminently useful as model 
systems for molecular biology research, but were still thought to be of little significance to the 
functioning of the biosphere. There simply could not be enough environmental phages to 
2 
matter, given the then measurable number of potential prokaryotic hosts counted by culturing 
techniques. Since typically only ~ 1% of the Bacteria were culturable by methods at that time, 
bacterial populations were routinely underestimated by two orders of magnitude: the “great 
plate count anomaly” (Staley and Konopka, 1985) . In the late 1970s, the reported 
environmental bacterial populations jumped 100-fold or more with the development of 
improved direct counting methods employing epifluorescence microscopy (Hobbie, Daley, 
and Jasper 1977). In 1979 Torrella and Morita (Torrella and Morita 1979) concentrated 
particles larger than 0.2 μm from Oregon bay water by filtration and made direct counts of 
virus-like particles (VLPs) by transmission electron microscopy. Their counts, only about 104 
mL–1 or one VLP per microbial cell, overlooked VLPs <0.2 μm, the majority of phages. This 
omission was corrected in 1989 when Bergh and associates centrifuged water samples directly 
onto grids for viewing by transmission electron microscopy (Bergh et al. 1989). They reported 
direct virion counts up to 1.5 × 107 mL–1, an order of magnitude greater than their hosts. 
Moreover, based on several reasonable assumptions, they predicted that in marine 
environments, as much as one-third of the bacterial population suffered phage attack daily—
hardly insignificant.  
This was only the beginning as abundant microbes, and even more numerous phages, 
were then found in many environments, including inhospitable locations such as glacial ice 
(Anesio et al. 2007), bubbling acidic hot springs (Bolduc et al. 2015), deep-sea vents 
(Ortmann and Suttle 2005), and deep sediments (Engelhardt et al. 2014). Based on subsequent 
methodological developments, viruses are now recognized for what they are: the winners in 
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the game of life. They are the most abundant and the most diverse life forms, and are of great 
import for ecology and evolution. 
A Global Census 
How many viruses are there on Earth, and where are they located? One would expect 
to find the most viruses in the habitats with the most host organisms. The most abundant 
cellular organisms are the prokaryotes with an estimated 4.15 × 1030 cells, the majority of 
which are found in soil, subseafloor sediments, and marine waters (Table 1.1) (Whitman, 
Coleman, and Wiebe 1998; Williamson, Radosevich, and Wommack 2005; Kallmeyer et al. 
2012; DeLong 2003). The number of microbial eukaryotes, including algae, is comparatively 
small, in the range of only 103 to 104 mL–1 in seawater and other planktonic environments 
(Rocke et al. 2015).  
Taking a global phage census poses methodological challenges. Current methods for 
direct counting of VLPs commonly combine nucleic acid stains with EFM or flow cytometry. 
These methods were developed for aquatic environments, and their application to soil and 
sediment is problematic. Additional steps are required to detach prokaryotes and VLPs from 
particles and surfaces, and successful methods are specific to particular situations. Both may 
be obscured by opaque particles, and background fluorescence can interfere. The marine 
environment remains the most extensively sampled and best studied biome. Other intensively 
studied locations, such as the human gut and freshwater, make a relatively small contribution 
to the global total. Soils and the extensive subsurface sediments warrant more attention as 
their contribution is expected to be major.  
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Table 1.1 Estimated number of virus-like particles on Earth. Virus-to-microbe ratios 
(Supplemental Table 2 in Cobián et al., 2016) were extracted from 53 previous studies ratios 
(Supplemental Table 1 in Cobián et al., 2016) and used to calculate virus-like particles in each 
biome. Numbers of prokaryotic cells in marine, freshwater, other aquatic, sediment, and soil 
biomes are from Whitman at al., 1998. Number of cells per human is from Sender et al. 2016; 
human population is from United Nations, 2016. Median virus-to-microbe ratio for human 
biome is from Kim et al., 2011. 
Biome 
Number of 
prokaryotic 
cells 
Median virus-
to-microbe 
ratio 
Virus-like 
particles 
per biome 
Percentage of 
total virus-like 
particles 
Marine 1.01 x 1029 12.76 1.29 x 1030 2.6828 
Freshwater 1.26 x 1026 14 1.76 x 1027 0.0037 
Other aquatic 2.44 x 1027 30 7.32 x 1028 0.1524 
Sediment 3.80 x 1030 11 4.18 x 1031 87.0131 
Soil 2.50 x 1029 19.5 4.88 x 1030 10.1481 
Human-associated 2.80 x 1023 0.1 2.80 x 1022 0.0000 
Other host-associated Unknown 25 Unknown Unknown 
Total 4.15 x 1030 12 4.80 x 1031 
Marine sediment contains up to 105 times more organic matter than the water column 
above, supporting bacterial densities about 103 times higher (Kallmeyer et al. 2012). Summed 
globally, the total number of prokaryotes in subseafloor sediment (2.9 × 1029) is roughly equal 
to the estimates of Whitman et al. (Whitman, Coleman, and Wiebe 1998) for the total number 
of prokaryotes in seawater (1.2 × 1029) and in soil (2.6 × 1029). Cell densities alone would 
predict good hunting for the phage, as the probability of non-specific phage-host contact 
would be ~103 times greater on average than in the water column above. Indeed, VLP counts 
of 109 ml–1 in sediment have been reported, three orders of magnitude greater than that 
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observed in the overlying water column at that depth (Danovaro and Serresi 2000). Similarly, 
the large numbers of prokaryotes in soil, the rhizosphere, and the rhizosheath, and their 
associated phages, remain largely terra incognita despite their accessibility and their 
importance to agriculture.  
VLPs outnumber their hosts by approximately a factor of ten-to-one in various oceanic 
locations (Wommack and Colwell 2000), and similar ratios have been observed in some other 
biomes (Figure 1.1). It is not understood what drives this consistency, nor the observed 
variations. On this basis, earlier extrapolations from the prokaryote abundances in the major 
biomes yielded an estimated 1.2 × 1030 in open ocean, 2.6 × 1030 in soil, 3.5 × 1031 oceanic 
subsurface, and 0.25–2.5 × 1031 in terrestrial subsurfaces, consistent with the rule-of-thumb 
estimate of 1031 viruses on Earth (Mokili, Rohwer, and Dutilh 2012). Here we revisited this 
question by combining the prokaryote populations drawn primarily from the classic 1998 
paper by Whitman et al. (Whitman, Coleman, and Wiebe 1998) with the median measured 
VMRs from 53 previously-reported studies (Supplemental Table 1 in Cobian et al. 2016). In 
addition to the major biomes, we included some specialized environments of particular 
interest, such as niches associated with humans and other hosts. From a global perspective, 
the majority of prokaryotes inhabit soil, seawater, and the sediments. Thus, we expected that 
these biomes would also account for the majority of viruses.  
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Figure 1.1 Virus-to-microbe ratios for major biomes. Box plots of biome virus-to-microbe 
ratios drawn from 53 previous studies (see Supplemental Methods). The means are indicated 
with gray diamonds. The medians are indicated with red lines. 
This approach yielded 1.29 × 1030 VLPs in marine waters, 4.18 × 1031 in sediments, 
and 4.88 × 1030 in soil (Table 1.1). Adding in other lesser contributors brought the global total 
to 4.80 × 1031 VLPs (details in Supplemental Table 2 in Cobian et al. 2016). This confirms 
and slightly augments the oft-quoted number of 1031. Given that the vast majority of cellular 
entities are prokaryotes, this number represents the global phage population. Significantly, 
sediments and soil combined accounted for 97% of the global total. In sum, phages are the 
most abundant life forms, exceeding the runner-up, the prokaryotes, by more than an order of 
magnitude. Populations of this magnitude dictate that phage evolution is driven by selection, 
with the contribution of drift being insignificant (Kimura 1962).  
Caveats: To the best of our knowledge, there are only two published reports of VMRs 
for human-associated communities. One reported VMRs of 38.6 and 7.9 for gum-associated 
mucus and the adjacent milieu, respectively (Barr et al. 2013), while the other reported a 
mean VMR of 0.129 and a median VMR of 0.1 in fecal matter (M.-S. Kim et al. 2011). Since 
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the vast majority of human-associated microbes and VLPs are in the distal gut (Sender, Fuchs, 
and Milo 2016; Haynes and Rohwer 2011), the fecal VMR was used to calculate the total 
VLPs for the human-associated biome. Admittedly, that fecal VMR, being two orders of 
magnitude lower than the VMRs typical of most other biomes, was suspect. However, 
combining it with the recently revised estimate of 3.9 × 1013 human-associated prokaryotes 
(Sender, Fuchs, and Milo 2016) yields 3.9 × 1012 human-associated VLPs, in good agreement 
with the previous estimate of 3.0 × 1012 (Haynes and Rohwer 2011). Unraveling the phage-
host dynamics in the human-associated microbiome will require further investigation. 
Several factors may result in underestimations of phage abundance. 1) Equating the 
number of VLPs with the number of phages overlooks those residing as prophages in bacterial 
genomes—not an insignificant number (see below). 2) Some stains used to enumerate 
microbial cells and VLPs by EFM, such as SYBR Green, are relatively insensitive to single-
stranded DNA and RNA, thus overlook many small viruses. A more representative assay can 
be made using SYBR Gold (Tuma et al. 1999). 3) VLP counts for soil and sediment are 
biased by reduced extraction efficiencies, while visualization and identification of VLPs can 
be compromised by particulate matter in samples of fecal matter, soil, sediment, etc. 4) Some 
VLP isolation methods for EFM include filtration through 0.2 μm filters which miss larger 
virions and also virions stuck to particulate matter. 5) The 0.02 μm grids used for TEM 
viewing miss the smallest virions.  
Conversely, are these VLPs really viruses? In some environments, some VLPs may be 
gene transfer agents (GTAs), i.e., packaged cellular genes masquerading as tailed phage 
particles (Lang, Zhaxybayeva, and Beatty 2012). Although GTAs are produced by 
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roseobacters, a group that may account for more than 25% of the prokaryotes in some marine 
environments (Lang, Zhaxybayeva, and Beatty 2012), it remains unknown whether GTAs 
make a significant contribution to marine VLP counts. Also unknown is what fraction of the 
VLPs in various environments are infectious, and what percentage were defective upon 
release or subsequently inactivated by UV irradiation, physical damage, or enzymatic attack.  
Phages Matter 
How much do 1031 viruses matter? One measure of this is to consider the matter they 
contain. The mass of a typical phage virion containing 50 kbp DNA packaged inside an 
icosahedral capsid is calculated to be 0.0823 fg; of this, 0.054 fg is DNA and 0.0283 fg is the 
protein capsid (Antoni Luque, personal communication). For comparison, each 
Prochlorococcus, a particularly small autotrophic marine bacterium, has a mass of 300 fg. 
Based on this virion mass, the 4.80 × 1031 VLPs on Earth have a total mass of 3.95 × 1015 g or 
3.95 Pg. The stoichiometry of carbon, nitrogen, and phosphorus (C/N/P) in this typical virion 
is 20/6/1 (Jover et al. 2014), which partitions that mass as approximately 0.06 fg C, 0.02 fg N, 
and 0.0075 fg P. Calculation based on these data suggests that the Earth's VLPs represent 
roughly 2.9 Pg C, i.e., two orders of magnitude less than the 350-500 Pg total carbon 
previously estimated for Earth's prokaryotes (Whitman, Coleman, and Wiebe 1998). 
Compared to microbial cells, virions are enriched in both nitrogen and phosphorus, with 
estimated global totals of 0.96 Pg N, and 0.36 Pg P. As a result of this enrichment, >5% of the 
total marine DOP and DON pools is estimated to reside in virions in some locations (Jover et 
al. 2014).   
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It is now widely recognized that microbes are of tremendous importance for global 
biogeochemical processes, and consequently, that which controls the microbes — the 
phages — runs the world. Prokaryotes are subject to predation by both heterotrophic protists 
and phages. Grazing by protist predators is size-selective, whereas lysis by phages is strain-
specific. Moreover, in the oceans grazing moves the organic carbon and nutrients to higher 
trophic levels, whereas lysis routes these components instead through the viral shunt as 
dissolved organic matter (DOM). This DOM feeds the heterotrophic microbial community, 
thereby increasing net primary productivity and slowing the movement of carbon to the deep 
ocean (Fuhrman 1999; Weinbauer 2004; Wommack and Colwell 2000; Weitz et al. 2015; 
Proctor and Fuhrman 1990; C A Suttle 2005). Because of the stoichiometric mismatch 
between virions and their host cells, after lysis, a disproportionate amount of the P is found in 
the progeny virions, leaving the cellular debris that feeds the heterotrophs depleted in P (Jover 
et al. 2014). An estimated 1028 marine bacteria are lysed daily including ~30% of the 
cyanobacteria and ~60% of the heterotrophic bacteria (Curtis A.  Suttle 2007; Proctor and 
Fuhrman 1990). This selective, strain-specific lysis profoundly impacts prokaryote 
community diversity increasing both richness and evenness (Wommack and Colwell 2000; 
Fuhrman 1999; T.F. Thingstad 2000; T.F. Thingstad et al. 2015; Sandaa et al. 2009). 
Phages also add a horizontal dimension to microbial evolution by mediating the 
transfer of genes between cells (John H Paul 1999). They nab useful metabolic genes from 
their hosts, maintain them, evolve them further to suit their own needs, and then sometimes 
return the new version to the microbial gene pool (Frank et al. 2013; Lindell et al. 2004; 
Sullivan et al. 2006; D.B. Goldsmith et al. 2011). On an ecosystem level, the phage 
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community encodes environment-specific repertoires of microbial metabolic genes (Dinsdale 
et al. 2008).  
Through lysogeny, phage genes are a continual presence in microbial communities. 
Identification of prophages in microbial genomes is challenging, and numerous bioinformatic 
methods have been developed (Bose and Barber 2006; Zhou et al. 2011; McNair, Bailey, and 
Edwards 2012; Akhter, Aziz, and Edwards 2012; Fouts 2006)  Estimates of the percentage of 
prokaryotes in various biomes that carry one or more prophages have ranged between 0% and 
100% (J.H. Paul 2008). Approximately 82% of the sequenced prokaryotic genomes available 
as of 2015 are predicted to contain at least one prophage (Katelyn McNair, personal 
communication). Resident prophages often account for the differences between strains within 
a bacterial species (Canchaya et al. 2003). Prophage-encoded exotoxin genes cause many 
notable human diseases, including cholera, diphtheria, and enterohaemorrhagic diarrhea 
(Casas et al. 2006) as well as diseases that plague our agriculture and aquaculture.  
We do not yet understand the factors influencing the prevalence of lysogeny in any 
biome. Siphoviruses have long been associated with the temperate lifestyle, although 
lysogeny is not confined to that family. This group was observed to dominate the community 
in the Southern Ocean, marine sediment, desert, hypersaline ponds, and human fecal samples, 
accounting for 44% of the total in sediment (M. Breitbart et al. 2004; M Breitbart et al. 2002; 
M. Breitbart et al. 2003; Brum et al. 2015; Adriaenssens et al. 2015; Roux et al. 2016).
However, whether a temperate phage will follow the lytic or lysogenic pathway is decided at 
the start of each infection in response to host and environmental factors. The common 
interpretation based primarily on studies of coliphage λ posits that host abundance, as sensed 
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by a low multiplicity of infection (MOI), favors lytic replication, while high MOI favors 
lysogeny (Herskowitz and Hagen 1980). A recent analysis of phage communities on coral 
reefs suggests more complex dynamics (Knowles et al. 2016). 
How many different viruses? 
Ever since the discovery of phages, it has been evident that there are different ones 
capable of killing different bacteria. However, one hundred years later we are still do not 
know the extent of this diversity, its biogeography, or its dynamic role in ecosystem function. 
While the diversity of all cellular life has been probed using universal genes such as the small 
subunit ribosomal RNA gene, the polyphyletic viruses have no gene in common, thus 
precluding a comprehensive PCR-based survey of viral diversity (F Rohwer and Edwards 
2002; Dwivedi et al. 2012). Therefore, other methods had to be devised.  
Two approaches based on data available in 2003 both yielded an estimated 100 million 
phage 'species' (F. Rohwer 2003). One conservatively assumed that 10 phage 'species' infect 
each of the estimated 10 million microbial species — thus 100 million different phages. This 
alone does not measure genetic diversity since two 'different' phages might differ in only one 
or two key proteins that determine host range. Similarly, the swapping of structural gene 
modules can yield a new 'species' that differs in virion morphology without any increase in 
the global genetic diversity, while two phages indistinguishable by morphology and host 
range can differ significantly in other genome modules. The second approach compared all 
the sequenced phage ORFs in GenBank at that time using BLAST and clustered the ORFs 
using a E-value of 10–4. From this data the non-parametric estimator Chao1 (Chao 1984) 
predicted that 2 × 109 phage ORFs remained to be discovered. Assuming 50 ORFs per phage 
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genome with 50% of those being novel, calculations based on the Chao1 value predicted 100 
million different phages.  
A decade later, armed with more metagenomic data and new analysis tools, Sullivan 
and colleagues presented an analysis based on protein clustering that reduced the estimated 
total number of phage ORFs from 2 × 109 to only 3.9 × 106 (Ignacio-Espinoza, Solonenko, 
and Sullivan 2013), a demotion of almost three orders of magnitude. The debate continues. 
Signature Genes 
Although there is no universal phage gene, diversity within phage groups can be 
assessed using signature genes shared by all group members (Adriaenssens and Cowan 2014). 
For instance, the capsid portal gene (g20) is conserved among many of the large 
cyanomyophages that inhabit marine and freshwater environments. Several studies using g20 
reported rich community diversity, typically 100 or more OTUs and including clades for 
which there are no cultured isolates (Zhong et al. 2002; Jameson et al. 2011). Attempts to 
correlate variations in community composition with depth, host abundance, season, and 
geographic distance yielded inconsistent results. Some OTUs demonstrated consistent 
seasonal variation while others persisted in moderate abundance from year to year (Chow and 
Fuhrman 2012). Sampling across a north-south Atlantic Ocean transect found similar 
cyanomyophages to be widely distributed with no apparent geographical segregation 
(Jameson et al. 2011), while others were present in both marine and freshwater environments 
(Dorigo, Jacquet, and Humbert 2004). However, some diversity within this group eluded 
these surveys; of 39 cyanophage isolates from the Gulf of Mexico, only 63% carried 
detectable g20 sequences (McDaniel, DelaRosa, and Paul 2006).  
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The entire T4 superfamily (Myoviridae) was similarly surveyed using their major 
capsid protein (MCP, gp23). In aquatic environments, these are primarily T4-like 
cyanomyophages. The results here echoed the same trends: diversity (more than 100 OTUs) 
exceeding that represented in cultured isolates (Comeau and Krisch 2008), seasonal 
succession patterns, and long-term persistence of some OTUs (Chow and Fuhrman 2012; 
Pagarete et al. 2013). In some cases persistent OTUs were also the most abundant (>4% 
relative abundance), thus contradicting predictions of both the Bank Model of viral 
community structure and the classic Kill-the-Winner dynamic (T. Thingstad and Lignell 
1997; Pagarete et al. 2013; M. Breitbart and Rohwer 2005).  
These analyses based on g20 and gp23 are limited to the myophages (predominantly 
cyanomyophages) and miss the podophages and the abundant siphophages. A more inclusive 
assessment of cyanophage diversity, including myophages and podophages, used psbA, the 
gene that encodes the D1 protein of oxygenic photosystem II (Chenard and Suttle 2008). 
Phage-encoded sequences clustered by both phage family and by host, separate from the host 
psbA genes, and included clusters with no cultured isolates. Multiple clusters coexisted in 
some locales while some clusters extended over vast geographic distances. Moreover, one 
cyanopodovirus subcluster was found to be globally distributed based on its DNA polymerase 
gene (pol) (Huang et al. 2010). 
Other signature genes can provide a more complete picture of marine phage diversity. 
For example, the phosphate-starvation gene phoH is present in nearly 40% of all marine 
phages compared to 4% of non-marine phages, reflecting the scarcity of phosphate in the 
marine environment (D.B. Goldsmith et al. 2011). It is not restricted to a single viral family 
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and is found in phages that infect heterotrophs as well as autotrophs, even in viruses of 
photosynthetic green algae. A phoH-based marine survey found, yet again, that most of the 
environmental diversity was not represented in cultured isolates, that phoH homologs are 
widely distributed with most clusters represented in multiple oceanic regions, and that marine 
phage community composition varies with depth and geographical location. A subsequent 
survey of the phoH genes in Sargasso Sea phage communities at depths of 0 to 1,000 m over a 
two-year period identified 3,619 OTUs (97% identical) and provided new insights into 
community dynamics (Dawn B Goldsmith et al. 2015). Approximately 96% of those OTUs 
were rare, each accounting for <0.01% of the total sequences, while more than 50% of the 
sequences were from five abundant OTUs. The presence of a few abundant OTUs (1-4 in any 
particular sample) and many rare ones is consistent with the Bank Model of phage community 
structure. However, whereas that model predicts the cycling of phages between the two 
groups over time, here the rare OTUs remained rare, and the most abundant OTUs persisted 
through seasons and years. 
To date, signature genes have been developed for only some viral families. They are 
strikingly lacking for the Siphoviridae, the family that includes many temperate phages and 
that dominates both metagenomic datasets and cultured isolates. In even the best cases, 
signature genes fail to capture the full richness present in natural communities. However, they 
have provided insights into the global distribution of specific phage genes. The DNA 
polymerase conserved in the T7-like podophages and restricted to that group was found in 
multiple biomes (M. Breitbart, Miyake, and Rohwer 2004). Moreover, identical or nearly-
identical 533 bp segments were recovered from different biomes, indicating that phages, or at 
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least phage genes, have moved between biomes in recent evolutionary time. Similarly, >98% 
identical sequences from algal virus DNA polymerase genes were found from the northern 
Pacific Ocean to Antarctica (Short and Suttle 2005). These observations could represent either 
the movement of phages or of individual phage genes. That phages from freshwater, 
sediment, and soil are able to infect marine prokaryotic communities suggests that phages can 
move successfully between biomes (Sano et al. 2004). These, and similar observations, 
suggest that the global viral diversity may be less than previously estimated based on the 
diversity in individual biomes.  
Phage Metagenomics 
Expansion of the field of view from signature genes to assessment of phage 
community diversity was made possible by the development of viral metagenomics. Earlier 
sequencing methods that required cloning of phage DNA had often encountered issues. Many 
phages carry genes that are lethal to the cloning host cells, or their DNA contains modified 
bases that block cloning. An alternative method, linker-amplified shotgun sequencing, was 
first used to assess near-shore marine communities (M Breitbart et al. 2002). Sample 
preparation included passage through a 0.16 μm tangential flow filter, purification of VLPs by 
CsCl gradient centrifugation, and subsequent DNA extraction. This procedure did not recover 
large viruses (e.g., algal Phycodnaviruses) or RNA phages. This initial marine survey found 
that more than 65% of the phage sequences were novel. Four years later, viromes prepared 
using next generation sequencing from four oceanic regions contained >90% unknowns 
(Angly et al. 2006). Even 15 or more years later, despite the increased number of sequenced 
viral genomes in the public databases, 60-99% of the sequences in viromes from diverse 
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biomes are still unknowns (Mokili, Rohwer, and Dutilh 2012; Brum and Sullivan 2015; 
Adriaenssens et al. 2015; Watkins et al. 2015; Roux et al. 2016). More than 99% of viral 
genetic diversity remains to be explored (Mokili, Rohwer, and Dutilh 2012).  
Even though most sequences recovered are unknowns, bioinformatics methods can 
provide insights into community structure. Metagenomic reads are assembled into contigs in 
silico. The more diverse the community, the lower the probability of sequencing two 
overlapping fragments from the same genome, thus shorter contigs and more unassembled 
singleton reads. Plots of contig spectra (number of contigs versus contig length) were best 
represented by power-law based mathematical models and provided estimates of both the 
richness and evenness of the sampled community (M Breitbart et al. 2002). Application of 
this approach to near-shore marine communities estimated 374 – 7,114 genotypes present. Of 
these, the most abundant one represented only 2 – 3% of the total community, while only 
three contributed more than 1% of the reads. Subsequent metagenomic surveys of diverse 
environments reported genotypes numbering in the hundreds to tens of thousands [reviewed 
in (Youle, Haynes, and Rohwer 2012); data in (M. Breitbart et al. 2003; Angly et al. 2006; 
Tseng et al. 2013; Bolduc et al. 2015; Youle, Haynes, and Rohwer 2012)]. 
Virome Meta-analysis 
We have developed a new bioinformatics method, FRAP (Fragment Recruitment, 
Assembly, Purification) (Figure 1.2, Supplemental Methods) and used it to assess global 
phage diversity by analyzing 1,623 publicly available viromes (Supplemental Table 3 in 
Cobian et al. 2016). To create a reference library of the observed phage genotypes on Earth, 
all reads from each of the viromes were assembled separately using SPAdes with the K value 
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adjusted to maximize the incorporation of base pairs into contigs (Bankevich et al. 2012). 
Comparative evaluations of assembler performance on metagenomic datasets had ranked 
SPAdes among the best based on contig accuracy (García-López, Vázquez-Castellanos, and 
Moya 2015). We assumed that each ≥ 1kbp contig represented a partial phage genotype that 
was relatively abundant in that biome. Rarely more than one non-overlapping contig might 
have been recovered from the same genotype. All of these ≥1 kbp contigs were added to the 
reference library. In addition, the 2,669 sequenced phage genomes (December 2015) and 67 
archaeal virus genomes (February 2016) in the NCBI Viral Genomes database were added to 
the library, along with an additional 123 bacteriophage genomes from the Broad Institute 
Marine Phage Sequencing Project. Subsequent dereplication by CD-HIT (Li and Godzik 
2006) at 98% identity yielded 2,267,978 phage contigs plus genomes.  
Given this reference library, the fragment recruitment step could then retrieve the 
matching reads from any virome. In principle this FRAP method could be used to retrieve and 
thus purify sequences that are only minor components of any dataset. For our analysis all 
reads from all viromes were mapped to the reference library at 90%. 95%, and 99% identity, 
and the normalized number of hits to each contig was tallied for each biome (Table 1.2, 
Supplemental Methods). This yielded the fractional abundance in each biome of every contig 
that is also present in the reference library (Figure 1.3 b–g). Parallel mapping was performed 
on a pooled global virome prepared by proportionate subsampling of the individual biome 
files (Figure 1.3 a). Of these pooled reads, 87% were from sediment and 10% were from soil. 
The ten most abundant viral contigs in each case occupied the same rank for all three mapping 
identities, evidencing the robustness of the method.  
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Figure 1.2 Bioinformatics pipeline for the FRAP (fragment recruitment, assembly, 
purification) method (see Supplemental Methods). 
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Table 1.2 Virome metrics. 1For the Tara Oceans Virome data set, only 1% of the reads were 
used. Including all would increase the number of reads from the marine biome to 
1,688,798,702. 
Biome 
Number 
of 
viromes 
Number of 
reads 
Percentage 
of reads 
assembled 
into ≥1 kbp 
contigs 
Percentage of reads mapped 
to reference library 
90% 
identity 
95% 
identity 
99% 
identity 
Marine 192 56,676,5171 11.83 38.1 29.4 20.4 
Freshwater 48 11,519,523 19.51 15.7 11.4 8.1 
Other aquatic 19 3,342,537 14.04 40.2 35.8 27.3 
Sediments 21 15,729,082 10.00 54.7 51.7 44.2 
Soil 9 2,459,152 15.54 41.9 36.6 29.0 
Human-
associated 1158 481,172,486 25.16 30.3 27.2 12.4 
Other host-
associated 167 34,600,192 
3.81 34.6 31.1 25.3 
Other 7 396,889  28.22 44.3 36.8 17.4 
Total 1621 605,896,378 16.01 31.8 28.1 14.7 
Mapping at 99% identity provided the most conservative estimate of the number of 
identified viral contigs and was used to calculate the number of viral genotypes potentially 
encoded for each biome (Figure 1.3). Here we summed the lengths of all observed phage 
contigs and divided by the assumed average phage genome size of 50 kbp. The most viral 
genotypes were observed in the marine and human-associated biomes, the least in soil. This 
reflects the size of the datasets: 192, 1158, and 7 viromes for marine, human-associated, and 
soil, respectively. This meta-analysis demonstrated that even when using all the information 
currently available for DNA-containing phages, we detect only 1,160 viral genotypes in the 
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pooled global virome, likely due to the low number of viromes from soil and sediment 
biomes.  
The rank abundance plots for each biome are best described by a power law model 
(Supplemental Table 5 in Cobian et al. 2016). Using this model, we calculated the predicted 
richness of each biome (Supplemental Methods). This approach predicted only 24,795 viral 
genotypes for the marine biome, which is not realistic (Supplemental Table 5 in Cobian et al. 
2016). We conclude that we have insufficient information about the shape of the curve to 
calculate the actual viral richness of each biome. Further work is needed before we even know 
how much we still do not know, i.e., how far we are from understanding the viral dark matter 
of the biosphere.  
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Figure 1.3 Viral rank abundance curves for (a) marine, (b) sediment, (c) freshwater, (d ) soil, 
(e) other aquatic, and ( f ) human-associated biomes. Reads in these six major biomes were
mapped to the genotypes present in the reference library at 90%, 95%, and 99% identity. In
each case, the relative abundance of all recovered viral genotypes is shown as well as the
observed coding capacity expressed as the potential number of different 50-kbp phage
genomes and the predicted viral genotypes using both the curve fit and tail fit methods.
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How many different phages on Earth? 
Providing a direct answer to this question remains challenging, in part because we do 
not know whether phages are provincial or cosmopolitan. If a biome is sampled in two 
geographic locations, A and B, and the number of phage genotypes present in each is 
estimated, is the richness of the phage community in that biome equal to A + B, or is it 
significantly less? Likewise, if the number of phage genotypes in each biome is known, are 
we justified in summing them to calculate the global virome? Other studies have addressed 
this by assessing the fraction of genotypes shared between biomes or geographical regions. A 
three-pronged analysis of viromes from four oceanic regions (the Pacific off the coast of 
British Columbia, Arctic Ocean, Gulf of Mexico, and Sargasso Sea) found that a large 
fraction of the phage community is cosmopolitan, that is they are found in two, three, or even 
four of the surveyed regions (Angly et al. 2006). Within this global distribution, the phage 
communities showed regionalization in that community members, including the cosmopolitan 
and the most abundant, shifted in relative abundance from region to region. Assembly of 
reads from each region separately yielded a total of ~150,000 genotypes, whereas co-
assembly reduced the total to only 57,600 different genotypes. Similarly, a recent study of 
hypersaline ponds on three continents found that community composition varied with the 
level of salinity but that communities in the same salinity are genetically connected across the 
globe (Roux et al. 2016). Conversely, phage communities present in three soil biomes shared 
essentially no genotypes (Fierer et al. 2007).  
The cosmopolitan range of individual phage genes or gene modules is another factor 
that complicates determination of the ecological or geographical range of phage genotypes. 
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Studies described earlier that found nearly identical sequences of signature genes to be 
globally distributed indicated a global phage gene pool, at least within the marine biome. 
However, even within that biome, this does not distinguish between the global travels of 
phage genes by horizontal gene transfer and the presence of the same phage genotypes in 
geographically remote locations.  
Here we used the number of phage encoding capacity observed in our meta-analysis to 
estimate the number of possible phage genotypes on Earth (Supplemental Methods). In brief, 
we used the sum of lengths of all the phage contigs as a proxy for all phage DNA currently 
available in the databases, and then divided by the assumed 50 kbp average phage genome 
length (Supplemental Table 5 in Cobian et al. 2016). On this basis we estimate that the 
observed phage DNA is sufficient to encode 257, 698 different phages.  
This estimate is undoubtedly low. The sequenced samples so far represent only a 
minute fraction of the total phage-encoded information present in every biome. For example, 
including all 2.16 × 109 reads from the massive Tara Oceans Viromes dataset (average read 
length of ~101 bp) would provide 2 × 108 kbp of marine phage genomic sequence. To put this 
in perspective, 1.29 × 1030 marine VLPs with an average genome of 50 kbp would contain 6.5 
× 1031 kbp of DNA. 
Which are the most abundant phage genes? 
To explore this, we annotated the 10 most abundant contigs in each biome and in the 
pooled global virome (Supplemental Table 4 in Cobian et al. 2016). The majority of them 
have no significant similarity to sequences in the NCBI database. For the soil biome, none of 
the 10 have similarities to known sequences. A podovirus polymerase is the most abundant 
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contig in the marine biome followed by several uncultured virus clones and unknown 
sequences. For the freshwater biome, nonstructural viral genes were detected among the most 
abundant ones, as well as others with no similarities to known sequences. Similarly, for the 
global virome the most abundant contigs have no significant hits in the databases, followed by 
contigs annotated as circovirus, a circular virus, and a cryptic MLU1 plasmid from 
Micrococcus.  
Caveats: Our reference database was clustered at 98% identity. The 2 most abundant viral 
contigs in the marine biome were podovirus polymerase genes that share >98% identity 
among themselves. Methodological improvements allowing clustering at 100% identity 
sequences would eliminate this issue.  
Further, all of our results are unavoidably skewed due to the biased distribution of the 
current viromes. Of the 1,623 viromes, 71% were from human-associated communities, 10% 
from communities associated with other animals or plants, and 11% from marine 
environments (Table 1.2). Thus 92% of the viromes explored 3% of the VLPs on Earth, while 
only 1.8% investigated the two biomes with 97% of the VLPs — soil and sediment (Table 
1.1). Some biomes remain virtually unsampled. Even in the marine biome, only a very limited 
geographic territory and range of environmental parameters have been sampled. Despite the 
surging interest in the human microbiome, published counts for human-associated prokaryotic 
cells and VLPs are strikingly lacking.  
The publicly available viromes are further compromised by poor methods. Of those 
viromes, 132 (7.5%) were omitted from our library because they were mislabeled microbial 
metagenomes or showed obvious contamination with human or microbial sequences. Some 
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contained abundant φX174 sequences due to either the amplification bias of multiple 
displacement amplification (K.-H. Kim and Bae 2011; Duhaime and Sullivan 2012) or, when 
sequencing on the Illumina platform, the failure to remove the PhiX quality control sequences 
prior to submission to the public databases. In the sediment biome, the highly abundant 
fragments from Staphylococcus aureus plasmids could be from phages or GTAs, or from 
bacterial contaminants of viromes due to inadequate viral purification during sample 
preparation. Many sources of error can be avoided and more quantitative data obtained by 
carefully adhering to current best practices (Duhaime and Sullivan 2012; Duhaime et al. 2012; 
K.-H. Kim and Bae 2011). Still needed is the comparable development of methods for RNA 
viruses and ssDNA phages, as well as VLP purification procedures that do not exclude the 
largest viruses.  
The future for FRAP 
Given a high-quality reference library, FRAP can be used to get rid of the crap, i.e., to 
fish out matching sequences from a metagenomic dataset, even when they comprise only a 
small percentage of the reads. This can potentially eliminate some sample purification steps or 
enable you to selectively retrieve different components from a mixed sample. However, 
FRAP's utility depends on the completeness and quality of the reference library. Library 
development, in turn, calls for clean sample preparation methods, sequencing of more bp, and 
longer read lengths (such as the 10 to 15 bp lengths now possible with PacBio SMRT℗ 
sequencing). 
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Recent advances in phage ecology have heightened our awareness that we live in a phage 
world. Much of that world remains a terra incognita. For the careful researcher equipped with 
today's technology, the opportunities for discovery are vast.  
Summary Points 
1. Phages are the winners: the most numerous and genetically diverse life forms on
Earth. The estimated 4.80 × 1031 VLPs on Earth comprise at least 257,698 different phage 
genotypes. 
2. We have barely begun to explore phage diversity. Metagenomic studies have
focused on a few biomes and have ignored soil and sediment—the two that combined contain 
97% of the global phage population. Sampling has been sparse at best, while numerous 
environments remain terra incognita.  
3. Global phage diversity far exceeds that represented by cultured isolates.
4. One cannot fully understand the ecology or evolution of any ecosystem without
including the phages. 
5. Our current knowledge of the fractional abundances of phages on each biome is
limited and we need better strategies to describe the population structure of the phages on 
each biome. 
Future Issues 
1. Metagenomic sampling has been narrowly focused on selected regions of the
marine environment and on host-associated communities, primarily human-associated. Most 
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of the globe and most biomes await exploration. Initial surveys of the human-associated 
phage community uncovered anomalous dynamics that await resolution. 
2. Viruses that have chromosomes of RNA or single-stranded DNA are significant
components of some communities, but have been generally ignored. Correcting this requires 
new inclusive methods for both their direct VLP counts and their metagenomics. 
3. Some phages and some phage genes are cosmopolitan, while others appear to be
geographically or ecologically restricted. The question remains: do all phages share the same 
global gene pool, with varying levels of access? 
4. Genomic analysis of both phages and their hosts indicates that lysogeny is
commonplace. Awaiting further exploration are the prevalence of temperate phages in various 
environments, the lysis-lysogeny decision, and the impact of lysogeny on the ecology and 
evolution of both phages and their hosts. 
5. Phages are the greatest reservoir of unexplored genetic diversity on Earth. Current
estimates of the number of different proteins encoded by phages vary widely. After more than 
a decade of phage metagenomics, the majority of phage sequences remain novel. Sequencing 
technology has advanced rapidly, and now enhanced bioinformatics methods are essential to 
analyze the mushrooming metagenomic data.  
6. Assignment of function to phage-encoded proteins based on sequence homology is
limited by the rapid rate of phage evolution. Other approaches are called for in order to 
translate environmental metagenomic data into the metabolic potential of phage communities. 
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7. The species concept is not directly applicable to viruses. An alternative, generally-
accepted metric is needed to facilitate discussion of viral diversity, ecology, and evolution.  
8. In the current era of the microbiome, researchers are actively investigating the roles 
of microbes in processes including human health, ecosystem functioning, and global 
biogeochemical cycles. Now, a century after the discovery of phage, exploration of the role of 
phage in these and other activities is overdue.  
Definition of terms 
Virome: a viral metagenome  
OTU: operational taxonomic unit 
Phage: a virus that infects a prokaryote (Bacteria and Archaea) 
Microbe: a prokaryote, i.e., an archaeon or a bacterium 
PFU: plaque-forming unit 
Virion: the intercellular transport form of a virus, typically comprising the chromosome(s) 
enclosed within a protein capsid  
VLP: virus-like particle 
VMR: the virus-to-microbe ratio 
EFM: epifluorescence microscopy 
fg: 10–15 g 
Pg: 1015 g 
Prophage: a phage chromosome that resides within a host cell (lysogen) without immediately 
engaging in lytic replication 
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Cyanophage: a phage that infects cyanobacteria 
Myophage: a member of the family Myoviridae 
Podophage: a member of the family Podoviridae 
Siphophage: a member of the family Siphoviridae 
DOP: dissolved organic phosphorus 
DON: dissolved organic nitrogen 
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Appendix for Chapter 1 
Supplemental methods 
Global VLP calculation 
A total of 6,154 VMR measurements were collected from 53 research papers 
(Supplemental Table 2 in Cobian et al. 2016). When specific VMR values were not provided 
in the manuscript, the VMRs were extracted from the published plots using Web Plot 
Digitizer (Rohatgi). Each VMR value was assigned to one of 7 major biomes (marine, 
freshwater, other aquatic, sediments, soil, human-associated, and other host-associated) and 
both the mean and median VMRs were calculated for each biome. Boxplots for each biome 
VMR were generated using R (R Core Team 2013). Sources for the number of prokaryotic 
cells are noted on Figure 1. For each biome, the number of VLPs was estimated by 
multiplying the number of prokaryotic cells by the calculated median VMR. The global VMR 
was calculated by summing the VLPs for all 7 biomes and then dividing by the sum of the 
number of prokaryotic cells.  
Virome collection 
Virome FASTA sequences were obtained from MGRAST (Meyer et al. 2008), 
MetaVir (Roux et al. 2011), iVIRUS (Bolduc et al.), SRA (SRA), and ENA (ENA). Since 
there is overlap between these databases, virome duplicates were removed by manual 
curation. Only viromes accompanied by a peer-reviewed paper were included. For the large 
Tara Ocean Viromes dataset, one sequencing run per site was selected, of which a 1% 
subsample without replacement was used for analysis. FASTA sequences from MGRAST 
were downloaded after quality filtering using MGRAST API (Wilke et al. 2015); those from 
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SRA and ENA were quality filtered with PRINSEQ (Schmieder and Edwards 2011) (99% 
quality); raw FASTA files were used from MetaVir and iVIRUS. Six viromes (metavir_2726, 
metavir_2727, MGRAST: 4519681, 4519682, 4519683, 4519684) had been spiked with PhiX 
control DNA; those introduced sequences were eliminated from the FASTA files using in-
house scripts (SMALT mapping at 95% identity to the φX174 genome; Genbank accession 
J02482.1). When viromes had been sequenced as paired-end, only one read was used for 
subsequent analysis. Of the 1,622 viromes collected, 1,615 were assigned to one of the 7 
major biomes (marine, freshwater, other aquatic, sediments, soil, human-associated, and other 
host-associated). The remaining 7 viromes were classified as 'other' (fermented food and air 
viromes). The available metadata and major biome classification for each virome are provided 
in Supplemental Table 3. 
Reference library creation 
Each virome was assembled de novo using SPAdes (Bankevich et al. 2012) and all 
contigs ≥1000 nt from all viromes were  merged into a single file for further analysis. A 
prokaryotic virus reference database was created from 2,699 bacteriophage genomes and 67 
archaeal virus genomes from the NCBI RefSeq database (January 2016) (RefSeq), plus an 
additional 123 bacteriophage genomes from the Broad Institute Marine Phage Sequencing 
Project (Broad Institute). The virome contig file and the prokaryotic virus reference database 
were merged into a single file and clustered using CD-HIT-EST (Fu et al. 2012) at 98% 
identity. BLASTn (e-value cutoff of 0.001) was used to identify cloning vectors (UNIVEC) 
and rRNA (SILVA) sequences (using SSU Ref NR and LSURef_123_10_07_15). Removal of 
these sequences left a reference library containing 2,258,219 phage (sensu lato) contigs.  
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Size of the global virome 
All assembled contigs <1000 nt were merged into a single file and clustered at 98% 
identity using CD-HIT-EST to generate the small_contigs_98 database.  The lengths of every 
sequence in this database, and in the reference library were obtained and summed to yield the 
size of the global virome in nucleotides (1.29 × 1010). This total was divided by 50 kbp, the 
assumed average phage genome size, to yield the number of viral genotypes on Earth.   
Virome mapping to the reference library 
All viromes were mapped individually to the reference library using SMALT 
(SMALT) in 3 separate runs using 99%, 95%, and 90% alignment identity cutoff values. The 
mapping at 99% alignment identity was used when calculating both observed and predicted 
viral genotypes.  
In addition, a separate global analysis was performed by first creating a pool of all 
virome FASTA sequences for each of the 5 biomes with the most VLPs. A pooled global 
virome (1,000,000 reads) was then generated by subsampling with replacement from each 
biome pool, with the percentage contributed by each biome being the percentage of global 
VLPs present in that biome (i.e., 26,857 marine reads, 37 freshwater, 1,525 other aquatic, 
870,833 sediments, and 101,667 soil). This pooled global virome was mapped to the reference 
library as above.  
Fractional abundances of viral genotypes 
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Mapping as described above yielded the number of hits to each genotype in the 
reference library for each virome. The fractional abundance (f) of each viral genotype in each 
virome was then calculated as:  
Equation 1.1 Fractional abundance of viral genotypes 
𝑓(𝑖) ≅
𝑟(𝑖)
𝑇(𝑗)
∗
𝐿(𝑚𝑒𝑎𝑛)
𝐿(𝑖)
where 
f (i): the fractional abundance of contig i in this virome 
r (i): the number of reads that map to contig i 
T (j): the total number of reads in virome j 
L (mean): the mean genome length (bp), assumed to be 50,000 bp (Steward, Montiel, and 
Azam 2000) 
L (i): the length (bp) of contig i 
Then the fractional abundance of contig i in a biome was calculated as: 
Equation 1.2 Fractional abundance of contigs 
𝑓(𝑖𝑏𝑖𝑜𝑚𝑒) ≅
𝑓(𝑖)
𝑁
where 
f (ibiome): the fractional abundance of contig i in the biome 
N: number of viromes in biome 
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Parallel calculations were made to calculate the fractional abundance of contig i in the global 
virome sample. Rank abundance plots for each biome and the global virome sample were 
generated using R. 
Annotation  
The 10 viral genotypes with the greatest fractional abundance in each biome and in the 
pooled global virome were annotated through online NCBI BLASTn against the nr/nt 
database. 
Observed viral genotypes  
For each biome and the pooled global virome, the sum of the lengths of every contig 
with a fractional abundance at 99% identity > 0 was divided by 50,000 (the assumed average 
phage genome length) to estimate the number of observed viral genotypes. 
Predicted viral genotypes 
Curve fitting was performed for the 99% identity rank abundance plots for each biome 
using the Matlab Curve Fitting ToolboxTM R2015b (Mathworks, Inc.). Several curve fit 
models were evaluated when applied to the first 100, 1,000, and 10,000 fractional abundance 
ranks for each sample (Supplemental Table 5 in Cobian et al. 2016). The power law model 
gave the best fit and was therefore used to calculate the predicted number of viral genotypes 
for each biome. Estimated a and b for each curve were used to calculate the number of VLPs 
on each rank of the curve as follow: 
Equation 1.3 Estimated a and b for rank abundance curves 
𝑉𝑖 = 𝑎𝑖
𝑏 × 𝑉𝑡𝑜𝑡𝑎𝑙
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where 𝑉𝑖 is the number of VLPs on rank i, and 𝑉𝑡𝑜𝑡𝑎𝑙 is the total number of VLPs in the 
biome (from Table 1.1). The values for 𝑉𝑖 were summed until the following condition was 
met: 
Equation 1.4 Number of viral genotypes prediction 
𝑉𝑡𝑜𝑡𝑎𝑙 = ∑ 𝑎𝑖
𝑏  ×  𝑉𝑡𝑜𝑡𝑎𝑙
𝑥
𝑖=1
. 
At that point, the sum was considered to be the predicted number of viral genotypes. For the 
soil virome, the curve was asymptotic, and x was not calculated.  
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Chapter 2: Fragment Recruitment Assembly Purification (FRAP): Put bioinformatics 
back into the hands of biologists. 
Abstract 
A strict or exact match strategy for the analysis of metagenomes is presented as 
Fragment Recruitment Assembly Purification. This strategy reduces the problem of 
metagenomic assignments to text matching using strict or exact hits from a dataset to a 
database. Such databases are constructed by the user and tailored to adrress specific biological 
questions. With the increasing number of available genomes, and the high number of reads 
generated by current sequencing technologies, unreliable assignments can be eliminated from 
the analysis. Reliable assignments can be identified by using only strict and exact matches, 
such strategy limits the occurrence of false positives. Here the implementation of Fragment 
Recruitment Assembly Purification is presented as well as a set of auxiliary tools that allow 
the user to quickly build heatmaps, coverage plots, and fragment recruitment plots; and then 
use these data to make biological inferences. The performance of the presented algorithm was 
tested in aquatic, and host associated metagenomes. Fragment Recruitment Assembly 
Purification was used for the exploration of The Global Virome (Chapter 1) and in the 
analysis of Cystic Fibrosis metagenomes and viromes (Chapter 4).   
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Introduction 
Current bioinformatics 
Current bioinformatic methods have become a convoluted land for biologists. In 
metagenomic studies, once next generation sequencing (NGS) data (Singer et al. 2016) is 
generated, there are a myriad of options (Fonseca et al. 2012; Naccache et al. 2014; 
Huttenhower 2019; Huson et al. 2016) and opinions (Greninger 2018) about the best way to 
analyze (Sczyrba et al. 2017; 2019, n.d.; McIntyre et al. 2017) such data.  
Bioinformatic metodologies to compare a dataset (i.e. a metagenome) to a database 
(i.e. viral reference genomes) rely heavily on statistics in calculating the probability that a 
DNA fragment originated from a given organism (reference genome). Variability in the 
results of metagenomic analyses using different methods and pipelines is embedded in several 
steps such as: 1) the scoring systems used for each application (i.e. BLAST family algorithms 
developed by Altschul et al. 1990), 2) the construction of k-mer profiles with different 
databases, k-mer sizes and inference methods (i.e. KAIJU(Menzel, Ng, and Krogh 2016) and 
FOCUS2 (Silva, Dutilh, and Edwards 2016)), and 3) the use of different sets of marker genes 
for taxonomical inferences (i. e. MetaPhlan2, MetaVir (Roux et al. 2011)). Such variability in 
the search methods can result in distinct biological interpretations when comparing the 
analysis of the same dataset through different software or platforms.  
To overcome these issues, Fragment Recruitment Assembly Purification (FRAP) was 
developped, as a simple and reproducible method to compare a dataset to a database through 
strict or   exact hits. FRAP assign strict (96% identity over 100% of the read) or exact hits 
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(100% identity over 100% of the read) in the dataset to a custom database specific to the 
biological problem at hand.  
Why use FRAP? 
FRAP aims to be a simple approach to bioinformatics with a fast learning curve. Exact 
hits are reliable and reproducible, which is defined as 100% of the read matching to the 
database with 100% identity. As the probability of having a specific 100 nucleotides sequence 
by chance is 1/4100, it is hard to argue that an exact hit is not a true positive. The exact hits 
approach is possible because the amount of sequences in the databases and in the datasets is 
large enough so that non perfect matches can be ignored or used for separate analysis. 
Databases and datasets size will continue to increase(Stephens et al. 2015), so much so that 
eventually we will have the Earth’s metagenome.  As the databases become bigger, the more 
FRAP will become relevant. 
The FRAP approach has an adaptable design in which datasets and databases are any 
collection of sequences in fasta format. This makes the strategy directed towards answering 
biological questions and researchers can easily construct databases relevant to their questions. 
FRAP reduces metagenomic assignments to text strings comparisons which have been 
implemented in several operating systems (such as Unix) as low level functions. This allows 
FRAP to be a “never break” pipeline which should be stable across platforms and versions. 
String matching algorithms have at worst lineal time complexity(Pandiselvam, Marimuthu, 
and Lawrance 2014). Regardless of the method used to obtain exact hits, FRAP results should 
always be the same.  
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How to use FRAP? 
Databases and datasets are nucleotide fasta files. Datasets are usually short DNA 
fragments (reads) from metagenomes, metatrascriptomes or viromes. Databases are usually a 
set of genomes of interest such as bacteria representative genomes, archaea reference 
sequences, and viral reference sequences; or a set of genes of interest such as bacteria 
metabolic genes (i.e. the SEED (Overbeek et al. 2014) database), virulence factors (Sayers et 
al. 2019; Chen et al. 2016), or antibiotic resistance genes (Jia et al. 2017). These are popular 
examples, but a dataset and a database can be any collection of sequences in a fasta file 
format.  
Several exact hit implementations were explored in this study, such as the use of 
mapping algorithms with adjusted parameters to obtain exact hits such as smalt (“SMALT 
Manual” 2010) and HISAT (Kim, Langmead, and Salzberg 2015); the implementation of a 
search via a hash table, called hash exact hit (heh), and the use of the Unix command grep.  
FRAP has two main applications: basic FRAP and blind FRAP. Basic FRAP 
compares a set of reads to a set of known reference genomes or genes. Examples include 
comparing aquarium metagenomes to bacteria and archaea representative genomes and 
comparing lung metagenomes to virulence factors genes and antibiotic resistance genes. In 
basic FRAP the reported fractional abundances are interpreted as taxonomical or functional 
assignments. Basic FRAP  can also be used to filter out or retrieve reads present in a database 
of interest, for example to filter out the human genome reads present in a lung metagenome 
and keep the remaining reads for further analysis, or to retrieve the viral reads in a lung 
metagenome and assemble all of them together to discover viral like contigs.  
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Furthermore, basic FRAP aids in the detection of contamination in samples or in 
databases. For example, a marine bacteria was detected in a lung metagenome. Upon closer 
inspection, all the detected reads map to a single short region of the marine bacteria genome, 
in this case the sample was contaminated with a marine bacteria PCR product. Contamination 
in the databases can be detected, for example a human biopsy sample had exact hits to a 
bacteria and all hits were in a very short region, further exploration led to the identification of 
a human genome region in the assembly of the bacteria in the reference database.  
Blind FRAP compares a dataset to itself via contigs or reads. In blind FRAP the 
database has no identified function or taxa and the databases are usually contigs assembled 
from the dataset or contigs assembled from another dataset. One example of blind FRAP is 
presented in Chapter 1, where contigs assembled from viromes were used as a database and 
reads from the same viromes were used as datasets. The resulting fractional abundances for 
each contig represent the abundance of viral-like elements that have no functional or 
taxonomical annotation yet. A second example of blind FRAP is obtaining viromes and 
metagenomes from the same sample and using the contigs from a virome as database and the 
reads from metagenomes as datasets, in this case the fractional abundances of virome derived 
contigs is interpreted as the presence of viral-like elements in metagenomes.  
Challenges in the development of FRAP 
FRAP needs further development to become portable and fast. ideally FRAP should be 
easy to use, not requiring the use of the terminal and where dataset and database files can be 
dragged and dropped into the analysis window.  
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Computational challenges in the development of FRAP are: 1) The development of 
efficient search algorithms (So 2017) for text search which is currently limited by database 
size, and 2) Determine the amount of computational power needed for large scale analysis, for 
example, how much computing power do we need to use the Earth’s metagenome?  
Biological challenges in the development of FRAP rely on the compilation of reliable 
databases that are vetted for reproducible results. 
Results and Discussion 
FRAP was used in several projects. FRAP generalized pipeline (Figure 2.1) inputs are 
a single fasta file containing a database and one or multiple fasta files containing the reads in 
a dataset or datasets. The implemented methods to obtain exact hits are smalt at 100% 
identity, HISAT at 100% identity, hash exact hit, and grep. FRAP outputs are a tab delimited 
file containing the fractional abundances of each element in the database in each dataset, a tab 
delimited file containing the number of hits to each element in the database in each dataset 
and fragment recruitment plots for the 10 database elements with the highest fractional 
abundances. In addition, frap-tools can be used to obtain a fasta file containing the reads that 
have hits to the database (si_hits.pl) or a fasta file containing the reads that have no hits to the 
database (no_hits.pl). FRAP can be accessed through the GitHub repository 
https://github.com/yinacobian/frap  
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Figure 2.1 Fragment Recruitment Assembly Purification general case. 
Basic FRAP 
The simplest implementation of FRAP is the “just map FRAP” approach (Figure 2.2-
A). FRAP normalization to obtain fractional abundances from exact hits (Figure 2.2-B) is 
based on the principle that datasets have different sizes and the length of each element in the 
database is different. The fractional abundance of each element in the database (f(i)) is 
calculated by dividing the number of hits to an element in the database (r(i)) by the total 
number of sequences in the dataset (T(j)), next this term is multiplied by the mean length of 
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the elements in the dataset (L(mean)) divided by the length of the database element (L(i)). 
Fractional abundances are then scaled by a factor of 1,000,000.  
Figure 2.2 FRAP basic concept and normalization. A) FRAP implementation as “Just map 
FRAP” which is implemented in the script jmf.pl B) FRAP normalization to fractional 
abundances 
L(mean) values represent the average genome length. When the database is composed 
of complete genomes, the L(mean) value can be pre-determined and used for the calculations. 
Microbial average genome length was calculated from publicly available complete genomes 
included in RefSeq-release80 (Table 2.1). Based on this set of genomes, virus average 
genome length is 29,936 bp, bacteria average genome length is 4,028,000 bp and archaea 
average genome length is 2,730,000 bp. For fungi and protozoa, the average genome length 
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was calculated using locus length, which can be the complete genome, or a chromosome 
(Table 2.2). Subsequent calculations are needed to get accurate average genome lengths for 
this organisms. L(mean) values represent the average gene length when the database is 
composed of genes. The average gene length for virus, bacteria, archaea, fungi and protozoa 
was calculated (Table 2.3). The average gene length for virus is 741 bp, for bacteria 899 bp, 
for archaea 855 bp, for fungi 1,660 bp and for protozoa 1,798 bp.  
Table 2.1 Average genome length for FRAP normalization. RefSeq-release80 published on 
January 9, 2017. Genomes/ASSEMBLY_REPORTS/ published on March 6, 2017. Virus: 
obtained from all viral genomes available at refseq. Bacteria: obtained from assembly reports, 
the average genome length per taxid group was used as input, 67,706 genomes are distributed 
in 964 taxid groups. Archaea: obtained from assembly reports, the average genome length per 
taxid group was used as input, 192 genomes are distributed in 11 taxid groups. Information 
not available for fungi and protozoa, everything is together in an eukaryotes genome size file. 
GENOME LENGTH 
N minimum  1st quartile median mean 3rd quartile maximum 
Virus 8,321 200 2,737 7,233 29,936 38,124 2,473,870 
Bacteria 67,706 162,600 2,425,000 3,912,000 4,028,000 5,193,000 11,930,000 
Archaea 192 174,700 2,150,000 2,486,000 2,730,000 3,046,000 4,568,000 
54 
Table 2.2 Average locus length for FRAP normalization. Locus length for L-mean in FRAP 
normalization. RefSeq-release80 published on January 9, 2017. A LOCUS is a refseq entry, in 
the case of viruses one locus is one genome, for the rest of the groups a locus can be either a 
compelte genome, a plasmid, a contig or any refseq entry. 
LOCUS LENGTH 
N minimum 
1st 
quartile median mean 
3rd 
quartile maximum 
Virus 8,321 200 2,737 7,233 29,936 38,124 2,473,870 
Bacteria 8,067,030 16 886 4,656 36,891 25,351 14,782,125 
Archaea 20,952 4 2,851 11,354 30,810 32,179 4,064,496 
Fungi 74,670 86 664 2,226 89,939 14,047 11,880,248 
Protozoa 247,163 22 922 1,158 14,559 2,514 13,391,543 
Table 2.3 Average gene length for FRAP normalization. 1min represent the start site of 
regulatory regions in the database, therefore it does not represent an accurate minimum gene 
length. 
GENE LENGTH 
N min1 
1st 
quartile median mean 
3rd 
quartile maximum 
Virus 308,153 1 260 443 747 860 262,387 
Bacteria 291,916,012 1 437 773 899 1,179 110,417 
Archaea 1,638,741 1 419 731 855 1,124 32,447 
Fungi 2,195,385 3 857 1,394 1,660 2,100 186,159 
Protozoa 976,901 3 649 1,221 1,798 2,168 131,440 
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FRAP-tools are a set of auxiliary scripts to visualize and generate fasta files from 
jmf.pl outputs. Heatmaps are generated from fractional abundances (Figure 2.3). Fragment 
recruitment plots (Figure 2.4) are generated for the 10 elements in the database with the 
highest fractional abundances. In the case of complete genomes as a database, the confidence 
of the identification of a bacteria genome in the dataset is assessed by the distribution of 
fragments across most of the genome.  
A basic FRAP approach was used in a set of metagenomes from an aquarium water 
column microbial community establishment process, in which 47 samples were obtained over 
a 6 months period. The databases used were bacteria representative genomes (Figure 2.3-A) 
and archaea representative genomes (Figure 2.3-B). The dominant bacteria during the 
microbial community establishment was Phaeobacter galleciensis, whose hits are distributed 
across the whole genome (Figure 2.4) which provides evidence of the presence of the 
organism in the system. Results from this study will be further discussed and published by 
Calhoun S. et. al.  
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Figure 2.3 Heatmap of the 100 most abundant bacteria in the aquarium metagenomes. FRAP 
at 96% identity. A) Heatmap of the most abundant bacteria found in the aquarium 
metagenomes. B) Heatmap of the most abundant archaea in the aquarium metagenomes. 
Propionibacterium acnes was manually removed from the analysis since it is not a marine 
bacteria and is a possible contamination. 
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Figure 2.4 Fragment recruitment plot of Phaeobacter gallaciensis, the most abundant bacteria 
in the aquarium metagenomes. 
A basic FRAP approach was used in the analysis of CF associated microbial 
metagenomes obtained from sputum samples of acute exacerbations. These results are 
discussed in detail in Chapter 4 of this dissertation. Human DNA in the sputum metagenomes 
was removed using FRAP and FRAP-tools, in which the remaining sequences were compared 
to a set of bacteria reference genomes. In a sample from patient CF418, the microbial 
community was dominated by Achromobacter xylosoxidans, which is the closest reference 
genome and evidence for its presence in the clinical sample is supported by hits across the 
genome. In Chapter 4 of this dissertation a detailed analysis of the genome deletions supports 
the hypothesis that the genome deletions are phage regions which may be excising from the 
genome. In clinical metagenomic studies is essential to use exact hits with curated reference 
databases so clinicians receive complete information that they can trust for trearment 
consideration.  
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Visual inspection of fragment recruitment plots allows the identification of 
contaminants in the dataset or in the databases. In a sputum metagenome from patient CF01, 
sample contamination was detected when for three bacteria genomes hits in a 1,500 nt region 
were identified (Figure 2.5). Such bacteria were Delftia acidovorans, Bordetella petrii, and 
Marinomonas aquamarina and the identified regions are the result of amplicons amplification 
of such regions. Contamination in an assembled reference bacteria genome present in the 
bacteria representative genomes database was identified when a metatranscriptome from a 
human lung biopsy had hits to a small region of Microbacterium barkeri (Figure 2.6), in this 
case the region in the bacteria reference genome had a human origin, which implies it was 
contaminated during the sequencing and assembly process. It is important to identify and flag 
this reference genomes to avoid further misassignments.  
The reproducibility of FRAP was assessed using replicates of subsamples with 
replacement from a human plasma metagenome spiked with 104 copies of human 
immunodeficiency virus (Naccache et al. 2014). Five subsamples with replacement were 
compared to viral refseq (Supplemental Table 4.1), overall the fractional abundances of 
viruses in each replicates have low variability. The mean standard deviation from all datasets 
was 0.0109, which means the replicates show reproducibility.  
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Figure 2.5 Contamination detection in CF samples. The most abundant bacteria found in 
CF01 were Delftia acidovorans, Bordetella petrii and Marinomonas aquimarina. In these 3 
bacteria, all the hits mapped in one isolated position, supporting the idea of a sample 
contamination. 
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Figure 2.6 Genome contamination detection. Recruitment plot of the most abundant bacteria 
(Microbacterium barkeri) in a cancer biopsy sample. All the 2,295,340 reads map in the same 
position. 
Blind FRAP 
The second family of FRAP uses is the blind FRAP strategy. Its basic principle is the 
use of a database that does not have taxonomical or functional assignments to obtain 
fractional abundances for each contig in the datasets. The database are contigs assembled 
either from the dataset or an extended dataset. Functional assignments are obtained for the 
contigs with highest fractional abundances though distant evolutionary relationships 
assignments such as tBLASTx.  
A blind FRAP strategy was used in the global virome calculations presented in 
Chapter 1 of this dissertation. In that study a global virome database was constructed using 
available public viromes from several biomes. Datasets were viromes in each biome, the 
result was the fractional abundances of contigs per biome. The contigs with highest fractional 
abundance on each biome were annotated using tBLASTx, those contigs represent new 
diversity which has not yet been described.  
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A second blind FRAP strategy is proposed for the study of pairs of metagenomes and 
viromes from the same sample (Figure 2.7). The rationale behind this strategy is to estimate 
the fractional abundances of viral-derived elements in metagenomes, which otherwise would 
be missed since they are unrepresented viruses that are not yet in reference databases. 
Viromes to metagenomes FRAP was used in a test dataset of coral and algae interactions 
(Figure 2.8). The samples are punches from a coral-algae interaction transect in which 
samples A and B are coral punches, sample C is the interaction zone between coral and algae 
and samples D and E are algae tissue. Metagenomes were obtained from all samples and 
viromes were obtained from samples A, B and C. Hits to viral like elements derived from 
coral punches were identified in all the coral derived samples and in the interaction zone, in 
algae samples, two contigs had hits to the coral-derived viral elements. This data will be 
explored in further detail and published by Little M. et. al.   
A blind FRAP strategy in which reads and contigs originated from the same sample 
are compared to each other is proposed. In this case fractional abundance of contigs can be 
obtained from the samples themselves. This strategy was applied to two cheese rinds viromes. 
Viromes from Winnimere cheese and Bailey cheese rinds were obtained and contigs were 
assembled and used as a database, the reads were used as dataset. The percentage of exact hit 
reads to the contigs database was 77.5 % for Winnimere and 63.8% for Bailey (Table 2.4). 
From these estimates we can calculate false negatives as the number of fragments that don’t 
recruit to the assembly, which is 23% for Winnimere and 36% for Bailey. An assessment of 
how accurate the exact hit search algorithm is to compare reads to reads. In the case of cheese 
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rind viromes, the search strategies are good, with 99.8% reads recruited back to reads for 
Winnimere and 99.98% for Bailey (Table 2.5).     
Figure 2.7 Generalized FRAP pipeline to map metagenomes to viral assembled contigs. 
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Figure 2.8 FRAP metagenomes to viromes in coral-algae interactions. Samples 2A and 2B are 
coral punches, sample 2C is a punch of the coral-algae interaction zone, samples 2D and 2E 
are algae punches. Viromes were obtained for samples 2A, 2B and 2C. Metagenomes were 
obtained for all samples. Contigs fractional abundances were visualized in Anvi’o (Eren et al. 
2015). 
64 
Table 2.4 Exact hit, using smalt at 100% identity. Dataset: polished reads, q-phred>30 (99.9% 
base call accuracy), no low complexity (Shannon entropy 0.5) single end. Database: all 
assembled contigs (spades --only-assembler) from single end. 
Exact hit reads to contigs 
Winnimere 
cheese virome 
Bailey cheese 
virome 
number of reads 3,256,476 1,714,998 
number of nucleotides 497,990,024 262,232,327 
number of contigs 30,484 23,315 
number of nucleotides in contigs 26,541,438 13,239,529 
number of reads that map to contigs 2,523,962 1,095,563 
number of contigs with no reads mapped back 533 1,253 
percentage of reads that map back to contigs 77.51 63.88 
percentage of contigs with no reads 1.75 5.37 
Table 2.5 Exact hit, using smalt at 100% identity. Dataset: polished reads, q-phred>30 (99.9% 
base call accuracy), no low complexity (Shannon entropy 0.5) single end. Database: polished 
reads, q-phred>30 (99.9% base call accuracy), no low complexity (Shannon entropy 0.5) 
single end. 
Exact hit reads to reads 
Winnimere 
cheese virome 
Bailey cheese 
virome 
# reads 3,256,476 1,714,998 
# reads that map to reads 3,249,940 1,714,714 
% reads map back to reads 99.80 99.98 
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The future of FRAP 
A third family of FRAP uses is proposed, in which two or more sample groups are 
compared using blind FRAP, then the fractional abundances are used as input for machine 
learning algorithms such as random forests and a group of contigs that better differentiate 
among samples is identified. This strategy needs further exploration.  
FRAP aims to enable easy, robust and meaningful bioinformatics to accelerate 
biological discoveries. To get to this point, FRAP needs to be adapted as an easy to use 
platform and optimization of exact hits search are needed to be able to use large databases and 
datasets and obtain results in a short time.  
Biological insights from FRAP 
Inferences about biological mechanisms are enabled through FRAP analysis, 
ecological and evolutional processes can be elucidated using FRAP. For example, the co-
occurrence of changes across contigs shows an ecological relation among such contigs. 
Contigs that increase by the same amount are part of an ecological unit that co-varies. Also, 
the co-occurrence of changes at specific sites shows an evolutionary relation between such 
sites, viral quasispecies(Lauring and Andino 2010) can be identified in this way.  
Methods 
File types 
The input for FRAP are nucleotide fasta files.  Datasets are usually fasta files 
containing multiple reads (DNA fragments between 35 and 1000 nucleotides originated from 
an NGS instrument), several datasets can be used at the same time as long as each sample is in 
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a single fasta file and have a unique identifier. Databases are usually fasta files containing 
several reference genomes or genes. Databases or Datasets can also be contigs.  
FRAP outputs are tab delimited files, each column is a dataset and each row is an 
element of the database. Both files are provided as outputs in the basic version of FRAP, just 
map frap (jmp.pl). Such files are the hits file which contains the number of exact hits to each 
element of the database (hits.tab) and the normalized file (normalized.tab) which contains the 
FRAP values to each element of the database.   
Two graphical outputs are generated using frap-tools. The first one is a generic 
heatmap of the FRAP values. The second are fragment recruitment plots in which the x axis is 
the element in the database and the y axis is the identity of each hit.   
A fasta output with the reads that have exact hits to the database can be generated 
using the script si_hit.pl, a fasta file containing the reads that do not have exact hits to the 
database can be generated using the script no_hit.pl.  
FRAP implementations 
FRAP implementations using existing mapper algorithms are FRAP-smalt and FRAP-
HISAT, both can be used through the perl script jmf.pl. The arguments of jmf.pl are the 
complete path to the database fasta file, the path to the folder containing the datasets, the path 
to the results folder that would be created, the mapper to use, and the average L(mean) to use.  
FRAP-smalt is a FRAP implementation that uses the mapper smalt (“SMALT 
Manual” 2010) to find exact hits between dataset and database. To use smalt, the database is 
indexed using a k-mer of 10 (-k 10) with a step size of 5 (-s 5), next the dataset is mapped to 
67 
the database using an identity filter of 100% (y=1), the selected output format is samsoft (-o 
samsoft). From the samsoft file, the exact hits are counted, and tab delimited files generated. 
FRAP-HISAT is a FRAP implementation that uses the mapper HISAT (Kim, 
Langmead, and Salzberg 2015) to find exact hits between dataset and database. HISAT uses 
scores to evaluate if a read map to the database. To obtain a score equivalent to 100% identity 
over 100% of the read, the scores were back calculated to identity the corresponding identity 
to score (Figure 2,9). In a read of length 100, a score of 0 represents 75% identity, a score of 
120 represents 90% identity, a score of 160 represents 95% identity, a score of 200 represents 
100% identity. A score of 200 is used in FRAP.   
FRAP was implemented in Perl using a hash strategy, this implementation is called 
hash exact hit (heh). FRAP-heh is available in the repository 
https://github.com/yinacobian/frap-heh, to construct the index a k-mer size is selected, viral 
refseq index was contructed using 50, 100 and 200 k-mers, index construction is made using 
the program heh-db2.pl. The database in then indexed in a hash that is used to compare the 
dataset to, which is implemented in the program heh-compa.pl. Further development is 
needed to make FRAP-heh efficient.  
FRAP was implemented using the command grep. FRAP-grep is available in the 
repository  https://github.com/yinacobian/FRAP-grep, the database is converted to a single 
line, then each read is compared to the database. This approach in portable since grep is a 
broadly used command available in many operating systems. In an Ubuntu operating system 
with 156 Gb of RAM, each read took 0.5 seconds to be searched against viral refseq (7,194 
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genomes and 218Mb), which is very slow. FRAP-grep needs further development to be more 
efficient.  
Figure 2.9 Relation between HISAT2 score and identity for reads of length 100nt. HISAT2 
(Kim, Langmead, and Salzberg 2015) scores are calculated as following: score = ((number of 
mismatches * (match weight=2)) + (length – number of mismatches))*(mismatch weight=-6). 
In a read of length 100, a score of 0 represents 75% identity, a score of 120 represents 90% 
identity, a score of 160 represents 95% identity, a score of 200 represents 100% identity. 
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FRAP-tools 
Graphic outputs from FRAP are obtained using frap-tools, which uses R and python. 
The script Plot_Heatmap.R creates a heatmap from FRAP values, this is a generic heatmap 
that can be further customized by the user. The script fragplot2.py creates individual fragment 
recruitment plots. The program si_hit.pl is used to generate a fasta file containing the reads 
that map the dataset, the program no_hit.pl is used to generate a fasta file containing the reads 
that do not map to the database.  
Reference databases 
Three main databases were used in the presented FRAP examples: bacteria 
representative genomes, archaea refseq, and viral refseq. Bacteria representative genomes 
contains 5,460 complete genomes which include at least one genome from each branch of the 
bacteria phylogenetic tree as calculated by NCBI(O’Leary et al. 2016). Archaea refseq 
contains 192 complete genomes. Viral refseq contains 8,321 complete genomes. All databases 
are part of RefSeq-release80 and were accessed on 01/09/2017.  
Denovo assemblies 
Denovo assemblies were performed using SPAdes (Bankevich et al. 2012) with the 
parameter –only-assembler. For some of the test cases, only contigs >900 nucleotides were 
used as database.  
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Appendix for Chapter 2 
Supplemental tables 
Supplemental Table 2.1. FRAP vs viral refseq of plasma metagenome spiked with 
HIV. Five subsample replicates. spikeHIV-mg-SRR1106548-2. 
id name R1 R2 R3 R4 R5 Mean SD 
gi|9628705|ref|NC_001710.1| GB virus 
C/Hepatitis G virus, 
complete genome 
899.54 899.54 899.54 899.54 899.54 899.54 0.0000 
gi|9629357|ref|NC_001802.1| Human 
immunodeficiency 
virus 1, complete 
genome 
324.90 324.90 324.90 324.90 324.90 324.90 0.0000 
gi|56718463|ref|NC_003287.2| Enterobacteria 
phage M13, 
complete genome 
17.59 17.70 17.59 17.33 17.73 17.59 0.1420 
gi|295413923|ref|NC_014075.1| Torque teno virus 
12, complete 
genome 
13.68 13.68 13.68 13.68 13.68 13.68 0.0000 
gi|9627425|ref|NC_001604.1| Enterobacteria 
phage T7, 
complete genome 
7.96 7.96 7.96 7.96 7.96 7.96 0.0000 
gi|339832375|ref|NC_015783.1| Torque teno virus, 
complete genome 
6.36 6.36 6.36 6.36 6.36 6.36 0.0000 
gi|29502191|ref|NC_002076.2| Torque teno virus 
1, complete 
genome 
5.72 5.72 5.72 5.72 5.72 5.72 0.0000 
gi|730977588|ref|NC_025824.1| Enterobacteria 
phage fd strain 
478, complete 
genome 
5.13 5.01 5.13 5.39 4.99 5.13 0.1420 
gi|295413965|ref|NC_014082.1| Torque teno mini 
virus 7, complete 
genome 
4.29 4.29 4.39 4.34 4.34 4.33 0.0382 
gi|9634957|ref|NC_002195.1| Torque teno mini 
virus 9, complete 
genome 
3.93 3.93 3.83 3.88 3.88 3.89 0.0387 
gi|9626243|ref|NC_001416.1| Enterobacteria 
phage lambda, 
complete genome 
3.13 3.09 3.13 3.13 3.13 3.12 0.0166 
gi|295413834|ref|NC_014073.1| Torque teno virus 
28, complete 
genome 
1.83 1.83 1.83 1.83 1.83 1.83 0.0000 
gi|295413918|ref|NC_014074.1| Torque teno virus 
27, complete 
genome 
1.74 1.74 1.74 1.78 1.74 1.75 0.0162 
gi|295413958|ref|NC_014081.1| Torque teno virus 
3, complete 
genome 
1.77 1.77 1.77 1.77 1.77 1.77 0.0000 
gi|295413928|ref|NC_014076.1| Torque teno virus 
10, complete 
genome 
1.56 1.56 1.56 1.56 1.56 1.56 0.0000 
gi|295441877|ref|NC_014089.1| Torque teno mini 
virus 5, complete 
genome 
1.56 1.56 1.56 1.56 1.56 1.56 0.0000 
gi|418487627|ref|NC_019445.1| Escherichia phage 
TL-2011b, 
complete genome 
1.27 1.27 1.27 1.27 1.27 1.27 0.0000 
gi|295441896|ref|NC_014094.1| Torque teno virus 
6, complete 
genome 
0.85 0.85 0.85 0.85 0.85 0.85 0.0000 
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Supplemental Table 2.1. FRAP vs viral refseq of plasma metagenome spiked with HIV. 
Five subsample replicates. spikeHIV-mg-SRR1106548-2. (Continued) 
id name R1 R2 R3 R4 R5 Mean SD 
gi|727071839|ref|NC_025726.1| Torque teno mini 
virus ALA22, 
complete genome 
0.72 0.72 0.72 0.72 0.72 0.72 0.0000 
gi|295441905|ref|NC_014096.1| Torque teno virus 
15, complete 
genome 
0.48 0.48 0.48 0.48 0.48 0.48 0.0000 
gi|209427726|ref|NC_011356.1| Enterobacteria 
phage YYZ-2008, 
complete prophage 
genome 
0.68 0.68 0.68 0.68 0.68 0.68 0.0000 
gi|46401626|ref|NC_005856.1| Enterobacteria 
phage P1, 
complete genome 
0.59 0.63 0.64 0.62 0.60 0.62 0.0179 
gi|557307526|ref|NC_022749.1| Shigella phage 
SfIV, complete 
genome 
0.70 0.66 0.66 0.68 0.71 0.68 0.0197 
gi|744692686|ref|NC_026013.1| Microviridae IME-
16, complete 
sequence 
0.71 0.71 0.71 0.71 0.71 0.71 0.0000 
gi|971482474|ref|NC_028748.1| Bacillus phage 
BMBtpLA, 
complete genome 
0.46 0.42 0.40 0.42 0.44 0.43 0.0206 
gi|374531645|ref|NC_016765.1| Pseudomonas 
phage 
vB_PaeS_PMG1, 
complete genome 
0.28 0.28 0.28 0.28 0.28 0.28 0.0025 
gi|124300942|ref|NC_008376.2| Geobacillus phage 
GBSV1, complete 
genome 
0.26 0.26 0.26 0.26 0.26 0.26 0.0000 
gi|221328618|ref|NC_011976.1| Salmonella phage 
epsilon34, 
complete genome 
0.32 0.32 0.32 0.32 0.32 0.32 0.0000 
gi|849250250|ref|NC_027339.1| Enterobacteria 
phage SfI, 
complete genome 
0.18 0.16 0.15 0.16 0.15 0.16 0.0109 
gi|82700933|ref|NC_007623.1| Pseudomonas 
phage EL, 
complete genome 
0.16 0.16 0.16 0.16 0.16 0.16 0.0000 
gi|295441884|ref|NC_014091.1| Torque teno virus 
16, complete 
genome 
0.16 0.16 0.16 0.16 0.16 0.16 0.0000 
gi|209447126|ref|NC_011357.1| Stx2-converting 
phage 1717, 
complete prophage 
genome 
0.15 0.15 0.15 0.15 0.15 0.15 0.0000 
gi|937456792|ref|NC_027991.1| Staphylococcus 
phage SA1, 
complete genome 
0.16 0.16 0.16 0.16 0.16 0.16 0.0000 
gi|939482395|ref|NC_002484.2| Bacteriophage D3, 
complete genome 
0.13 0.13 0.14 0.14 0.14 0.14 0.0024 
gi|428782011|ref|NC_019711.1| Enterobacteria 
phage HK629, 
complete genome 
0.14 0.13 0.15 0.13 0.15 0.14 0.0096 
gi|428782787|ref|NC_019723.1| Enterobacteria 
phage HK630, 
complete genome 
0.12 0.19 0.16 0.17 0.16 0.16 0.0220 
gi|29134936|ref|NC_004629.1| Pseudomonas 
phage phiKZ, 
complete genome 
0.11 0.11 0.11 0.11 0.11 0.11 0.0000 
75 
Supplemental Table 2.1. FRAP vs viral refseq of plasma metagenome spiked with HIV. 
Five subsample replicates. spikeHIV-mg-SRR1106548-2. (Continued) 
id name R1 R2 R3 R4 R5 Mean SD 
gi|428783345|ref|NC_019769.1| Enterobacteria 
phage HK542, 
complete genome 
0.04 0.03 0.03 0.03 0.04 0.04 0.0045 
gi|428783215|ref|NC_019767.1| Enterobacteria 
phage HK544, 
complete genome 
0.04 0.06 0.03 0.02 0.01 0.03 0.0169 
gi|428782316|ref|NC_019716.1| Enterobacteria 
phage mEp460, 
complete genome 
0.07 0.07 0.07 0.07 0.07 0.07 0.0000 
gi|966201269|ref|NC_028694.1| Propionibacterium 
phage PA1-14, 
complete genome 
0.03 0.04 0.05 0.05 0.07 0.05 0.0117 
gi|408905847|ref|NC_018852.1| Propionibacterium 
phage P100D, 
complete genome 
0.06 0.05 0.06 0.06 0.04 0.05 0.0088 
gi|543171632|ref|NC_022342.1| Propionibacterium 
phage 
PHL111M01, 
complete genome 
0.05 0.05 0.05 0.05 0.05 0.05 0.0021 
gi|330858351|ref|NC_015453.1| Propionibacterium 
phage PAS50 
endogenous virus, 
complete genome 
0.02 0.05 0.04 0.05 0.07 0.04 0.0185 
gi|849254459|ref|NC_027373.1| Propionibacterium 
phage PHL030N00, 
complete genome 
0.06 0.04 0.06 0.04 0.02 0.04 0.0150 
gi|408905837|ref|NC_018842.1| Propionibacterium 
phage P1.1, 
complete genome 
0.08 0.06 0.04 0.05 0.05 0.06 0.0128 
gi|682123269|ref|NC_024787.1| Listeria phage 
LMTA-148, 
complete genome 
0.02 0.02 0.02 0.02 0.02 0.02 0.0000 
gi|238801880|ref|NC_012753.1| Streptococcus 
phage 5093, 
complete genome 
0.02 0.02 0.02 0.02 0.02 0.02 0.0000 
gi|89152530|ref|NC_007805.1| Pseudomonas 
phage F10, 
complete genome 
0.03 0.03 0.03 0.03 0.03 0.03 0.0000 
gi|431809676|ref|NC_019914.1| Staphylococcus 
phage StB27, 
complete genome 
0.00 0.00 0.00 0.00 0.00 0.00 0.0000 
gi|849251120|ref|NC_027346.1| Propionibacterium 
phage 
PHL171M01, 
complete genome 
0.00 0.00 0.01 0.01 0.01 0.00 0.0038 
gi|543171262|ref|NC_022334.1| Propionibacterium 
phage PHL112N00, 
complete genome 
0.00 0.01 0.00 0.00 0.01 0.00 0.0025 
gi|906475910|ref|NC_027624.1| Propionibacterium 
phage SKKY, 
complete genome 
0.01 0.00 0.01 0.00 0.00 0.00 0.0025 
gi|422933554|ref|NC_019491.1| Cyprinid 
herpesvirus 1 strain 
NG-J1, complete 
genome 
0.00 0.00 0.00 0.00 0.00 0.00 0.0002 
gi|363539767|ref|NC_016072.1| Megavirus 
chiliensis, complete 
genome 
0.00 0.00 0.00 0.00 0.00 0.00 0.0000 
Mean of 
all SD 
0.0109 
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Chapter 3 : Cystic Fibrosis Rapid Response: Translating Multi-omics Data into 
Clinically Relevant Information 
Abstract 
Pulmonary exacerbations are the leading cause of death in cystic fibrosis (CF). To 
track microbial dynamics during acute exacerbations, a CF Rapid Response (CFRR) strategy 
was developed. The CFRR relies on viromics, metagenomics, metatranscriptomics and 
metabolomics data to rapidly monitor active members of the viral and microbial community 
during acute CF exacerbations. To highlight CFRR, a case study of a CF patient is presented, 
in which an abrupt decline in lung function characterized a fatal exacerbation. The microbial 
community in the patient’s lungs was closely monitored through the multi-omics strategy, 
which led to the identification of pathogenic shigatoxigenic Escherichia coli (STEC) 
expressing shiga toxin. This case study illustrates the potential for CFRR to deconstruct 
complicated disease dynamics and provide clinicians with alternative treatments to improve 
the outcomes of pulmonary exacerbations and expand the lifespans of individuals with CF. 
Introduction 
Cystic fibrosis (CF) is a recessive genetic disease in which defects or deficits in the 
cystic fibrosis transmembrane conductance regulator (CFTR) protein result in disease 
phenotypes of the pancreas, sweat glands and reproductive, respiratory and digestive systems 
(Knowles and Drumm, 2012).  In the lungs of individuals with CF, mucociliary clearance is 
impaired, which promotes chronic polymicrobial infections (Laguna et al., 2016). Antibiotic 
treatments and proper disease management have extended the average lifespan of CF patients; 
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nevertheless, these polymicrobial lung infections are still the primary cause of morbidity and 
mortality (Alexander et al., 2016). Common bacteria that colonize CF lungs over the long-
term include Pseudomonas aeruginosa, Staphylococcus aureus, Haemophilus influenzae, 
Burkholderia cepacia complex, Rothia mucilaginosa and Streptococcus spp. (Surette 2014; 
LiPuma 2010; Lim et al. 2013; Whiteson et al. 2014), but every CF individual presents a 
unique microbial community that changes over time (Lim et al., 2014a; Whelan et al., 2017; 
Zhao et al., 2012). This highlights the need to characterize the microbial communities in each 
CF individual. 
Microbial community dynamics in CF lungs follow the Climax Attack Model (CAM) 
(Conrad et al., 2013; Quinn et al., 2014), in which a climax community is acclimated to the 
host and dominates during stable periods, and a transient attack community is associated with 
exacerbations. Attack communities are virulent and colonize the CF lungs either from an 
external source or are already present in the CF lungs and become active during 
exacerbations. In the CAM, attack communities lead to Cystic Fibrosis Pulmonary 
Exacerbations (CFPE), declines in lung function, and eventually death. Preventing CFPE 
relies on quickly identifying attack viral and microbial communities and the genes they carry 
and express, such as those encoding specific toxins (Gallant et al., 2015), to efficiently tailor 
antimicrobial therapies.  
Herein we propose Cystic Fibrosis Rapid Response (CFRR), a strategy for 
determining microbial dynamics during CFPE. This strategy is a personalized multi-omics 
approach that uses viromes (Willner et al., 2012), metagenomes, metatranscriptomes (Lim et 
al., 2013b), and metabolomes (Quinn et al., 2016a; Whiteson et al., 2014) from longitudinal 
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samples to monitor the whole microbial community, particularly its active members and their 
metabolic products. Using CFRR to obtain personalized taxonomic and functional profiles of 
the lung microbial communities would provide clinicians with comprehensive information 
about each patient’s viral and microbial ecosystem. This information allows clinicians to 
generate testable hypotheses, test those hypotheses using standard clinical tests, and propose 
specific clinical interventions (e.g., precisely targeted antibiotic therapy) to improve CFPE 
outcomes.  
The ability to generate multi-omic datasets and analyze large amounts of data in a 
clinically relevant time frame (i.e., ≤ 48 hours) makes the CFRR approach applicable in CF 
clinical practice, especially in clinics closely related to research institutions. It requires access 
to a sequencing instrument, mass spectrometer, computational resources and specialized 
personnel in each one of these areas. In an optimal situation, the time between sample 
collection and data interpretation is 30 hours for metabolomes (Quinn et al. 2016), 38 hours 
for metagenomes and metatranscriptomes, and 48 hours for viromes. These times are 
expected to shorten as technologies improve. The rapid decrease in sequencing costs 
(National Human Genome Research Institute, 2018) and incorporation of sequencing cores 
within hospitals (Deurenberg et al., 2017) will increase CF patients accessibility to the CFRR 
in the foreseeable future.   
A case study is presented to demonstrate the potential of the CFRR strategy. A 37-
year-old male CF patient (CF01) was monitored over a two-year period with metagenomes, 
metatranscriptomes and metabolomes. Integrating the information from these sources led to 
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the identification of an attack community in which a strain of E. coli that likely produced 
shiga-toxin was detected during a fatal exacerbation. 
Results 
Patient CF01 fatal exacerbation expedited monitoring: metatranscriptomes and metabolomes 
An overall decline in lung function was observed in patient CF01 during his last year 
of life and four CFPEs were reported. In the last month of life 10% of predicted FEV1 was 
lost (Figure 3.1-A). During the last exacerbation, the patient was hospitalized at the intensive 
care unit (ICU) for seven days and then died. The fatal exacerbation was characterized by 
severe lung tissue damage (Figure 3.1- D, Supplemental Table 3.1A), an increase in white 
blood cell counts (Figure 3.1-B, Supplemental Table 3.1B) and a general decline in health. 
During the fatal exacerbation, clinical microbiology lab cultures from sputum samples tested 
positive for P. aeruginosa, Stenotrophomonas maltophilia, Aspergillus terreus and yeast 
(Figure 3.1-C, Supplemental Table 3.1C). Treatment alternated between the antibiotics 
aztreonam, azithromycin, in addition to a sulfonamide and a quinolone; at the ICU, colistin 
and meropenem were administered (Supplemental Table 3.1D) but no improvement was 
observed. 
The CFRR strategy was launched to rapidly identify the cause of the CFPE. Sputum 
samples were collected 7 and 8 days before death (samples D-7 and D-8). In samples D-7 and 
D-8 active members of the microbial community were determined using metatranscriptomics.
In sample D-8 small molecule profiles (using metabolomics) were characterized and a total 
DNA metagenome was sequenced.  
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Figure 3.1 Clinical data for the last 24 months of patient CF01’s life. (A) Percentage of 
predicted FEV1 of patient CF01 over the last 24 months of life. Solid dots are FEV1 
measurements. The line is included to highlight lung function dynamics and does not 
represent measurements. Seven exacerbation periods were reported and are shown in gray. 
(B) White blood cell (WBC) counts for the last month of life. (C) Clinical microbiology
positive cultures from patient CF01’s sputum samples over the last 24 months of life. Dots
represent days where cultures were positive for each microbe tested in the clinical
microbiology panel. Omics sampling points for metagenomes, metatranscriptomes, and
metabolomes are indicated by dots in the Omic panel. Performed X rays and WBC
measurement days are indicated with dots in the clinical care panel. (D) Patient CF01 chest X
rays in a frontal view with quantitative disease severity evaluation using Brasfield scores. D-
193, mild exacerbation; D-8, acute exacerbation, the time point where CFRR data were
obtained; D-1, 1 day before death. A lower Brasfield score represents a higher disease
severity. The Brasfield score scale is from 25 to 0, where 25 is lower disease severity and 0 is
higher disease severity. Parameters used for Brasfield scores calculations are air trapping,
linear markings, nodular cystic lesion, large lesions, and general severity, and individual
scores are shown in Supplemental Table 3.1A in the supplemental material.
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Metatranscriptomics data from sample D-8 showed that the most abundant microbial 
ribosomal RNAs (rRNA) belonged to the genera Bacillus (29.9%), Escherichia-Shigella 
(23.9%), Streptococcus (11.6%), Salmonella (6.9%) and Lactococcus (4.4%) among other 
genera (23.3%) (Supplemental Figure 3.1-A). The microbial messenger RNA (mRNA) 
composition was dominated by the genera Pseudomonas (97.1%), followed by 
Stenotrophomonas (1.9%) and Escherichia (0.07%) (Supplemental Figure 3.1-B). At species 
level resolution, the most abundant bacterial genomes (based on total RNA, Figure 3.2) were: 
Bacillus sp., E. coli (STEC), Salmonella enterica serovar Infantis, P. aeruginosa and S. 
maltophilia. Enterobacteria phage SP6, Pseudomonas phages and Stenotrophomonas phage 
S1 were also detected. Two members of the phylum Ascomycota were identified: Candida 
albicans and Aspergillus fumigatus. Metagenomics data of sample D-8 detected Pseudomonas 
(98.5%) as the dominant bacterial genus (Supplemental Figure 3.5-A). 
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Figure 3.2 The most abundant bacterial genera of fatal exacerbation sample D-8. The relative 
abundances of each genus as determined by rRNA, mRNA, and total RNA are shown. A 
reference genome from each genus was selected based on the number of reads recruited in the 
rRNA (Escherichia, Bacillus, and Salmonella) or mRNA (Pseudomonas and 
Stenotrophomonas) category. Fragment recruitment was visualized using Anvi’o, showing a 
logarithmic scale for mRNA and rRNA from 1 to 1,000. Anvi’o plots show reads mapped 
along the genome coordinates. Nonribosomal microbial reads were recruited against each 
reference genome using SMALT with an identity cutoff of 80% and are shown in brown 
along the external ring. rRNA reads were classified into each genus by BLASTn, were 
recruited against the corresponding reference genome using SMALT with an identity cutoff of 
60% and are shown in gray along the internal ring. 
 
The presence of Escherichia-Shigella in the lungs of a CF patient is unusual and thus a 
detailed analysis was performed to further resolve the taxonomy at strain level. Strain level 
analysis identified that E. coli present in CF01’s lungs was most closely related to the genome 
of E. coli (STEC) B2F1. This strain typically carries the shiga toxin 1 and shiga toxin 2 genes, 
both of which were identified in the metatranscriptomes (Figure 3.3-B, C).  Furthermore, the 
shiga toxin receptor, globotriaosylceramide (Gb3), was detected in the metabolome from 
sample D-8 (Figure 3.3-A). This suggests that shiga toxin, and its Gb3 target, were being 
produced in the lungs of CF01. Gb3 is produced in human cells by Gb3 synthase, which adds 
a sugar to a lactosylceramide molecule. Ceramide is produced by sphingomyelinase (SMase) 
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in the host cell or by the action of bacterial encoded SMase (Figure 3.5-B). The gene that 
encodes a P. aeruginosa secreted SMase, the hemolytic phospholipase C (PlcH) (Vasil et al., 
2009), was detected in the sample D-8 metatranscriptome (Supplemental Figure 3.2-B).  
Figure 3.3 Shiga toxin and its human receptor globotriaosylceramide (Gb3). (A) The masses 
of globotriaosylceramide and its precursors lactosylceramide and sphingomyelin from 
exacerbation sample D-8 and 14 historical nonexacerbation samples were determined by 
parent mass searching and validated by MS/MS matching. The fatal exacerbation sample is 
shown in gray. (B) STEC BRF1 was used as a reference genome for fragment recruitment to 
the Shiga-like toxin 2 subunit A protein sequence. The amino acid sequence position is shown 
on the x axis, and percent identity is shown on the y axis. The nucleotide sequences from 
patient CF01 metatranscriptome exacerbation sample D-8 were mapped to proteins using 
BLASTx with an E value cutoff of 0.001 and filtered by an identity of ⬎60%. (C) 
Metatranscriptome recruitment as explained above for panel B, except that in this case, reads 
were recruited to the Shiga-like toxin 2 subunit B amino acid sequence. 
In a longitudinal metabolomics dataset, Gb3 was highly abundant (p < 0.0001) in 
sample D-8 but was in low abundance in the prior samples (Figure 3.3-A). The Gb3 precursor 
lactosylceramide (18:1/16:0) (Sandvig et al., 2012) and its ceramide donor sphingomyelin 
(18:1/16:0) (Obrig et al., 2003) were abundant in all samples throughout the longitudinal 
dataset (Figure 3.3-A, Supplemental Table 3.2A). These data demonstrate that Gb3 precursors 
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were present for at least a year before the fatal exacerbation, but Gb3 was produced in 
significantly high quantities eight days before death (sample D-8).  
Gb3 levels positively correlate with shiga toxin levels (Boyd et al., 1993) although the 
mechanism behind this positive correlation is not clear. Gb3 is the only known functional 
receptor for shiga toxins (Aigal et al., 2015) and shiga toxins induce reorganization of lipids 
in the epithelial cell’s membrane. Shiga toxin B can bind up to 15 Gb3 molecules (Ling et al., 
1998) and this binding result in the aggregation of Gb3 in lipid rafts. The aggregation of Gb3 
in lipid rafts promotes a negative membrane curvature and internalization of shiga toxin (Betz 
et al., 2011). Spatial distribution of Gb3 in the cell membrane has a regulatory role in its 
presentation (Lingwood et al., 2010), thus higher recruitment of Gb3 in lipid rafts may induce 
the production of more Gb3.  
Antibiotic resistance genes were detected in the metatranscriptomes of D-8 and D-7 
samples. Transcripts encoding all the protein components were identified for two RND-type 
multidrug exporters, MexGH1-OpmD (Aendekerk et al., 2002) and MexA-MexB-OprM (Li et 
al., 1995) previously described in Pseudomonas, as well as the tetracycline efflux pump tet(C) 
previously described in Achromobacter. Transcripts encoding several beta-lactamases were 
identified, such as TEM-116, PDC-3, OXA-50 and BEL-3 (Jia et al., 2017), which are 
typically found in Pseudomonas, and CTX-M-21 (Saladin et al., 2002), which is usually 
found in Enterobacteriaceae. Transcripts encoding for enzymes that are involved in resistance 
to macrolides, aminoglycosides, lincosamide, diaminopyrimidine and glycopeptide antibiotics 
were detected; these enzymes were previously described in Pseudomonas, Achromobacter, 
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Escherichia, Streptomyces, Paenibacillus, Clostridium and Morganella (Supplemental Table 
3A).   
A partial P. aeruginosa genome sequence was recovered by assembling reads from the 
fatal exacerbation metatranscriptomes (D-8 and D-7) into contigs and then mapping those 
contigs to the P. aeruginosa PAO1 reference genome (Supplemental Figure 3.2-A). In the 
resulting P. aeruginosa CF01 contigs, 38 genes related to resistance to antibiotics and toxic 
compounds were identified (Supplemental Table 3.3B). Two prophages were also identified 
in the assembled P. aeruginosa CF01 contigs (D-8 and D-7); one was complete and the 
second one was a partial prophage (Supplemental Figure 3.2-C and 3.2-D).  
Bacterial small molecule profiles before and during fatal exacerbation.  
Longitudinal metabolomic data from CF01 historical samples and fatal exacerbation 
sample D-8 were compared to metabolic profiles from six pathogenic bacterial isolates 
previously detected in CF sputum (P. aeruginosa VVP172, Enterococcus sp. VVP100, E. coli 
VVP427, Streptococcus sp. VVP047, Stenotrophomonas sp. VVP327 and S. aureus 
VVP270). The goal was to identify metabolites produced by pathogenic bacteria and track 
how changes in their abundances might have preceded the fatal exacerbation. Metabolites 
from these pathogens were consistently detected throughout the longitudinal samples. In 
sample D-8 there was an increase (p < 0.001) in the number of metabolites that matched P. 
aeruginosa VVP172, E. coli VVP427, Streptococcus sp. VVP047 and S. aureus VVP270 
(Supplemental Figure 3.3, Supplemental Table 3.2B).  
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Active members of the microbial community during a stable period and the fatal 
exacerbation.  
Analysis of metatranscriptomes from a stable period 10 and 9 months before the fatal 
exacerbation event (samples D-303 and D-279) identified several differences between this 
stable period and the fatal exacerbation. First, Firmicutes was the most active phylum during 
the stable period whereas Proteobacteria was the most active during exacerbation (Figure 3.4-
A). Second, samples from the stable period showed an active microbial community that was 
more even and diverse than the community in exacerbation samples (Figure 3.4-D). Third, 
transcripts from Pseudomonas were detected at very low levels in stable samples (average 
relative abundance 3%), but at high levels (average relative abundance 37%) in exacerbation 
samples (Supplemental Figure 3.2-A). Fourth, the percentages of unclassified sequences were 
higher in the stable samples D-303 and D-279 (40.9% and 39.0%) than in the exacerbation 
samples D-8 and D-7 (27.6% and 17.0%). Fifth, a higher fractional abundance of 
bacteriophages was detected in the fatal exacerbation samples relative to the stable ones. 
Enterobacteria phage SP6, several Pseudomonas phages (Figure 3.4-B) and sarcoma viruses 
(Figure 3.4-C) were the dominant viruses in samples D-8 and D-7.  
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Figure 3.4 Actively transcribing members of the viral and bacterial communities in sputum 
samples of patient CF01. Metatranscriptomes from two exacerbations and two stable samples 
were obtained. (A) Bacterial taxonomical assignments were made using KAIJU at the genus 
level and are color-coded by phylum. (B) Fractional abundances of bacteriophages based on 
viral RefSeq mapping and FRAP normalization. (C) Fractional abundances of eukaryotic 
viruses based on viral RefSeq mapping and FRAP normalization. (D) Bacterial rank 
abundance plot generated using relative abundances at the genus level. Evenness was 
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calculated as H/In(S), where H is the Shannon diversity index and S is the total number of 
species. 
Microbial community dynamics during a non-fatal exacerbation. 
Two years before the fatal exacerbation, CF01’s lung function declined faster than in 
previous years (Supplemental Figure 3.4-A). The rate of lung function change in the last two 
years of life was -9.75 FEV1%/year (Supplemental Figure 3.4-C). The overall rate of lung 
function change during CF01 last 14 years of life was -1.39 FEV1%/year. During a two-year 
period of 4 and 3 years before death, the rate of lung function change was 1.30 FEV1%/year 
(Supplemental Figure 3.4-B).  
During the two-year period leading up to the fatal exacerbation, seven exacerbation 
events were reported, and sputum samples were periodically screened for fungi and bacteria at 
the clinical microbiology lab (Supplemental Table 3.1-C). P. aeruginosa was detected in all 
samples. Six months before the fatal exacerbation S. maltophilia was detected, and during the 
last two months of life, Enterobacter cloacae was detected. A. terreus was detected in two 
samples in the last six months of life. Yeast was detected in all screened samples, except for 
the final exacerbation samples. Based on this information, several antibiotics were prescribed 
to manage the exacerbations (Supplemental Table 3.1-D); these included monobactams, 
macrolides, quinolones, beta-lactams, sulfonamides and a cationic polypeptide.  
Two years before CF01’s death, metagenomics was used to monitor the microbial 
composition of the respiratory tract during an exacerbation event, the subsequent antibiotic 
treatment (samples D-724 to D-718), and a stable period that followed (samples D-409 and D-
286) (Supplemental Figure 3.5-A). The bacterial genera that best differentiated between
samples collected during antibiotic treatment (D-722 to D-718) and no antibiotic treatment 
89 
(D-724 and D-723) were Rothia, Campylobacter, Veilonella and Prevotella (Supplemental 
Figure 3.6). The antibiotics prescribed during this exacerbation were a fluoroquinolone 
(ciprofloxacin), and a tetracycline (doxycycline). Clinical microbiology lab tests performed 
on D-719 were positive for P. aeruginosa, Pseudomonas fluorescens, A. fumigatus and yeast 
(Supplemental Table 3.1C). Exacerbation and stable samples had Streptococcus phages, 
Staphylococcus phages and Pseudomonas phages, whereas only exacerbation samples had a 
shigatoxin-converting phage (Supplemental Figure 3.5-B), and stable samples had higher 
abundances of Herpesviruses (Supplemental Figure 3.5-D).  
Discussion 
CF01 fatal exacerbation mechanism 
The unusually fast decline of patient CF01 led to the implementation of the CFRR. 
During CF01 fatal exacerbation, E. coli mRNA, rRNA and metabolites were detected, which 
demonstrated not only the presence but also the activity of shigatoxigenic E. coli. The 
identification of a shigatoxinogenic E. coli is supported by ribosomal RNA (36,590 unique 
ribosomal RNA sequences in metatranscriptome D-8), messenger RNA (1,412 E. coli mRNA 
reads in metatranscriptome D-8, and 11 partial mRNA reads at 60% identity to STEC BRF1), 
and metabolites (10 matched metabolome spectra to E. coli in D-8). The presence of STEC in 
the lungs of a CF patient was alarming as this strain causes severe damage to the lung 
epithelium (Bergan et al., 2012; Uchida et al., 1999). Moreover, interactions between shiga 
toxin and the host epithelium were inferred from metabolomes. The molecule 
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globotriaosylceramide (Gb3), the receptor for shiga toxin, showed an increase of three orders 
of magnitude during the fatal exacerbation (sample D-8), compared to previous samples.  
Figure 3.5 Proposed model of lung dynamics resulting in patient CF01’s death. (A) A nonfatal 
exacerbation (days ⫺724 to ⫺718) was followed by a recovery of lung function, and attack 
and climax communities were diverse. (B) The fatal exacerbation was triggered by 
colonization by STEC, which is supported by the presence of its rRNA in the 
metatranscriptomes. This bacterium encodes Shiga toxin, which was likely taken into host 
cells by the human receptor globotriaosylceramide. (C) Later during the fatal exacerbation, 
Shiga toxin was internalized and then induced apoptosis, necrosis, and inflammation. P. 
aeruginosa was reestablished and came to dominate the community, as suggested by its 
abundant mRNA. 
Altogether, these multi-omics data support the following model of microbial dynamics 
that caused patient CF01’s death. At the beginning of the fatal exacerbation, STEC produced 
shiga toxin that remained inside the bacterial cells. Later in the exacerbation, STEC’s cell 
membranes were disrupted and the shiga toxin was released (Figure 3.5-B). This release may 
have been triggered by the action of the cationic polypeptide colistin (Gupta et al., 2009). 
Next, the toxin was taken up by lung epithelial cells through the host membrane receptor 
globotriaosylceramide (Gallegos et al., 2012) (Figure 3.5-C). Inside the lung epithelial cells 
(Uchida et al., 1999), shiga toxin inhibited host translation by blocking the ribosomes, thereby 
91 
inducing cell death, necrosis and an acute inflammatory response (Melton-Celsa, 2014; Obrig, 
2010; Uchida et al., 1999). The immune response and lung tissue damage was evident in the 
chest X-rays and the increase in white blood cells (Figure 3.1-D, D-8 and D-1). 
During the fatal exacerbation, STEC led the attack community that ultimately 
destabilized the climax community, a phenomenon previously reported in CF exacerbations 
(Conrad et al., 2013); this resulted in a decline of evenness (diversity index that quantifies 
how equal the community is (Pielou, 1979)) and diversity (the number of different species in 
a community (Shannon and Weaver, 1949)), a switch from a community dominated by 
Firmicutes to one dominated by Proteobacteria, and transcription of Enterobacteria and 
Pseudomonas bacteriophages and sarcoma viruses. This event was followed by a 
Pseudomonas and Stenotrophomonas bloom, characterized by active transcription, as both 
rRNA and mRNA were detected, as well as an increase in their metabolites. Pseudomonas 
was the most active member of the microbial community with an mRNA abundance of 97%, 
followed by 1.92% of Stenotrophomonas mRNA. Bacillus was either lysed or dormant as 
only rRNA was detected.  A feature that may have contributed to the success of Pseudomonas 
was its resistance to multiple antibiotics, as detected by the transcription of over 38 antibiotic 
resistance genes. This scenario is congruent with the one described by the clinical laboratory, 
as positive cultures for Pseudomonas and Stenotrophomonas were reported during the fatal 
exacerbation.   
Additional dynamics such as bacteriophage induction may have happened during the 
fatal exacerbation, as active transcription was detected from Enterobacteria phage SP6 and 
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Pseudomonas bacteriophages. Bacteriophage induction is known to play a role in the control 
of bacterial populations in CF lungs (James et al., 2015). 
CFRR for polymicrobial infections management, the importance of historical samples and a 
fast sample to results strategy.  
The CFRR emerged from the need to investigate the cause of acute exacerbations. The 
power of the CFRR is shown in the information obtained for CF01 case study. The CFRR is 
ideal for medical centers closely associated with research facilities where the equipment is 
available. However, as technologies improve and become more accessible, CFRR could be 
implemented within the clinic.  
A key component of the CFRR strategy is the comparison between acute exacerbation 
and stable periods. Because CF microbial communities are heterogeneous, a baseline needs to 
be determined for each patient. Longitudinal samples are essential to identify the changes in 
the microbial community and metabolites during acute exacerbations.   
In the presented CF01 case study, historical samples were essential to differentiate the 
attack community that led to a fatal exacerbation from the attack community associated with a 
non-fatal exacerbation. The increase in Gb3 abundance during CF01 fatal exacerbation 
(Figure 3.3) was detected when comparing its abundances in historical samples. In the case of 
metabolites, a baseline is necessary for each CF patient because for many compounds the 
basal levels are not known. Accumulation of ceramides and sphingomyelins is observed in CF 
lungs (Seitz et al., 2015). In particular, sphingomyelins, ceramides and lactosylceramide are 
significantly higher in CF lungs compared to non-CF ones (Quinn et al., 2015). 
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A challenging component of the CFRR is the collection and storage of historical 
samples. Sputum samples intended for viromes, metagenomes and metabolomes (Wandro et 
al., 2017) analysis are stable if stored at -20 ºC or -80 ºC. Metatranscriptomes are prone to 
RNA degradation and sputum collection intended for this purpose requires RNA stabilization 
prior to -20 ºC or -80 ºC storage. Given these considerations, each patient can be provided 
with a non-thaw cycle -20 ºC freezer where individual raw sputum samples can be stored for 
viromes, metagenomes and metabolomes (Supplemental Figure 3.7-A).  Sputum samples for 
metatranscriptomes can be collected during the patient’s visit to the CF clinic, where 
immediately after collection the RNA integrity is preserved by adding TRizol or RNAlater. 
RNA should then be extracted as soon as possible. A proposed sampling scheme, in which 
higher resolution of samples is desired close to an acute exacerbation and fewer samples far 
away from the exacerbation event is proposed (Supplemental Figure 3.7).  
Historical samples collected by the patient at home or during routine visits to the clinic 
are a valuable resource in the event of an acute exacerbation. In these cases, historical samples 
would be processed along with those from acute exacerbations in the CFRR pipeline (Figure 
3.6) and valuable information would be obtained in less than 48 hours. This information is 
then analyzed by a multidisciplinary scientific team along with the clinician to 1) validate the 
multi-omics findings with approved clinical tests and 2) identify appropriate therapeutic 
options.  
The information presented by the CFRR to the clinician is more detailed than that 
provided by classical clinical microbiology. A clear understanding of how this information is 
obtained and the exploratory nature of the findings needs to be considered when interpreting 
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the results. Discussion among clinicians and experts on the benefits and limitations of each 
‘omics approach is essential to identify the elements causing CF acute exacerbations and then 
select the course of action to prevent a fatality. The final treatment decision is always in the 
hands of the clinician, who evaluates the different lines of evidence for each finding and 
considers the cost to benefit ratio of possible therapeutic interventions. The application of the 
CFRR in a clinical context gives CF patients the opportunity for a better outcome based on an 
informed treatment decision. Another consideration when implementing the CFRR in the 
clinic is the availability of financial resources to perform the multi-omics strategy in 
exacerbation and historical samples.  
Figure 3.6 Cystic fibrosis rapid response. Our proposed multi-omics strategy is to analyze 
sputum samples from cystic fibrosis patients, in which metabolomes, metagenomes, 
metatranscriptomes, and viromes are obtained from a single sputum sample. Estimated times 
and equipment for each omics step are included, as are recommended transport conditions. 
Recommended transport condition temperatures can be achieved by using ice, dry ice, or 
liquid nitrogen. 
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Considerations about implementing the Cystic Fibrosis Rapid Response. 
This was a retrospective study in which the patient’s treatment was not modified based 
on the presented meta-omics results. The course of action of the CFRR strategy is to provide 
information to clinicians so that they can evaluate and confirm the findings before proceeding 
with pertinent treatment modifications.  
In the case of CF01’s fatal exacerbation, the information obtained from the CFRR 
strategy could have informed the course of action in the treatment with the following 
modifications: 1) use of different antibiotics, since colistin mechanism of action results in 
liberation of the bacteria cell contents such as shiga toxin, and 2) administration of 
neutralizing antibodies against shiga toxin. Colistin is a cationic polypeptide that disrupts the 
cell membrane of gram-negative bacteria through a detergent-like mechanism and it is often 
used in the treatment of multidrug-resistant exacerbation in patients with CF (Wishart et al., 
2018). 
In the presented case study only metatranscriptomes, metabolomes and metagenomes 
were used to elucidate the cause of a fatal exacerbation. In future CFRR case studies the use 
of viromes could be incorporated. The combination of metagenomes and viromes allows the 
identification of viral induction events, for example of prophages carrying toxins. 
Shigatoxigenic phages are capable of lysogenic conversion (Krüger and Lucchesi, 2015; 
Moons et al., 2013), and in the case of the CF01 fatal exacerbation, an early detection of 
shigatoxin in the viromes of historical samples could have provided valuable information 
about the coding potential of the viral community.  
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Time is crucial during the management of CF exacerbations. The estimated execution 
time of the CFRR in an ideal situation with specialized staff working 24/7 is 48 hours. Each 
step has room for improvement that would shorten the execution times. For example, real 
time direct sequencing, such as Oxford Nanopore, can eventually be used for the CFRR 
metagenomes, metatranscriptomes and viromes. These technologies provide genomic 
information as it is being sequenced (Greninger et al., 2015; Schmidt et al., 2017), which will 
be ideal for CFRR once sample preparation and data analysis are optimized for human DNA 
removal (Gu et al., 2016), and once high amounts of sputum starting material (400 ng of DNA 
needed for a Nanopore run) are no longer necessary for DNA for sequencing. 
Combining data from multiple ‘omics sources enabled the identification of 
shigatoxigenic E. coli as the likely cause of patient CF01’s fatal exacerbation. Although these 
‘omics data were not used to alter clinical treatment of CF01, future applications of CFRR are 
expected to provide information that is essential for improving therapy, e.g., antibiotic 
resistance predictions and gene expression in major attack community pathogens. Although 
each individual’s CF community is unique, these methods will allow for the observation of 
overarching trends within and between patients, for example a loss in diversity in acute 
exacerbations. 
Materials and methods 
Clinical data 
Sample collection procedures and access to clinical data were approved by the 
Institutional Review Board of University of California San Diego (HRPP 081510) and San 
Diego State University (IRB#1711018R). Clinical microbiology, hematology, and X-rays 
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were taken during the normal care of the patient at UCSD medical center. Spirometry tests 
were used to calculate the percentage of predicted FEV1 as previously described (Hankinson 
et al., 1999). Clinical status (exacerbation or stable) was determined by the clinician. Lung 
function dynamics were modeled using splines and linear model fitting as previously 
described (Conrad et al., 2017). 
Metagenome and Metatranscriptome shotgun sequencing 
Sputum samples were collected by expectoration in a sterile cup and processed for 
metagenomes or metatranscriptomes as previously described (Lim et al., 2014b). Metagenome 
libraries were constructed using Nextera DNA library preparation kit. Metatranscriptome 
libraries were constructed using TruSeq RNA library preparation kit. All libraries were 
sequenced on the Illumina GAIIx platform. Metatranscriptomes D-7 and D-8 were prepared 
using a modified procedure to obtain rRNA and mRNA in a single sequencing step, where 
half of the sample was depleted of rRNA using Ribo-Zero Gold kit (Lim et al., 2013b) while 
total RNA was extracted from the other half. Both fractions were pooled in a proportion of 
4:1, and then a single Illumina library was constructed and sequenced.  
Sequencing data processing  
Quality filtering and dereplication was done using PRINSEQ (Schmieder and 
Edwards, 2011) (-min_qual_mean 20 -derep 1245 -lc_method entropy -lc_threshold 50 -
ns_max_p 1 -out_bad null). Cloning vector sequences were removed using SMALT (-y 0.8 -
x) with 80% identity against the UniVec database (National Center for Biotecnology
Information, 2016a), possible sources of cloning vector sequences are reagents used in the 
library preparation (National Center for Biotecnology Information, 2016b; Woyke et al., 
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2011). Human genome sequences were removed using BLASTn (E value of 0.1) against the 
human reference genome GRCh38. The resulting FASTA files are available on NCBI SRA 
with the following accession numbers: (SAMN10605049 to SAMN10605062, n=12). 
Metagenome and metatranscriptome datasets presented in this study are summarized in 
Supplemental Table 3.1E. Microbial taxonomy assignments at the genus level were made 
from BLASTn against NT (E value of 0.001, the hit with lowest E value out of 10 hits was 
kept) for metagenomes and KAIJU (Menzel et al., 2016) for metatranscriptomes. Viral 
assignments were made by mapping reads against the viral reference genomes database 
(NCBI RefSeq, release 87) using SMALT (2010) with 80% identity. Fractional abundances 
were calculated using FRAP as previously described (Cobián Güemes et al., 2016) and 
expressed per million reads.  After quality filtering and removing reads that mapped to the 
human genome, metatranscriptome D-8 reads were compared to the SILVA SSU database 
using BLASTn with an E-value cutoff of 0.001, and taxonomy was assigned at the genus level 
using the best hit from 10000 subsample replicates. Non-ribosomal reads were compared to 
the NCBI nucleotide database (NT) using BLASTn with an E-value cutoff of 0.001. The best 
hit was selected and used to assign bacterial taxonomy at the genus level. Species level 
assignments were determined by the genome that recruited the most reads for each genus 
either at the rRNA (Bacillus, Escherichia, and Salmonella) or mRNA (Pseudomonas and 
Stenotrophomonas) levels. The bacterial genome with more hits in the BLASTn analysis was 
selected as the closest strain and used as reference genome. rRNA and mRNA reads were 
mapped against each one of the reference genomes using SMALT with an identity cutoff of 
60% and 80%, respectively, and the results were visualized using Anvi’o (Eren et al., 2015).  
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Reads from metatranscriptomes D-8 and D-7 were together assembled de novo using 
SPADES (Bankevich et al., 2012), and all resultant contigs were compared to NT using 
BLASTn with an E-value cutoff of 0.001; taxonomies were assigned using MEGAN6 (Huson 
et al., 2016). Contigs identified as Pseudomonas in all metatranscriptomes were separately 
mapped to the reference genome P. aeruginosa PAO1 using SMALT with an identity cutoff 
of 80%. Pseudomonas contigs (n=4965, a total of 2,686,355 base pairs) were annotated using 
PATRIC (Wattam et al., 2017); genes identified by subsystems classification as resistance to 
antibiotics and toxic compounds were summarized in Supplemental Table 3.3A .  All contigs 
were screened for antibiotic resistance genes using the Resistance Gene Identifier 
implemented in the CARD database (Jia et al., 2017). All perfect and strict hits were retained, 
as was any hit with an identity ≥ 80%. Metatranscriptomes D-8 and D-7 reads were mapped to 
the proteins shiga-like toxin subunit A and subunit B using BLASTx with an E-value cutoff 
of 0.1 and identity of 60%. Fragment recruitment plots were generated using custom python 
scripts.  
Samples comparison 
Random forest, a non-parametric statistical method, was used to determine the 
bacterial genera that best differentiated between (1) antibiotic treatment and no antibiotic 
treatment in the metagenomes and (2) stable from exacerbation states in the 
metatranscriptomes. The importance of each variable was assessed using the R 
implementation of the algorithm random forest (Wiener, 2002) using 2000 trees.  
The R package vegan (Jari et al., 2017) was used with the metatranscriptomes to 
calculate Pielou’s evenness using Shannon diversity.  
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Metabolomics 
LC-MS/MS metabolomics data were generated on the sputum sample D-8 and 
compared to a set of 15 samples routinely collected from the previous 426 days. Metabolite 
extraction (ethyl acetate and methanol), LC-MS/MS methods and data analysis were 
performed as described in (Quinn et al., 2016a). Data from these same sputum samples have 
been published previously (Quinn et al., 2016a), but the metabolites reported here were not 
presented in that study making these data novel (metabolomic data for this project are 
available under MassiVE dataset ID MSV000079444).  
Metabolomics data processing 
Metabolomics data were analyzed using molecular networking (Watrous et al., 2012) 
and GNPS (Wang et al., 2016). Molecular networking parameters were altered for this study 
and are as follows: cosine minimum of 0.7, 6 minimum matched peaks for spectral clustering, 
and a precursor mass and fragment ion mass tolerance of 0.1 Da. Molecular networks were 
visualized using the Cytoscape® software (Shannon et al., 2003). Molecules were annotated 
by searching the GNPS libraries and specific metabolites of interest were searched for using 
the MS1 parent mass and then compared to the Metlin MS/MS spectral libraries (Smith et al., 
2005). Area under the curve abundances of metabolites in the LC-MS/MS data were 
calculated using the mzMine 2 software (Pluskal et al., 2010) using selected masses. The 
parameters of the feature finding were as follows: minimum time span of 0.05 min, a 
minimum feature height of 2 and an m/z tolerance of 0.05 m/z or 15.0ppm. The 
chromatograms were deconvoluted, isotope peaks were grouped, and the peaks were aligned 
with the same ion mass tolerance and a retention time tolerance of 1 min. The final matrix of 
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features was gap filled. All metabolite annotations based on spectral alignment are considered 
level 2 according to the metabolomics proposed minimum reporting standards (Sumner et al., 
2007). 
Isolates of CF pathogens P. aeruginosa VVP172, Enterococcus sp. VVP100, 
Escherichia coli VVP427, Streptococcus sp. VVP047, Stenotrophomonas maltophilia 
VVP327 and Staphylococcus aureus VVP270 were obtained from the UCSD Center for 
Advanced Laboratory Medicine. These isolates were grown in artificial sputum medium 
according to the method of (Quinn et al., 2014) and their metabolomes were extracted using 
an ethyl acetate and methanol sequential extraction (the same method as for the sputum 
samples described in (Quinn et al., 2016a)). The LC-MS/MS data were generated with the 
same protocols as the sputum samples and the data were uploaded to GNPS. The MS/MS data 
from these bacterial isolates were used individually as a reference for searching for matching 
spectra in the CF01 longitudinal sputum data. Spectral matching parameters were as follows: 
parent and fragment mass tolerance of 0.1, minimum matched peaks of 6, cosine of 0.7 and a 
minimum spectral count of 3 in the dataset. Spectral matches between a sputum sample file 
and a bacterial isolate were summed for each sample for each bacterium and plotted to 
identify metabolite matches through the longitudinal datasets from pathogens known to be 
present in CF01 from clinical culture history (it must be noted these isolates were obtained 
from CF patients in the same clinic as CF01, but not from CF01). It is unknown if specific 
bacteria molecules were detected. 
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Data availability 
Sequencing data is available on SRA with the study number SRP173673 (Nacional 
Center for Biotechnology Information, 2016). Metabolomics data is available on GNPS with 
the MassiVE dataset ID MSV000079444 (GNPS, 2019). 
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Appendix for Chapter 3 
Supplemental figures 
Supplemental Figure 3.1 Total bacterial RNA composition during a fatal exacerbation 
(sample D-8). A) Bacterial ribosomal RNA composition was assigned with BLASTn against 
the SILVA SSU database, with an E-value cutoff of 0.001. The best hit from 10,000 
subsample replicates was used. Results are shown at the genus level. B) Bacterial non-
ribosomal RNA composition at genus level assigned by BLASTn vs NT with an E-value 
cutoff of 0.001. The best hit was selected.   
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Supplemental Figure 3.2 A) P. aeruginosa gene expression during a stable period (D-279 & 
D-303) and fatal exacerbation (D-7 & D-8) based on fragment recruitment to the P.
aeruginosa PAO1 reference genome. All microbial reads from metatranscriptomes D-303, D-
279, D-8, and D-7 were individually mapped to the reference genome with SMALT using an
identity cutoff 80%. Reads from samples D-8 and D-7 were denovo assembled into contigs.
Contigs were mapped to the reference genome using SMALT with an identity cutoff 80%. B)
P. aeruginosa SMase plcH coverage plot. Reads from metatranscriptome D-8 were mapped to
the gene PlcH using SMALT at 80% identity cutoff. C)  Predicted prophages from assembled
genome P. aeruginosa CF01.  Prophages were predicted using the online version of
PHASTER. Protein annotations for partial prophage 1. PLP: phage like protein, Sha: tail
protein, Fib: fiber protein. D) Predicted prophages from assembled genome P. aeruginosa
CF01.  Prophages were predicted using the online version of PHASTER Protein annotations
for complete prophage 2. PLP: phage like protein, Sha: tail protein, Fib: fiber protein, Coa:
coat protein, Por: portal protein, Att: attachment site.
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Supplemental Figure 3.3 Metabolomes from sample D-8 and their comparison to historical 
samples for CF01. Spectra from CF01 historical samples and fatal exacerbation sample D-8 
were mapped to the individual spectra from known bacteria.   
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Supplemental Figure 3.4 A) Percentage of predicted FEV1 of patient CF01 for 14 years. B) 
Percentage of predicted FEV1 of patient CF01 for years 4 and 3 before death. C) Percentage 
of predicted FEV1 of patient CF01 for last two years of life. In all panels measurements 
obtained are represented by black dots. The grey line is the calculated spline as described by 
Conrad et al. The red line is the fitting of a linear model for the measurements shown in each 
panel. The slope of the linear model fitting in shown in the header of each panel as the slope. 
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Supplemental Figure 3.5 Metagenomic analysis was performed from sputum samples 
collected over a seven-day exacerbation period, during a subsequent stable period of 10 to 14 
months and fatal exacerbation. A) Bacterial taxonomy was obtained at the genus level using 
BLASTn against NT. Relative abundances were calculated for genera whose abundances 
were greater than or equal to 0.1%. The phylum to which each genus belongs is indicated by a 
similar color gradient. B) The fractional abundances of phages obtained by mapping to 
ViralRefseq and FRAP normalization. C) Bacteria rank abundance plots for CF01 
metagenomes described in panel A. Relative abundances are shown at genus level, genera 
with a relative abundance lower than 0.1% were not included in the plots D) The fractional 
abundances of eukaryotic viruses obtained by mapping to ViralRefseq and FRAP 
normalization.  
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Supplemental Figure 3.6 Variable importance plot using mean decrease accuracy for a 
supervised random forest with 5000 trees. Taxonomical relative abundance at genus level in 
metagenome samples of an exacerbation event two years before CF01’s death. During the 
exacerbation event, two groups of samples were analyzed: antibiotic treatment and no 
antibiotic treatment.   
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Supplemental Figure 3.7 Sampling scheme for collection of “historical” sputum samples. A) 
Proposed at-home sample collection scheme where sputum samples are obtained daily. By the 
end of the first collection month, half of the samples are discarded (purple dots) and daily 
collection continues for the new month. By the end of the second month, half of all the 
previous months samples are discarded (purple and green dots) and so on. B) In an acute 
exacerbation event, the patient will bring the samples to the clinic and the CFRR methods will 
be applied to acute exacerbation and historical samples. With the proposed at home collection 
scheme, a higher sampling density will be obtained in the exacerbation month and less in the 
months before the exacerbation.  
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Supplemental tables 
Supplemental Table 3.1A Brasfield scores of CF01 X-rays. X-rays were performed as part of 
the patient’s regular clinical care.  
Day 
Air 
trapping 
Linear 
markings 
Nodular 
cystic 
lesions 
Large 
lesions 
General 
severity 
Brasfield 
score 
D-1 3 4 4 5 4 5 
D-8 2 3 3 0 3 14 
D-193 2 2 2 0 2 16 
Supplemental Table 3.1B Hematology of CF01 during their last month of life. White blood 
cell counts are expressed in cells per microliter. 
Day 
White Blood Cells 
count 
segmented 
neutrophils 
D-0 24,000 
96% 
D-1 17,400 
96% 
D-2 12,400 
95% 
D-7   7,100 
97% 
D-23 10,900 
95% 
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Supplemental Table 3.1C Bacteria and fungi cell culture results from the clinical 
microbiology laboratory for patient CF01 during their last two years of life.   
Day Status Bacteria Fungi 
D-0
exacerbation 
Pseudomonas aeruginosa Aspergillus terreus 
Stenotrophomonas maltophilia 
D-1
exacerbation 
Pseudomonas aeruginosa 
Stenotrophomonas maltophilia 
D-7
exacerbation 
Pseudomonas aeruginosa Yeast 
Stenotrophomonas maltophilia 
D-14
exacerbation 
Pseudomonas aeruginosa Yeast 
D-24
exacerbation 
Pseudomonas aeruginosa Yeast 
Enterobacter cloacae 
D-48
stable 
Pseudomonas aeruginosa Yeast 
Stenotrophomonas maltophilia 
Enterobacter cloacae 
D-192
exacerbation 
Pseudomonas aeruginosa Aspergillus terreus 
Stenotrophomonas maltophilia Yeast 
D-204
exacerbation 
Pseudomonas aeruginosa Yeast 
Stenotrophomonas maltophilia 
D-373
stable 
Pseudomonas aeruginosa Yeast 
D-414
stable 
Pseudomonas aeruginosa Yeast 
D-540
stable 
Pseudomonas aeruginosa Yeast 
D-547
stable 
Pseudomonas aeruginosa Yeast 
D-674
stable 
Pseudomonas aeruginosa 
D-719
exacerbation 
Pseudomonas aeruginosa Yeast 
Pseudomonas fluorescens 
Aspergillus 
fumigatus 
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Supplemental Table 3.1D  Antibiotic received as treatment during the last two years of 
CF01’s life. Class and mechanism of action were obtained from PubChem and DrugBank. 
Month Antibiotic Class Comments Mechanism of action 
M-0 Aztreonam monobactam 
Inhibit synthesis of bacteria cell 
wall, binds to and inactivates 
penicillin-binding-protein-3. 
Azithromycin 
macrolide → 
azalide 
Inhibit protein synthesis, 
reversible binding to 50S 
ribosomal subunit,  
- sulfa sulfonamide 
Interfere with folic acid 
synthesis, competition for the 
enzyme dihydropteorate 
synthetase  
- quinolone quinolone Inhibits DNA gyrase 
Colistin 
cationic 
polypeptide 
ER 
response 
Solubilize cell membrane 
through a detergent like 
mechanism.  
Meropenem 
beta-lactam → 
carbapenem 
ER 
response 
Inhibits cell wall synthesis, 
penetrates cell wall to reach 
penicillin-binding-protein targets. 
M-1 Aztreonam monobactam 
Inhibit synthesis of bacteria cell 
wall, binds to and inactivates 
penicillin-binding-protein-3. 
Azithromycin 
macrolide → 
azalide 
Inhibit protein synthesis, 
reversible binding to 50S 
ribosomal subunit, 
- quinolone quinolone Inhibits DNA gyrase 
- sulfa sulfonamide 
Interfere with folic acid 
synthesis, competition for the 
enzyme dihydropteorate 
synthetase 
M-6 Azithromycin 
macrolide → 
azalide 
Inhibit protein synthesis, 
reversible binding to 50S 
ribosomal subunit, 
- sulfa sulfonamide 
Interfere with folic acid 
synthesis, competition for the 
enzyme dihydropteorate 
synthetase 
- quinolone quinolone Inhibits DNA gyrase 
Meropenem beta-lactam 
ER 
response 
Inhibits cell wall synthesis, 
penetrates cell wall to reach 
penicillin-binding-protein targets. 
M-24 Doxycycline tetracycline 
Inhibit protein synthesis, 
reversible binding to 30S 
ribosomal subunit and possibly 
50S.  
Ciprofloxacin fluoroquinolone 
Inhibits topoisomerase II (DNA 
gyrase) and topoisomerase IV 
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Supplemental Table 3.1E Metagenome and metatranscriptome sequencing overview for CF01 
sputum samples. All libraries were sequenced on the Illumina platform. The Nextera library 
prep kit was used for all metagenomes whereas TruSeq was used for metatranscriptomes.  
Day Status Library type File name SRA ID 
D-724 Exacerbation  metagenome polihed_CF01mgD724.fasta SAMN10605062 
D-723 Exacerbation  metagenome polished_CF01mgD723.fasta SAMN10605061 
D-722 Exacerbation  metagenome polished_CF01mgD722.fasta SAMN10605060 
D-721 Exacerbation  metagenome polished_CF01mgD721.fasta SAMN10605059 
D-720 Exacerbation  metagenome polished_CF01mgD720.fasta SAMN10605058 
D-719 Exacerbation  metagenome polished_CF01mgD719.fasta SAMN10605057 
D-718 Exacerbation  metagenome polished_CF01mgD718.fasta SAMN10605056 
D-409 Stable metagenome polished_CF01mgD409.fasta SAMN10605055 
D-286 Stable metagenome polished_CF01mgD286.fasta SAMN10605054 
D-8 Exacerbation metagenome polished_CF01mgD8.fasta SAMN10605053 
D-303 Stable metatranscriptome polished_CF01mtD303.fasta SAMN10605052 
D-279 Stable metatranscriptome polished_CF01mtD279.fasta SAMN10605051 
D-8 Exacerbation metatranscriptome polished_CF01mtD8.fasta SAMN10605050 
D-7 Exacerbation metatranscriptome polished_CF01mtD7.fasta SAMN10605049 
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Supplemental Table 3.2A Comparison of molecules spectra between non-exacerbation 
samples (D-426 to D-248) and exacerbation sample D-8.  P-values were calculated from a 
single tail normal distribution (pnorm function in R).  
Supplemental Table 3.2B Comparison of number of specific bacteria spectra between non-
exacerbation samples (D-426 to D-248) and exacerbation sample D-8.  P-values were 
calculated from a single tail normal distribution (pnorm function in R).  
Molecule p-value z score 
Globotriaosylceramide ~0 512960.92 
Lactosylceramide ~0 44.60 
Sphingomyelin 0.90 -1.28
Bacteria spectra in D-8 CF strain ID p-value z score 
Escherichia coli VVP427 1.99e-17 8.41 
Enterococcus sp. VVP100 0.043 1.71 
Pseudomonas aeruginosa VVP172 3.38e-69 17.5 
Staphylococcus aureus VVP270 2.58e-05 4.04 
Stenotrophomonas maltophilia VVP327 0.005 2.51 
Streptococcus sp. VVP047 2.39e-14 7.53 
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Chapter 4 : Mobile genetic elements in Cystic Fibrosis exacerbations 
Abstract 
Phages and microbes colonize the respiratory airways of patients with Cystic Fibrosis 
causing persistent infections that impact lung function. Per treatment regimes, the microbial 
communities in Cystic Fibrosis respiratory airways is continuously exposed to antibiotics 
which confers enhanced antibiotic resistant to the population of bacterial pathogens present in 
the Cystic Fibrosis lung. In this work the microbiome of a group of patients whose lung 
function declined sharply and were non-responsive to the antibiotics treatment was studied 
through metagenomics. The lung microbiomes of Cystic Fibrosis patients in this study were 
characterized by enhanced bacterial growth with a reduction in community diversity and 
elevated lytic phage production. Four fatal exacerbations were dominated by Pseudomonas 
aeruginosa or Achromobacter spp. and four non-fatal exacerbations were dominated by 
Stenotrophomonas maltophilia, Mycobacterium avium-intracellulare or Streptococcus 
salivarius. The dominant bacteria in these exacerbations have between 3% and 6% of genome 
insertions, of which >60% of the coding sequences are phage-derived. Phages that encode 
toxins which damage the host tissue were identified, such as Stenotrophomonas phage 
phiSHP2 that encodes zonula occludens toxin. This work suggests phage activity in Cystic 
Fibrosis exacerbations as a likely mechanism of increased pathogenic virulence.      
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Introduction 
Cystic Fibrosis (CF) is a recessive genetic disease in which malfunctioning of the 
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) causes insufficient anion 
exchange across membranes and dehydration of mucosal surfaces. Mucus dysfunction in CF 
airways results in chronic polymicrobial infections (Laguna et al. 2016). Overtime, the 
vigorous innate and adaptive host immune responses to these chronic infections result in 
airway remodeling, gas exchange abnormalities and eventually respiratory failure. Airway 
clearance treatments, antibiotics, anti-inflammatory drugs, and new CFTR modulator 
therapies have extended median lifespan of CF patients, yet these polymicrobial lung 
infections persist as the major drivers of CF morbidity and mortality for the foreseeable future 
(Alexander et al. 2016).  
Common bacteria that chronically colonize CF airways include Pseudomonas 
aeruginosa, Staphylococcus aureus, Stenotrophomonas maltophilia, Achromobacter spp., 
Haemophilus influenzae, and Burkholderia cepacia (Surette 2014; LiPuma 2010; Lim et al. 
2013; Whiteson et al. 2014), but every CF individual has a unique microbial community that 
changes over time (Whelan et al. 2017; Zhao et al. 2012; Lim et al. 2014). This highlights the 
need to characterize the microbial communities temporally in each CF patient. Viruses 
(eukaryotic and bacteriophage) contribute to these unique microbial signatures among CF 
patients by acting as remodeling agents of bacterial communities (Reyes et al. 2015). How 
phage lytic-lysogenic life cycles provide top down control (James et al. 2015) of specific 
bacterial populations and drive bacterial population rank abundance and metagenomic 
composition is largely unexplored in the CF lung environment (Silveira and Rohwer 2016). 
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An accurate description of the dynamics between these viruses and their bacterial hosts is 
critical to understanding the drivers of the microbial community dynamics, the capacity for 
virulent metabolic processes, and the subsequent host immune response. Phage are known to 
transfer exotoxins (Wilson and Ho 2006; Krüger and Lucchesi 2015; Dobrindt et al. 2015), 
antibiotic resistance genes (Budzik et al. 2004), and virulence factors (Busby, Kristensen, and 
Koonin 2013) to bacterial populations which can confer enhanced virulence in host-pathogen 
systems. Detailed exploration of phage insertions in CF bacterial infections is needed to 
understand CF disease progression.  
In this work we applied a Cystic Fibrosis Rapid Response strategy (Cobián-Güemes et 
al. 2019) to reveal genetic exchange between viral and bacterial populations during CF 
exacerbations. To accomplish this, a personalized multi-omics approach was used to 
characterize viromes (Willner et al. 2012), metagenomes and metatranscriptomes (Lim et al. 
2013) in order to comprehensively monitor the microbial and viral dynamics during CF 
pulmonary exacerbations. The CF exacerbations of each patient were all dominated by a 
single pathogenic bacteria, resulting in low community diversity and were associated with 
host tissue damage via toxins. Using a tailored bioinformatics approach, we identified 1) 
previously unidentified pathogens in the CF lung, 2) toxin production and 3) unique mobile 
elements.   
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Results  
Clinical characterization of Cystic Fibrosis pulmonary exacerbations. 
To investigate the microbial community composition of CF acute exacerbations, eight 
patients in the UCSD adult Cystic Fibrosis clinic that suffered pulmonary exacerbations 
(CFPE) and required hospitalization within a one-year interval were included in this study 
(Table 4.1). Four patients suffered fatal exacerbations (CF01, CF094, CF116 and CF418) and 
four patients survived the exacerbation event (CF318, CF409, CF292 and CF146). 
Exacerbations were defined by the treating clinician and were characterized by a decrease in 
lung function (measured as FEV1), no response to antibiotics treatment, and general health 
decline.  
The study population age ranged from 18 to 40 years. Exacerbations ranged from 8 to 
63 days and a loss of lung function relative to each patient baseline ranged between 10% to 
48%. The clinical laboratory reported the presence of Pseudomonas aeruginosa (CF01, 
CF094, CF146), Stenotrophomonas maltophilia (CF01, CF409, CF318), Achromobacter sp. 
(CF116), Achromobacter xylosoxidans (CF116, CF418), Mycobacterium avium-intracellulare 
(CF292, CF318), Multidrug Resistant Staphylococcus aureus (CF409), Aspergillus terreus 
(CF01), and yeast (not Cryptococcus neoformans) (CF409, CF318, CF292).  
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Table 4.1 Cystic Fibrosis patients clinical data during exacerbations (Ex.) that required 
hospitalization. 
Ex. 
Outcome 
Patient 
ID 
Gender Age 
Ex. 
FEV1 
loss 
Ex. length 
(days) 
Clinical 
microbiology 
during Ex. 
Antibiotics used 
during Ex. 
Fatal CF01 Male 37 10% 8 ●Pseudomonas
aeruginosa
●Stenotrophomona
s maltophilia
●Aspergillus
terreus
aztreonam, azithromycin, 
colistin, meropenem 
Fatal CF094 
Fatal CF116 Male 30 43% 27 ●Achromobacter
species
●Achromobacter
xylosoxidans
ceftazidime-avibactam, 
doxycycline, 
sulfamethoxazole-
trimethroprim, vancomycin, 
tigecycline, colistin, 
azithromycin, meropenem,  
imipenem-cilastatin,  
minocycline 
Fatal CF418 
Non-fatal CF409 Female 18 40% 63 ●MRSA
●Stenotrophomona
s maltophilia
●Aspergillus
fumigatus
●Yeast, not
Cryptococcus
neoformans
sulfamethoxazole-
trimethroprim, ceftaroline, 
minocycline, linezolid, 
ceftazidime, tobramycin 
Non-fatal CF318 Male 27 29% 37 ●Stenotrophomona
s maltophilia
●Mycobacterium
avium-intracellulare
●Yeast, not
Cryptococcus
neoformans
levofloxacin, 
sulfamethoxazole-
trimethroprim, minocycline, 
meropenem 
Non-fatal CF292 Female 34 48% 53 ●Mycobacterium
avium-intracellulare
●Yeast, not
Cryptococcus
neoformans
aztreonam, linezolid, 
moxifloxacin, amikacin, 
azithromycin, ethambutol, 
rifampin 
Non-fatal CF146 Male 31 36% 14 ●Pseudomonas
aeruginosa
colistin, 
piperacillin-tazobactam 
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Cystic Fibrosis exacerbations display higher microbial loads and phage production. 
Viral and microbial counts and virus to microbe ratios from the CF lungs were 
obtained for exacerbation samples and for a set of stable CF samples (n=16) (Figure 4.1). 
Exacerbation samples had an average bacterial abundance of 2.9 x 109 cells ml-1, an average 
viral abundance of 2.5 x 1010 VLPs ml-1, and an average virus to microbe ratio of 12.5. Stable 
samples were nearly an order of magnitude lower than exacerbation samples with an average 
bacterial abundance of 5.8 x 108 cells ml-1, an average viral abundance of 3.1 x 109 VLPs ml-1, 
and a virus to microbe ratio of 6.5. Exacerbation samples showed a significantly higher virus 
to microbe ratio than stable samples, suggesting enhanced bacteria growth and viral activity in 
CF exacerbations. 
Figure 4.1 Virus to Microbe Ratio (VMR) in CF sputum samples quantified by 
epifluorescence microscopy. Exacerbation and stable samples VMR are significantly different 
(T-test p-value < 0.05, Wilcoxon test p-value 0.010 and w=88).  
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Microbial community composition of pulmonary exacerbations. 
The microbial community composition of the described CFPEs was obtained from 
sputum or bronchioalveolar lavage samples and characterized molecularly using total DNA 
metagenomes or total RNA metatranscriptomes. The exacerbation microbial communities 
presented low diversity in both evenness and richness (Supplemental Figure 4.1) and were 
dominated by a single microbe (Figure 4.2). Diversity indexes were compared to a cohort of 
CF patients suffering mild exacerbations (Losada et al. 2016). Acute exacerbations presented 
here have significantly lower diversity than mild exacerbations. Species-level resolution was 
obtained from each dataset by comparing the microbial reads to bacterial reference genomes 
at a high identity (>96% identity over 100% of the read length). P. aeruginosa was the most 
active microbe in two fatal exacerbations, CF01 (96% relative abundance) and CF094 (98% 
relative abundance), as shown by transcriptomic analysis. Achromobacter spp. was the 
dominant genus in two fatal exacerbations. In CF116, Achromobacter ruhlandii relative 
abundance was 80% and in CF418 Achromobacter xylosoxidans relative abundance was 76%. 
In non-fatal exacerbations, the microbial community was dominated by Stenotrophomonas 
maltophilia (CF318 and CF409), Mycobacterium intracellulare (CF292) and Streptococcus 
salivarius (CF146) (Figure 4.2). Propionibacterium acnes was detected in all samples and is 
probably ubiquitous in CF respiratory samples. The yeast Candida glabrata was identified in 
CF292 (Supplemental Figure 4.2).  
In exacerbations dominated by the genus Achromobacter, other members of the 
microbial community had a very low fractional abundance. In Stenotrophomonas-dominated 
exacerbations, the genera that followed in abundance were Rothia, Streptococcus and 
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Achromobacter. In Patient CF292, the genus Mycobacterium had the highest fractional 
abundance followed by the genera Rothia and Streptococcus. Patient CF146 microbial 
community was more diverse, Streptococcus was the genera with higher fractional abundance, 
followed by Rothia, Neisseria and Prevotella.  
Figure 4.2 Bacterial abundance in CF exacerbations metagenomes. Polished reads were 
mapped to bacteria RefSeq database (n=66,000 genomes) using fragment recruitment 
assembly purification (FRAP) at 96% identity over 100% of the read. Fractional abundances 
from individual genomes were added by bacteria genera. 
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Temporal dynamics of microbial community composition 
Longitudinal sampling of patient CF318 for a month before the acute exacerbation 
event showed that the microbial diversity (evenness) decreased from 0.88 to 0.28 
(Supplemental Figure 4.3-A). The dominant genera in this microbial community was 
Stenotrophomonas (Supplemental Figure 4.16-B) during the sampling period, but the absolute 
abundance increased by an order of magnitude (from ~2x108 cells ml-1 to ~1x109 cells ml-1). 
An increase in relative abundance of virulence factors was also observed during the 
exacerbation period (Supplemental Figure 4.3-C), which may be explained by the 
colonization of a different Stenotrophomonas species carrying these virulence factors.  
Genomic insertions and deletions in CF pulmonary exacerbations. 
Genome plasticity appeared common in the dominant bacteria present in CF 
exacerbation metagenomes, therefore insertions and deletions were quantified based on 
comparisons to the closest reference genome. Deletions that met a criteria of > 10,000 
nucleotides were observed between 13 and 24 excised regions in the most abundant bacteria 
present in each patient metagenome (Supplemental Figures 4.4 to 4.9). These deleted coding 
sequences represented between 5% and 13% of the bacterial reference genomes. Annotation 
of these excised regions also showed that between 10% and 66% of the excised regions 
coding sequences were phage related (Table 4.2). 
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Table 4.2 Deletions in dominant genomes. 
Patient 
ID 
Reference 
genome 
Deletions 
(nt) 
% of genome 
deletions 
Phage and hypothetical 
CDS in deletions (%) 
CF116 
Achromobacter ruhlandii 
(CP017433.1) 
327,280 5.14 71.72 
CF418 
Achromobacter xylosoxidans 
strain FDAARGOS_150 
(CP014028.1) 
376,964 6.01 63.32 
CF409 
Stenotrophomonas maltophilia 
strain FDAARGOS_325 
(CP022053.2) 
410,006 8.45 79.91 
CF318 
Stenotrophomonas maltophilia 
strain FDAARGOS_325 
(CP022053.2) 
347,490 7.16 81.93 
CF292 
Mycobacterium intracellulare 
(CP023149.1) 
859,906 15.32 58.68 
CF146 
Streptococcus sp. 
(CP014264.1) 
285,568 13.11 60.11 
Insertions were determined as regions >10,000 nucleotides present in metagenome 
assembled contigs but not in the closest reference genome (Supplemental Figures 4.10 to 
4.12). Three bacterial genomes had enough coverage to obtain quality sequence assemblies in 
order to detect insertion regions (A. ruhlandii, and S. maltophilia strains from two different 
patients; Table 4.3). Between 3% and 6% of these assembled bacterial genomes were 
annotated as insertions.  
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Table 4.3 Insertions in dominant genomes. 
ID 
Microbial community 
dominant bacteria  
Nucleotide
s in contigs 
> 1000 nt
Insertions 
(nt) 
% of genome 
that are 
insertions 
Phage and 
hypothetical CDS in 
insertions (%) 
CF116 Achromobacter ruhlandii 6,636,892 283,932 4.2 77.1 
CF318 
Stenotrophomonas 
maltophilia 
4,845,908 190,605 3.9 67.8 
CF409 
Stenotrophomonas 
maltophilia 
4,917,770 311,160 6.3 68.4 
Annotations of these inserted regions showed that between 67% and 77% of the 
coding sequences are phage-related. In A. ruhlandii assembled from CF116 metagenome, 12 
insertions were identified, two of which were annotated with high confidence as phages 
(Figure 4.3-A). From 13 inserted regions identified in S. maltophilia assembled from CF318 
metagenome, three of the regions encode phage-related proteins and two of them encode 
integrases (Figure 4.3-B). In S. maltophilia assembled from CF409, 14 inserted regions were 
identified, two of which are phages (Figure 4.3-C). S. maltophilia 409 insertion 14 is a 61.4 
Kb region with phage replication and structural coding sequences (Figure 4.4-A). S. 
maltophilia 409 insertion 7 is a 23.3 Kb region inside a contig which is 51 Kb and is flanked 
by tRNAs (Figure 4.4-B). Both the insertion and the contig have coding sequences annotated 
as phage replication and structural proteins. 
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Figure 4.3 Insertions in CF exacerbation dominant genomes. Insertions are defined as regions 
>10,000 bp that are present in metagenome assembled contigs but are not present in the
closest reference genome. A) Achromobacter ruhlandii CF116 B) Stenotrophomonas
maltophilia CF318 C) Stenotrophomonas maltophilia CF409.
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Figure 4.4 Stenotrophomonas insertions are phages. Annotations from PATRIC are in black. 
Annotation from the Conserved Domains Database are in grey. A) S. maltophilia CF409 
insertion 14. B) S. maltophilia CF409 insertion 7 and the complete contig where the insertion 
was detected. 
Phage activity in pulmonary exacerbations 
The dominant microbes present in CF exacerbations are lysogens carrying known and 
uncharacterized prophages in their genomes. In exacerbations that led to patient mortality, an 
Achromobacter phage was detected in CF116 whose dominant bacteria was A. xylosoxidans. 
Lysogens in CFPEs that were not fatal were also observed, such as a Streptococcus phage 
detected in CF146 whose dominant bacteria was S. salivarius, and Stenotrophomonas phages 
were detected in CF409 whose dominant bacteria was S. maltophilia. Additional phages were 
detected in both fatal and non-fatal exacerbations such as, Burkholderia phage, Pseudomonas 
phage, Staphylococcus phage, Salmonella phage and nine other phages (Supplemental Figure 
4.13-B). 
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Phages are known to carry toxins that can enhance replication and virulence of 
bacterial pathogens. An exotoxin carried by Stenotrophomonas phage phiSHP2 (Hagemann, 
Hasse, and Berg 2006) was identified during CF409 exacerbation. Stenotrophomonas phage 
phiSHP2 is a 5.8 Kb phage (Figure 4.5-A) that encodes nine proteins, only two of them with 
functional annotations: a replication protein and zonula occludens toxin. CF409 microbial 
community was dominated by S. maltophilia carrying a prophage that was induced during the 
exacerbation, as detected by the recovery of the viral genome in the total metagenome (Figure 
4.5-B and C) and viral particle-enriched virome (Figure 4.5-D). This bacteriophage was 
carrying the exotoxin zonula occludens which disrupts tight junctions in epithelial cells (Di 
Pierro et al. 2001).  
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Figure 4.5 Stenotrophomonas phage SHP2 and zonula occludens toxin. CF409 exacerbation 
sample metagenome in which Stenotrophomonas relative abundance was 97%. A) S. 
maltophilia phage phiSHP2 complete genome annotation, a replication protein and zonula 
occludens toxin are annotated, the remaining 7 ORFs are annotated as hypothetical proteins. 
B) Fragment recruitment plot. C) Coverage plot from metagenome. D) Coverage plot from
virome.
Discussion 
CF exacerbations and bacteria genomic insertions 
The microbial communities of the CF exacerbations explored in this study were 
dominated by distinctive bacteria strains that had unique genomic insertions. Such insertions 
included prophages encoding toxins and other mobile elements carrying antibiotic resistance 
genes. These results illustrate that precise identification of not only strain level, but unique 
genomic material in the CF microbiome is essential to understand each CF exacerbation.  
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Achromobacter in CF exacerbations 
Achromobacter is an emerging genera in CF exacerbations (Amoureux et al. 2013; 
Rudkjøbing et al. 2012; Ridderberg, Nielsen, and Nørskov-Lauritsen 2015). In this study, the 
lung microbial community of two CF fatal exacerbations was dominated by A. ruhlandii and 
A. xylosoxidans, respectively. Potential mechanisms contributing to the development of fatal
exacerbations by Achromobacter spp. include direct attack to the host tissue via toxins, 
resistance to antibiotics (Bador et al. 2013), and the ability to perform aerobic and anaerobic 
respiration (Jakobsen et al. 2013). Hemolysins were detected in both fatal exacerbations 
(Supplemental Figure 4.13-C); these hemolytic proteins are known to be carried by 
Achromobacter and can directly damage host tissues (Benz 2015). In addition to hemolysins, 
Achromobacter can deliver other virulence factors to host tissues using type III secretion 
systems and attack competing bacteria with the protein colicin V (Swenson and Sadikot 2015; 
Jakobsen et al. 2013; Rodrigues et al. 2016). These factors are posited to contribute to 
Achromobacter pathogenicity in the CF lung, leading to fatal exacerbations. 
Stenotrophomonas in CF exacerbations 
Stenotrophomonas acquisition is related to a decrease in lung function in CF (Waters 
et al. 2013; Barsky et al. 2017). In this study, two exacerbations were dominated by S. 
maltophilia, one of which carried the Stenotrophomonas phage phiSHP2 encoding zonula 
occludens toxin (Figure 4.5). S. phage phiSHP2 was active in this exacerbation, since its 
genome was identified in viral particles. Zonula occludens toxin is an exotoxin that induces 
actin depolymerization, which provokes opening of tight junctions and disruption of epithelial 
integrity (Di Pierro et al. 2001; Fasano et al. 1991; Uzzau et al. 2001). This mechanism 
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possibly contributed to the disruption of lung epithelial cells (Ruan et al. 2014) in this CF 
exacerbation.    
Unique mobile elements in CF exacerbations 
Phages and genomic islands are the main components of a unique CF mobilome in 
every exacerbation presented in this study. The mobilome facilitates pathogen adaptation to 
the local environment (Dobrindt et al. 2015; Jeukens et al. 2017). The detailed comparative 
genomics methods presented here allowed for the identification of already characterized 
phages such as Stenotrophomonas phage phiSHP2, previously uncharacterized genomic 
islands, and new prophages identified in inserted regions of Achromobacter spp. and 
Stenotrophomonas spp.  
Microbial ecology models of acute CF exacerbations. 
The CF mobilome is an essential component to understand the pathogenesis of CF 
microbial communities. In this study, acute exacerbations were characterized by low 
microbial diversity and the dominance of a single microbe with a unique mobilome. Toxins 
that directly attack host tissues were also present in the described CF exacerbations. These 
exacerbations were distinct from CF exacerbations previously studied by our group (Lim et al. 
2014; Quinn et al. 2014; Whiteson et al. 2014) and others (Moran Losada et al. 2016; 
Feigelman et al. 2017). Therefore, the following model for descriptions of the microbial 
ecology in CF acute exacerbations is proposed: pathogens dominance, in which acute 
exacerbations are characterized by low diversity, dominance of a single microbe with unique 
mobile elements including toxins and lysogenic phages. In this model, the CF mobilome plays 
an essential role to understand and treat CF acute exacerbations.  
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Materials and methods 
Clinical data. 
Sample collection procedures and access to clinical data were approved by the 
Institutional Review Board of University of California San Diego (HRPP 081510) and San 
Diego State University (IRB#1711018R). 
Samples collection and pre-processing. 
Sputum samples were collected by hospital personnel during the patient’s stay at the 
hospital. Expectorated phlegm was collected in a sterile cup and stored at 4 ºC while 
transported to the research lab. In the research lab samples were homogenized with a syringe 
(no needle) and distributed into 500µl aliquots.  
Viral and microbial enumeration. 
Sputum samples were homogenized in SM buffer (1:6 dilution) and treated with 
DNAse (1000 U ml-1) for 1h. Next, they were filtered sequentially through Whatman 
Nucleopore Track-Etched Membranes of 8 um and 2 um pore sizes to remove large particles 
and eukaryotic cells. The filtrate was fixed with paraformaldehyde (2%), stained with SYBR 
Gold (Life Technologies, USA) and filtered on a 0.02 um Anodisc membrane (Whatman) for 
epifluorescence microscopy. Viral and microbial particles were quantified based on size 
(viral-like-particles < 0.2 um, and bacterial cells > 0.2 um) in at least 10 images for each 
sample. The dilution factors were used to calculate viral particles or cells per ml.  
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Total DNA metagenomes. 
Five hundred microliters of sputum were transferred to a cryovial. The tube was 
submerged in a dry-ice and ethanol bath for 5 minutes, then transferred to a water bath at 
100ºC for 5 minutes, this process was repeated 3 times. The sample was transferred to the 
beads tube from Qiagen power soil DNA extraction kit and homogenized by shaking for 45 
minutes. The rest of the Qiagen power soil DNA extraction kit protocol was used. Ten 
nanograms of DNA were used for Nextera library prep. Libraries were sequenced on Illumina 
MiSeq using 150 cycles as single end. This procedure is illustrated in Supplemental Figure 
4.14 
Total RNA metatranscriptomes. 
Five hundred microliters to 2 ml of sputum were mixed with 4 mL of guanidinium 
thiocyanate (TRIzol, Invitrogen), homogenized by vortexing and stored at -80 ºC until further 
processing. Samples were defrosted and 0.2 volume of chloroform was added, the mixture 
was homogenized by vortexing and incubated for 20 minutes at 4 ºC. Samples were 
centrifuged at 13,800 x G for 20 minutes at 4 ºC and the aqueous layer was transferred to a 
new RNase free tube. Aqueous phase volume was measured and an equal volume of 
isopropanol and 2µl of glycogen (20mg ml-1) were added, the mixture was incubated at 4 ºC 
for 20 minutes to precipitate nucleic acids. The sample was centrifuged at 13,800 x G for 20 
minutes at 4 ºC and the supernatant was removed and discarded. The pellet was washed with 
1 ml of 75% ice cold ethanol and centrifuged 5 minutes at 4 ºC, this procedure was repeated 2 
times. The pellet was air dried for 15 minutes and resuspended in 50 µl of molecular grade 
water and incubated at 55 ºC for 5 minutes. DNase treatment was performed by adding 2 µl of 
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TURBO DNase and 5 µl of DNase buffer, the mixture was incubated at 37 ºC for 30 minutes, 
0.2 volume of DNase inactivation reagent was added and incubated 5 minutes at room 
temperature. The sample was centrifuged at 10,000 x G for 1.5 minutes at 24 ºC and the 
aqueous phage was transferred to a new RNase free tube.  RNA concentration was measured 
using Qubit (between 50 and 200 ng µl-1 were obtained in all samples). Total RNA 
sequencing libraries were prepared using Illumina TruSeq total RNA without ribosomal RNA 
depletion and no fragmentation. One µg of total RNA in 8.5 µl of molecular grade water was 
used as input for library prep. RNA was mixed with 8.5 µl of fragment prime finish mix and 5 
µl of 5X first strand buffer and incubated at 65  ºC for 5 minutes, at 72 ºC for 5 minutes and 4 
ºC for 5 minutes. Next 1 µl of superscript II reverse transcriptase and 8 µl of first strand mix 
ActD were added and the protocol followed without modifications, in the last PCR 15 cycles 
were used. When libraries were ready the volume was brought up to 50 µl and a right-side 
selection was performed using SPRIselect beads in a ratio of 0.9X. Libraries quality was 
evaluated using Bioanalyzer. Libraries were sequenced on Illumina MiSeq using 150 cycles 
as single end. 
Virome 
Sputum samples were homogenized in SM buffer (1:6 dilution) and treated with 
DNAse (1000 U ml-1) for 1h. at 37 ºC Next, they were filtered sequentially through 8 um, 2 
um and 0.45 um filters to remove large particles and eukaryotic cells. The filtrate was mixed 
with chloroform (10 %) and homogenized by hand for 5 min. The sample was centrifuged at 
3,000 g for 5 min and the chloroform was removed. CsCl was added to the chloroform-treated 
sample at 1.15 g ml-1 density. The sample was was added onto a CsCl gradient comprised of 4 
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layers: 1.7 g ml-1, 1.5 g ml-1, 1.35 g ml-1 and 1.2 g ml-1 prepared with SM buffer. The sample 
was centrifuged at 4 ºC for 14 h at 35,000 rpm in a Beckman Coulter Ultracentrifuge using the 
rotor SW41 (151263 x g average and 210053 x g max). The 1.5 g ml-1 fraction was collected 
after the centrifugation using a needle and transferred to an epi tube. A 50 ul aliquot was 
checked for purity using epifluorescence microscopy, as described above. The remaining 
sample was subjected to DNA extraction using the formamide and CTAB protocol (Thurber 
et al 2009). The DNA was prepared for sequencing using the Accel-NGS 2S library prep kit 
(Swift Biosciences) using Covaris fragmentation (Covaris). Library quality was evaluated 
using Bioanalyzer and the libraries were sequenced on the Illumina MiSeq Platform. 
Clinical isolates genome sequencing. 
 Stenotrophomonas spp. and Achromobacter spp. isolates were characterized at the 
clinical lab. Liquid cultures were grown overnight in LB media at 37ºC. Cells were pelleted 
and resuspended in 200µl of PBS, DNA extraction was performed using DNeasy blood and 
tissue kit (Qiagen). Four hundred nanograms of gDNA were used for Nanopore sequencing, 
libraries were prepared and sequenced in individual flow cells on the MinION instrument. 
Reads were base called using ALBACORE, error correction and contigs assembly were 
performed with CANU(Koren et al. 2017) with an estimated genome length of 5Mb. Contigs 
were annotated using RAST(Overbeek et al. 2014) server.  
Mycobacterium spp. isolates were characterized at the clinical lab. A scrap of the 
bacteria growing on the solid media tube (1.5g) was homogenized in a cryovial with buffer 
from the Qiagen power soil DNA extraction kit. The tube was submerged in a dry-ice and 
ethanol bath for 5 minutes, then transferred to a water bath at 100ºC for 5 minutes, this 
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process was repeated 3 times. The sample was transferred to the beads tube from Qiagen 
power soil DNA extraction kit and homogenized by shaking for 45 minutes. The rest of the 
Qiagen power soil DNA extraction kit protocol was used, and DNA was obtained at a 
concentration of 20 ng µl-1 in 200 µl.  
Metagenomes, metatranscriptomes and viromes data analysis. 
Raw fastq files were filtered and dereplicated using PRINSEQ++ with minimum 
quality threshold 20, dereplication and entropy threshold 50. Cloning vector sequences were 
removed using SMALT with 80 % identity against the NCBI UniVec database. Human 
genome sequences were removed using SMALT with 80 % identity against the human 
reference genome GRCh38 (Supplemental Figure 4.15). The remaining reads are refered as 
polished reads. Polished reads were mapped to the NCBI RefSeq database of complete 
bacterial genomes using SMALT at 96 % identity. Hits were normalized using Fragment 
Recruitment Assembly Purification (FRAP, code available at 
https://github.com/yinacobian/frap). This procedure is illustrated in Supplemental Figure 4.16 
Genomic insertions and deletions identification. 
The closest reference genome for each dataset was identified as the genome that 
recruited more reads at 96% identity over 100% of the read. Regions >10,000 bp with no 
coverage in the reference genome were identified and extracted from the reference genome 
(code available at https://github.com/yinacobian/getholes). Insertions were identified by 
mapping de novo assembled polished reads (SPAdes –only-assembly) to the closest reference 
genome using MEDUSA. Regions >10,000 bp that were present in assembled contigs but not 
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in the reference genome were identified as insertions and extracted from the contigs (code 
available at https://github.com/yinacobian/getaddons).  
Insertions and deletions annotations. 
Fasta files of insertions and deletions were annotated using PATRIC 
(https://www.patricbrc.org/), Conserved Domains Database 
(https://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml) and PHANNS 
(https://edwards.sdsu.edu/phanns). Genome maps were generated with EasyFig. 
Technical considerations for CF sputum metagenomics. 
CF sputum is a complex mixture of host derived cells, free DNA and mucus 
(Manzenreiter et al. 2012; Martínez-alemán, Campos-garcía, and Palma-nicolas 2017) in 
which viral, bacterial and fungi cells are entangled (DePas et al. 2016). Methods to get rid of 
host cells and DNA or RNA result in biases in the microbial community composition 
sampling. To preserve the abundances of each microbe in the system, a procedure with 
minimal sample manipulation was implemented.  
Raw sputum or BAL samples were homogenized, and total DNA extracted without 
host removal or further manipulation. This procedure result in a high abundance of human 
genome reads (between 52% to 95% of total reads) in the metagenomes (Supplemental Figure 
4.15). A sequencing depth of at least 5 million reads per sample is needed to detect the 
microbial community reads in this samples. Since sequencing costs are decreasing, we 
consider this strategy viable in the future of CF clinical metagenomics efforts.  
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In the CF microbial community, the detection of Mycobacterium and fungi is very 
important and cannot be ignored. To make sure that DNA from this hard to lyse 
microorganisms was extracted from sputum samples, a modified DNA extraction protocol 
was developed. It consists of three rounds of submerging the sputum sample in a cold bath 
(ethanol and dry ice) for 5 minutes and in a hot bath (water bath at 100 ºC) for 5 minutes, 
after which a bead-beating step was incorporated and DNA extraction performed with power-
soil DNA kit. We showed that this procedure opens Mycobacterium and Candida cells, which 
are both concerns in CF clinical care. Metagenomic data analysis was designed for precise 
identification at strain level resolution. Recruitment at 100% identity allowed the 
identification of closest reference strain, in addition insertions and deletions were detected in 
CF patients metagenomes. This addresses the individual nature of CF disease progression, 
where even the same bacteria species have a distinctive mobilome. Genome plasticity can be 
identified with metagenomes and careful genomes analysis considering uncharacterized 
mobile elements.     
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Appendix for Chapter 4 
Supplemental figures 
Supplemental Figure 4.1 Bacteria diversity in acute and mild CF exacerbations. Bacteria 
relative abundance was obtained from sputum metagenomes from acute exacerbations (this 
study) and mild exacerbations (Losada, 2016). A) Relative abundance of most abundant 
member of the microbial community. B) Shannon diversity (H). C) Evenness calculated as 
H/In(S). D) Richness (S) calculated as the total number of bacteria species. An unpaired two-
samples Wilcoxon test between the acute and mild groups was performed for all 
measurements, in all cases the two populations are significantly different with a p-value < 
0.01. Wilcoxon test results are: rank 1 relative abundance w=81, p-value 0.015, Shannon 
diversity w=10, p-value=0.002, richness w=17, p-value=0.015, evenness w=20, p-value 
0.030. 
154 
Supplemental Figure 4.2 CF292 exacerbation sample metagenome and gram-stain. B) 
Candida glabrata genome coverage. C) Gram-stain of sputum sample, Candida glabrata cells 
stained gram positive. 
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Supplemental Figure 4.3 CF318 historical sampling. Weekly monitoring of hyper-variable CF 
patient CF318 for one month which includes three stable samples (D-21, D-14 and D-7) and 
one exacerbation sample (D-1). A) Microbial community structure from bacteria relative 
abundances obtained from metagenomes. B) Bacteria genus absolute abundances inferred 
from metagenomes relative abundances combined with microbial cells/mL counts. C) 
Virulence factors fractional abundances obtained from sputum metagenomes. D) Viral 
particles and bacteria cells quantification by epifluorescence microscopy. 
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Supplemental Figure 4.4 Excised regions in Achromobacter ruhlandii from CF116 
exacerbation metagenome.  
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Supplemental Figure 4.5 Excised regions in Achromobacter xylosoxidans from CF418 
exacerbation metagenome.  
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Supplemental Figure 4.6 Excised regions in Stenotrophomonas maltophilia from CF409 
exacerbation metagenome.   
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Supplemental Figure 4.7 Excised regions in Stenotrophomonas maltophilia from CF318 
exacerbation metagenome.  
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Supplemental Figure 4.8 Excised regions in Mycobacterium intracellulare from CF292 
exacerbation metagenome.  
161 
Supplemental Figure 4.9 Excised regions in Streptococcus sp. from CF146 exacerbation 
metagenome.  
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Supplemental Figure 4.10 Insertions in contigs from CF116 metagenome A) Synteny between 
the closest reference genome and contigs assembled from CF116 metagenome. B) Addon 
regions identified in assembled contigs.  
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Supplemental Figure 4.11 Insertions in contigs from CF409 metagenome A) Synteny between 
the closest reference genome and contigs assembled from CF409 metagenome. B) Addon 
regions identified in assembled contigs.  
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Supplemental Figure 4.12 Insertions in contigs from CF318 metagenome A) Synteny between 
the closest reference genome and contigs assembled from CF318 metagenome. B) Addon 
regions identified in assembled contigs.  
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Supplemental Figure 4.13 Bacteria and bacteriophages fractional abundance in metagenomes 
from CF acute exacerbations. A) Bacteria refseq database (n=66,000 genomes) B) 
Bacteriophages refseq (n=4,500 genomes). Polished metagenomes were compared to each 
database using fragment recruitment assembly purification (FRAP) at 96% identity over 
100% of the read. C) Virulence factors. Polished metagenomes were compared to virulence 
factors database Set A using fragment recruitment assembly purification (FRAP) at 96% 
identity over 100% of the read. 
166 
Supplemental Figure 4.14 CF sputum bronchioalveolar lavage total DNA metagenomes 
prodecure.  
167 
Supplemental Figure 4.15 CF metagenomes composition. Raw reads were quality filtered 
using prinseq++ (q-phred > 30), compared to the human reference genome using smalt (y = 
0.5). Polished sequences were compared to NT using BLASTn with an e-value cutoff of 0.1 
with output taxonomy for each hit, the best hit was kept.  
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Supplemental Figure 4.16 CF metagenomes bioinformatic methods.  
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Chapter 5 : Compounding Achromophages for therapeutic applications 
 
Abstract 
Achromobacter spp. colonization in Cystic Fibrosis respiratory airways is an 
increasing concern. Two adult Cystic Fibrosis patients colonized by Achromobacter 
xylosoxidans CF418 or Achromobacter ruhlandii CF116 experienced fatal exacerbations. 
Achromobacter species are naturally resistant to several antibiotics, therefore the use of phage 
therapy for the control of Achromobacter is proposed in this study. Twelve lytic phages were 
isolated and characterized at a morphological and genomic level. They are presented as the 
Achromobacter phages Kumiai collection. The proposed methods for large-scale production 
of phages and removal of endotoxins resulted in a phage concentrate of 1x109 plaque forming 
units per mililiter with an endotoxin concentration of 65 endotoxin units per mililiter, which is 
below the Food and Drugs Administration recommended maximum threshold for human 
administration. The infectivity of all phages in the Kumiai collection was tested in 23 
Achromobacter clinical isolates. Eighteen out of the 23 tested Achromobacter isolates were 
lysed by at least one phage. Six distinctive Achromobacter phage genome clusters were 
identified based on a comprehensive phylogenetic analysis of all publicly available 
Achromobacter phage genomes. A cryptic prophage was induced in Achromobacter 
xylosoxidans CF418 when infected with lytic phages. This prophage genome was also 
characterized and is presented as Achromobacter phage CF418-P1. Thus lytic-lysogenic 
phage interactions require further exploration in the context of phage therapy interventions. 
This study provides a framework for the isolation and characterization of phages to 
kill Achromobacter species in order to manage Cystic Fibrosis pulmonary infections.  
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Introduction 
Achromobacter spp. were identified as the dominant member of the microbial 
community in sputum samples from two Cystic Fibrosis (CF) patients that suffered acute 
exacerbations. Achromobacter spp. are Proteobacteria of the order Burkholderiales, they can 
use anaerobic metabolism in the presence of nitrate or nitrite and can use denitrification for 
respiration. Achromobacter spp. are long term colonizers of the CF lungs (Ridderberg, 
Nielsen, and Nørskov-Lauritsen 2015) and of increasing concern. Achromobacter 
xylosoxidans isolated from CF patients have pathogenic characteristics such as the presence of 
toxins and virulence factors (Jakobsen et al. 2013). In addition to infections in the CF lungs, 
Achromobacter spp. have been reported to cause urinary tract infections (Tena et al. 2008), 
endocarditis (Tokuyasu et al. 2012), meningitis (Manckoundia et al. 2011), and ocular 
infections (Park, Song, and Koh 2012). 
Bacteriophages (phages) have been used as therapeutics to modify the microbiome and 
aid in the clearance of bacterial infections (Gordillo-Altamirano and Barr 2019, Kortright et 
al. 2019). A CF patient was treated with therapeutic phages targeting Achromobacter spp. 
(Hoyle et al. 2018). The use of phages as therapeutics has been empirical and the phages 
applied to patients are not always characterized (Kutateladze and Adamia 2008), which poses 
a safety concern.  
There are 24 publicly available Achromobacter phages (Achromophages) genomes in 
the literature (Table 5.1). The first sequenced Achromophages (Wittmann, Dreiseikelmann, 
Rohde, Meier-Kolthoff, et al. 2014) are members of the N4-like phages, Achromobacter 
phage JWAlpha and Achromobacter phage JWDelta, both of them are Podoviridae. Several 
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Achromophages have been isolated, but their genomes are not sequenced (Wittmann, 
Dreiseikelmann, Rohde, et al. 2014).  
The need for lytic phages targeting Achromobacter is addressed by the isolation and 
characterization of twelve lytic phages. Their host range was tested in 23 Achromobacter 
clinical isolates from CF patients. Phage preparation methods to remove endotoxins were 
successful in providing high titer phages with low endotoxin levels. Achromobacter 
xylosoxidans CF418 carries a temperate phage that was induced when the strain was infected 
with lytic phages. These dynamics deserve further attention. Considerations when isolating 
and characterizing phages for therapeutic applications are addressed, such as the presence of 
prophages in the host strain, presence of toxins in the isolated phages, and lack of functional 
annotation on most phage proteins.   
Results 
Cystic fibrosis and Achromobacter 
Achromobacter spp. were identified as the dominant members of the microbial 
community in two CF fatal exacerbations. Patient CF116 respiratory tract microbial 
community was dominated by A. ruhlandii with a relative abundance of 98.5% based on a 
sputum metagenome. The clinical laboratory reported the presence of Achromobacter sp. and 
A. xylosoxidans. Patient CF116 was treated with the following antibiotics over a month during
the acute exacerbation: ceftazidime-avibactam, doxycycline, sulfamethoxazole-trimethoprim, 
vancomycin, and tigecycline. A second scheme during the acute exacerbation was composed 
of colistin, azithromycin, meropenem, imipenem-cilastatin, azithromycin, and minocycline. 
 172 
Patient CF116 Achromobacter spp. infection was not resolved and the patient died three 
months after the acute exacerbation.  
Patient CF418 respiratory tract microbial community was dominated by A. 
xylosoxidans with a relative abundance of 76.7% based on a bronchioalveolar lavage 
metagenome obtained during an acute exacerbation. The clinical laboratory reported a 
rhinovirus infection one week before the acute exacerbation and chronical presence of 
Achromobacter sp. and Pseudomonas aeruginosa. Patient CF418 was on cardiopulmonary 
bypass and waiting for a lung transplant. Patient CF418 died during the acute exacerbation. 
These unresolved Achromobacter spp. infections in two fatal exacerbations motivated 
the implementation of a phage therapy strategy to kill the bacteria.  
Achromobacter clinical isolates 
Achromobacter spp. clinical isolates were obtained during acute exacerbations of 
patients CF116 and CF418. These isolates were characterized by 16S rDNA amplicon Sanger 
sequencing and whole genomes were obtained using Nanopore and Illumina sequencing. 
Strains are further referred as Achromobacter ruhlandii CF116, and Achromobacter 
xylosoxidans CF418.  
Twenty additional Achromobacter clinical isolates from CF patients were obtained 
from the San Diego CF clinic. A reference Achromobacter xylosoxidans strain C54, HM-235 
from a non-CF individual was obtained from the BEI collection (BEI, 2019).   
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Achromophage isolation and characterization 
Availability of genomically characterized Achromophages is limited. Twenty four 
Achromophage genomes (Wittmann, Dreiseikelmann, Rohde, Meier-Kolthoff, et al. 2014; 
Rohde, Nimtz, and Wittmann 2017; Ma et al. 2016; Li, Yin, et al. 2016; Li, Zhao, et al. 2016) 
were available in public databases (Table 5.1). 
Two genomically characterized Achromophages were obtained from the DSMZ-
German collection of microorganisms (Leibniz Institute, 2019). These are Achromobacter 
phage JWalpha (DSM 26830) and Achromobacter phage JWDelta (DSM 26829). Their 
propagation was not succesfull in any of the Achromobacter spp. strains in our collection 
(n=23). A previous study reported the use of Achromophages in a CF patient as a phage 
therapy clinical intervention (Hoyle et al. 2018). Access to these phages was requested to the 
research group, but it was not granted. This motivated a phage hunt strategy to construct a 
publicly available Achromophage library whose genomes are characterized. 
Table 5.1 Achromobacter lytic phages in the literature (n=24).  
Phage name Genome 
length 
(bp) 
Accession 
number 
Clade Morphology 
(virus 
family) 
Reference Propagation 
strain 
Achromobacter 
phage 
vB_AXyS_19-
32_Axy04 
73,834 MK962626 JWAlpha 
Unpublished 
(Pourcel C, 
et al., 2019) 
Achromobacter 
xylosoxidans 
I2BC 
Achromobacter 
phage 
vB_AXyS_19-
32_Axy06 
45,830 MK962627 JWX 
Unpublished 
(Pourcel C, 
et al., 2019) 
Achromobacter 
xylosoxidans 
I2BC 
Achromobacter 
phage 
vB_AXyS_19-
32_Axy09 
43,287 MK962628 Axy09 
Unpublished 
(Pourcel C, 
et al., 2019) 
Achromobacter 
xylosoxidans 
I2BC 
Achromobacter 
phage 
vB_AXyS_19-
32_Axy10 
73,898 MK962629 JWAlpha 
Unpublished 
(Pourcel C, 
et al., 2019) 
Achromobacter 
xylosoxidans 
I2BC 
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Table 5.1 Achromobacter lytic phages in the literature (n=24). (Continued) 
Phage name Genome 
length 
(bp) 
Accession 
number 
Clade Morphology 
(virus 
family) 
Reference Propagation 
strain 
Achromobacter 
phage 
vB_AXyS_19-
32_Axy11 
73,413 MK962630 JWAlpha 
Unpublished 
(Pourcel C, 
et al., 2019) 
Achromobacter 
xylosoxidans 
I2BC 
Achromobacter 
phage 
vB_AXyS_19-
32_Axy12 
74,096 MK962631 JWAlpha 
Unpublished 
(Pourcel C, 
et al., 2019) 
Achromobacter 
xylosoxidans 
I2BC 
Achromobacter 
phage 
vB_AXyS_19-
32_Axy13 
70,103 MK962632 JWAlpha 
Unpublished 
(Pourcel C, 
et al., 2019) 
Achromobacter 
xylosoxidans 
I2BC 
Achromobacter 
phage 
vB_AXyS_19-
32_Axy14 
46,703 MK962633 JWX 
Unpublished 
(Pourcel C, 
et al., 2019) 
Achromobacter 
xylosoxidans 
I2BC 
Achromobacter 
phage 
vB_AXyS_19-
32_Axy16 
46,178 MK962634 JWX 
Unpublished 
(Pourcel C, 
et al., 2019) 
Achromobacter 
xylosoxidans 
I2BC 
Achromobacter 
phage 
vB_AXyS_19-
32_Axy18 
45,500 MK962635 phiAxp1 
Unpublished 
(Pourcel C, 
et al., 2019) 
Achromobacter 
xylosoxidans 
I2BC 
Achromobacter 
phage 
vB_AXyS_19-
32_Axy19 
46,036 MK962636 phiAxp1 
Unpublished 
(Pourcel C, 
et al., 2019) 
Achromobacter 
xylosoxidans 
I2BC 
Achromobacter 
phage 
vB_AXyS_19-
32_Axy20 
46,352 MK962637 phiAxp1 
Unpublished 
(Pourcel C, 
et al., 2019) 
Achromobacter 
xylosoxidans 
I2BC 
Achromobacter 
phage 
vB_AXyS_19-
32_Axy21 
43,049 MK962638 Axy09 
Unpublished 
(Pourcel C, 
et al., 2019) 
Achromobacter 
xylosoxidans 
I2BC 
Achromobacter 
phage 
vB_AXyS_19-
32_Axy22 
71,710 MK962639 JWAlpha 
Unpublished 
(Pourcel C, 
et al., 2019) 
Achromobacter 
xylosoxidans 
I2BC 
Achromobacter 
phage 
vB_AxyS_19-
32_Axy23 
43,773 MK962640 Axy09 
Unpublished 
(Pourcel C, 
et al., 2019) 
Achromobacter 
xylosoxidans 
I2BC 
Achromobacter 
phage 
vB_AxyS_19-
32_Axy24 
74,744 MK962641 JWAlpha 
Unpublished 
(Pourcel C, 
et al., 2019) 
Achromobacter 
xylosoxidans 
I2BC 
Achromobacter 
phage phiAxp-
1 
45,045 NC_029033.1 phiAxp1 Siphoviridae 
(Li E, et al., 
2016) 
Achromobacter 
xylosoxidans 
A22732 
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Table 5.1 Achromobacter lytic phages in the literature (n=24). (Continued) 
Phage name Genome 
length 
(bp) 
Accession 
number 
Clade Morphology 
(virus 
family) 
Reference Propagation 
strain 
Achromobacter 
phage phiAxp-
2 
62,220 NC_029106.1 phiAxp2 Siphoviridae 
(Li E, et al., 
2016) 
Achromobacter 
xylosoxidans 
A22732 
Achromobacter 
phage phiAxp-
3 
72,825 NC_028908.2 JWAlpha Podoviridae 
(Ma Y, et 
al., 2016) 
Achromobacter 
xylosoxidans 
A22732 
Achromobacter 
phage 83-24 
48,216 NC_028834.1 JWX Siphoviridae 
(Rohde M, 
et al., 2017) 
Achromobacter 
xylosoxidans 
HER 83-190 
Achromobacter 
phage JWX 
49,714 NC_028768.1 JWX Siphoviridae 
(Rohde M, 
et al., 2017) 
Achromobacter 
xylosoxidans 
LMG 3465 
Achromobacter 
phage JWF 
81,541 NC_029075.1 JWF Siphoviridae 
(Rohde M, 
et al., 2017) 
Achromobacter 
xylosoxidans 
CCUG 48136 
Achromobacter 
phage 
JWDelta 
73,659 KF787094.1 JWAlpha Podoviridae 
(Wittmann 
J, et al., 
2014) 
Achromobacter 
xylosoxidans 
DSM 11852 
Achromobacter 
phage 
JWAlpha 
72,329 NC_023556.1 JWAlpha Podoviridae 
(Wittmann 
J, et al., 
2014) 
Achromobacter 
xylosoxidans 
DSM 11852 
Twelve lytic phages were isolated from environmental water sources including lakes, 
ponds, fountains, and influents of wastewater treatment plants in San Diego, CA (Table 5.2). 
The set of 12 phages is referred to as the Achromobacter phages Kumiai collection. Seven 
Achromophages were isolated on A. ruhlandii CF116 using LB media. It was not possible to 
isolate phages in A. xylosoxidans CF418 using LB media. Therefore the media was changed 
to BHIS and five Achromophages were isolated in A. xylosoxidans CF418. A previously 
uncharacterized prophage was induced from A. xylosoxidans CF418 when the strain was 
infected with lytic phages. The 12 new Achromophage names etymologies are from the 
Kumiai language spoken by native San Diegans (also known as Kumeyaay). 
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Table 5.2 Achromobacter bacteriophages isolated in this study. Etymologies are from the 
Kumiai language. All isolation sources are from San Diego, CA. Coding sequences, tRNAs 
and repeat regions were annotated from PATRIC. 
 
Phage name Genome 
length 
(bp) 
GC 
content 
CDS tRNA repeat 
regions 
Clade Host Phage 
isolation 
source 
Phage 
name 
etymology 
 
Achromobacter 
phage nyashin 
45,982 56.31 68 0 2 phiAxp1 
A.ruhlandii 
CF418 
Influent 
water 
nyashin – 
sun 
Achromobacter 
phage shaaii 
45,029 56.11 63 0 0 phiAxp1 
A.ruhlandii 
CF418 
Influent 
water 
shaaii - 
buzzard 
Achromobacter 
phage nyaak 
46,478 55.77 66 1 2 JWX 
A. 
ruhlandii 
CF116 
Influent 
water  
nyaak -
north 
Achromobacter 
phage kewaak 
46,215 56.19 66 1 0 JWX 
A. 
ruhlandii 
CF116 
SDSU 
fishpond  
kewaak -
south 
Achromobacter 
phage wiik 
50,543 55.75 83 1 37 JWX 
A. 
ruhlandii 
CF116 
Lake 
Murray 
wiik - east 
Achromobacter 
phage tuull 
47,460 55.79 92 1 15 JWX 
A. 
ruhlandii 
CF116 
Influent 
water 
site 2 
tuull - 
west 
Achromobacter 
phage maay 
46,086 56.31 62 1 2 JWX 
A. 
ruhlandii 
CF116 
Influent 
water 
site 1 
maay - 
clouds or 
sky 
Achromobacter 
phage xasilly 
46,478 55.77 65 1 2 JWX 
A. 
ruhlandii 
CF116 
Influent 
water 
site 3 
xasilly - 
sea or 
waves 
Achromobacter 
phage ahaak 
46,435 56.17 64 1 0 JWX 
A.ruhlandii 
CF418 
Influent 
water 
ahaak – 
raven 
Achromobacter 
phage emuu 
46,012 55.86 62 1 2 JWX 
A.ruhlandii 
CF418 
Influent 
water 
emuu - 
mountain 
sheep 
Achromobacter 
phage ewii 
43,305 55.51 64 1 0 JWX 
A.ruhlandii 
CF418 
Influent 
water  
ewii - 
snake 
Achromobacter 
phage kwar 
33,215 55.59 73 0 6 JWX 
A. 
ruhlandii 
CF116 
Influent 
water 
site 4 
kwar - red 
Achromobacter 
prophage 
CF418-P1 
58,030 65.63 73 1 2  
A.ruhlandii 
CF418 
  
 
Achromophage genomes were sequenced using Illumina (Supplemental Table 5.1) and 
Nanopore (Supplemental Table 5.2) platforms. Genome lengths were between 33,215 bp and 
50,543 bp. The GC content was between 55% and 56%. The number of coding sequences on 
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each phage was between 62 and 92. A tRNA was identified in 10 phages. Achromophage 
genome sizes for 10 out of 12 phages were corroborated by Pulse Field Gel Electrophoresis 
(PFGE), all the genomes were close to the 48.5 Kbp marker (Supplemental Figure 5.1). 
Achromophage morphology was determined by Transmission Electron Microscopy (TEM); 
siphoviridae and podoviridae morphologies were observed (Supplemental Figure 5.2).    
Achromophage comparative genomics 
Protein level whole genome comparisons to the Phage Proteomic Tree (Rohwer and 
Edwards 2002) were performed among previously published Achromophages (n=24, Table 
5.1) and Achromophages form this study (n=12, Table 5.2) using VIPTree (Nishimura et al. 
2017) (Figure 5.3-A). Isolated Achromophages clustered in 2 clades (Figure 5.1-B). Clade 
JWX (from A. phage JWX, NC_028768.1) included Achromobacter phage tuull, 
Achromobacter phage emuu, Achromobacter phage ahaak, Achromobacter phage kewaak, 
Achromobacter phage maay, Achromobacter phage kwar, Achromobacter phage nyaak, 
Achromobacter phage xasilly, Achromobacter phage wiik, and Achromobacter phage ewii. 
Clade phiAxp-1 (from A. phage phiAxp-1, NC_029033.1) included Achromobacter phage 
shaaii and Achromobacter phage nyashin. Achromobacter phage 83-24 (NC_028834.1) 
clustered in the JWX clade. Achromobacter phage phiAxp-2 (NC_029106.1) did not clustered 
with other Achromophages, it clustered with Burkholderia and Xylella phages. A third cluster 
identified as JWDelta (after A. phage JWDelta, KF87094.1) was formed by A. phage 
JWDelta, A. phage JWAlpha and Achromobacter phage phiAxp-3. Achromobacter phage JWF 
(NC_029075.1) did not clustered with other Achromophages and was more distantly related 
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to the rest of Achromophages, it clustered close to the Archaea virus Natrinema virus SNJ1 
and four Holoarcula viruses.  
 
 
Figure 5.1 Achromobacter phages on The Phage Proteomic Tree. 
 
Small variations were observed between phages in the Clade JWX (Figure 5.2). A. 
phage emuu, A. phage ahaak, and A. phage kewaak showed variation in a 3.5 Kbp region 
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containing 6 CDS. A. phage ahaak and A. phage kewaak showed variation in a tail fiber 
protein. A. phage kwar was closely related to A. phage maay and A. phage nyaak. Deletions 
were observed in A. phage kwar. A. phage nyaak, and A. phage xasilly differed only by 50 
nucleotides in a CDS that is 118 aminoacids long and contains a ribon-helix-helix domain. A. 
phage xasilly, A. phage wiik, and A. phage ewii were closely related and rearrangements on 
their genomes were observed in the synteny plots, a 4 Kbp insertion was observed in A. phage 
wiik.    
 
Figure 5.2 Achromobacter phages clade phiAxp1. 
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Figure 5.3 Achromobacter phages clade JWX, genomes comparisons. 
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In clade phiAxp1 (Figure 5.3) A. phage phiAxp-1, and A. phage shaaii were similar, 
with variation in a 3.2 Kbp region that contained 8 CDS, this variation region was also 
observed in A. phage nyashin.  
 
Achromophage genome annotation  
Achromophages genomes from the Kumiai collection encode between 62 and 92 CDS 
per genome. Genome annotations using protein comparisons based on k-mers (Brettin et al. 
2015) resulted in mostly hypothetical proteins, which is a common challenge in phage 
annotations. Further annotations using conserved domains (CDD), hidden Markov models 
(HMMER Search), and artificial neural networks (ANNs for structural proteins), followed by 
expert curation, were used to annotate the phage genomes. Using this holistic approach, the 
number of hypothetical proteins was reduced. A terminase was identified in all analyzed 
phage genomes. The small and large terminases form the packaging machinery (Sun et al. 
2012) which is responsible for feeding the DNA into the phage capsids. A transcriptional 
regulator was identified in all analyzed phage genomes, its original annotation was done in the 
ACLAME server (ACLAME, 2019). A tRNA was identified on each genome of the clade 
JWX, no tRNA was identified in the phages of clade phiAxp1.  
 
Toxins annotations in Achromophages 
A concern in the use of phages for therapeutic application is the production of toxins. 
Achromophages from the Kumiai collection have no identified toxins or virulence factors 
when annotated using PATRIC resources, which perform protein level comparisons to the 
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virulence factors database (~30,000 virulence factors reported by Chen et al. 2016), 
VICTORS (5,296 virulence factors reported by S. Sayers et al. 2019), and a PATRIC curated 
virulence factors database (1,293 virulence factors reported by Wattam et al. 2017). 
Conserved domains database annotations identified a potential toxin in one phage. A 39 aa 
long CDS in A. phage tuull was annotated by HMMER Search (EBI, 2019) as a hemolysin-
type calcium binding region, 12 out of 19 aa were recognized as part of the toxin motif.  
 
Achromophage lifestyle determination  
The use of temperate phages for phage therapy is not desirable since the integration of 
phages in bacteria genomes may have unexpected results. No integrases were detected in any 
of the Achromobacter phages of the Kumiai collection. Lifestyle characterization using 
PHACTS (McNair, Bailey, and Edwards 2012) classified A. phage shaaii and A. phage 
nyashin as lytic, the lifestyle classification for the remaining 10 phages was inconclusive, 
potentially due to the lack of well characterized Achromophages for comparisons 
(Supplemental Table 5.4).  
Prophage CF418-P1 induction and characterization 
Multiple phage genomes were identified in the genome sequencing of phage lysates 
LB5, LB7 and LB8 (Supplemental Figure 5.3). A new prophage CF418-P1, was identified 
(Figure 5.4-A). It was induced when A. xylosoxidans CF418 was infected by Achromophages. 
Prophage CF418-P1 was induced with the following pairs of phages: A. phage shaii and A. 
phage ahaak were present in lysate LB5; A. phage nyashin, and A. phage ewii were present in 
phage lysate LB7; and A. phage nyahin and A. phage emuu were present in lysate LB8. Reads 
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from lysates LB6, LB5, LB7, and LB8 were mapped to the reference genome Achromobacter 
xylosoxidans NCTC10807 and showed recruitment in the prophage region (Supplemental 
Figure 5.4).  
 
Figure 5.4 Achromobacter prophage induced when infected with other lytic phages. A) 
Prophage in A. xylosoxidans CF418.The prophage genome was assembled from samples LB5, 
LB7 and LB8 using SPades (Bankevich et al. 2012). Prophage annotation using PATRIC, 
CDD, HMMER and ANNs. B) Prophage in A. xylosoxidans CF418 in bacteria genomes. C) 
Prophage in A. xylosoxidans CF418. Fragment recruitment plots of phage lysate against 
Achromobacter xylosoxidans NCTC10807 reference genome. Prophage region recruited reads 
around 5.8 Mbp (highlighted in red square).  
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Prophage CF418-P1 showed identity to A. xylosoxidans NCTC10807 (96.85% 
identity and 73% query coverage), Achromobacter xylosoxidans strain FDAARGOS_150 
(95.70% identity and 74% query coverage), and Achromobacter denitrificans strain PR1 
(82.77% identity and 55% query coverage) (Figure 5.4-B). Prophage CF418-P1 is not closely 
related to the Achromophages from the Kumiai collection, it formed a separate branch in the 
Phage Proteomic Tree and shared 6 short regions with low identity to Pseudomonas virus H66 
and Pseudomonas virus F116 (Supplemental Figure 5.5).  
Prophage CF418-P1 genome length is 58,030 bp, with a GC content of 65.7%, it 
encodes an integrase and has a temperate lifestyle. Nucleic acid metabolism and structural 
proteins were identified, as well as an endopeptidase and a peptidoglycan hydrolase. Most 
likely, Prophage CF418-P1 packages pieces of the host genome in its viral capsids, being 
able to perform generalized transduction. The fragment recruitment plots to the host genome 
(Figure 5.4-C) suggested that.  
 
Host range determination for Achromophages  
The host range of Achromophages from the Kumiai collection was tested in 22 
Achromobacter isolates from 13 patients with CF in the San Diego clinic, and the reference 
strain A. xylosoxidans HM-235 (Figure 5.5). Eighteen out of the 23 tested Achromobacter 
isolates were lysed by at least one phage from the Kumiai collection (n=12). Additional 
phages were isolated to cover a broader host range, these five phages (Supplemental Table 
5.5) are Achromobacter phage SE2, Achromobacter phage M1, Achromobacter phage ENA1, 
Achromobacter phage M2, and Achromobacter phage MW2. Twenty out of the 23 
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Achromobacter strains were infected and lysed by at least one of the isolated lytic phages. 
Three Achromobacter clinical strains were not infected by any of the isolated phages, we 
hypothesize that these strains carry more prophages which prevent further infections and pose 
a challenge for lytic phages isolation. A. phage SE2 presented the broadest host range, it 
infects 13 out of 23 tested strains. A. phage nyashin showed a generalist behavior since it 
infected 10 out of 23 tested strains, and A. phage MW2 showed a specialist behavior since it 
only infected 2 out of 23 tested strains.   
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Figure 5.5 Achromobacter phages host range test. Twentytwo Achromobacter strains isolated 
from CF patients sputum and characterized by the clinical lab were used for host range test. 
Achromobacter reference strain (HM-235) was also used for host range test. Host range test 
was tested by spot test on a lawn of the host bacteria.  
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Achromobacter phages lysates preparation for therapeutic applications 
Phage production for therapeutic application requires a high titer phage lysate with a 
low concentration of lipopolysaccharides (also known as LPS, lipoglycans or endotoxins). 
Thus, the production method needs to preserve the phage titer and ideally concentrate it, be 
fast, and avoid the use of toxic compounds. This method was illustrated using A. phage nyaak 
(Figure 5.6), the final preparation is a 0.15 M NaCl solution with a phage concentration of 
1x1011 PFU ml-1 and a lipopolysaccharides concentration of 6500 EU ml-1.  
The proposed production method for Achromophages (Figure 5.6) started with one 
liter of overnight phage culture in LB media with a titer of 1x109 PFU ml-1. Bacterial cell 
debris was reduced by centrifugation and decantation, followed by the elimination of 
remaining bacteria cells by filtration. It is important to note that remaining bacterial cells were 
not disrupted by chloroform treatment to avoid an increase in LPS in the solution. This 
solution was concentrated to a volume of 55 ml using tangential flow filtration. It had a phage 
titer of 1x1010 PFU ml-1. Phages are more stable in SM buffer than in LB, thus a buffer 
exchange and further concentration was performed via ultrafiltration using a 100 kDa 
regenerated cellulose membrane, this step resulted in a 10.6 ml solution with a phage titer of 
1x1011 PFU ml-1. Lipopolysaccharides were removed by 1-Octanol (Szermer-Olearnik and 
Boratyński 2015; Morrison and Leive 1976). The residual 1-Octanol was eliminated from the 
solution via dialysis, this resulted in 13 ml of a 0.15 M NaCl solution with a phage titer of 
1x1011 PFU ml-1. Lipopolysaccharides in the phage stock solution were quantified as 
endotoxin units (EU) using recombinant factor C based fluorescence detection (EndoZyme II, 
Biomérieux). 
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Figure 5.6 Achromobacter phage nyaak high titer lysate production and endotoxin removal 
procedure.   
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Discussion  
 
Achromophages hunting  
Phages capable of killing Achromobacter spp. were isolated from water samples 
collected around San Diego, CA. A. ruhlandii CF116 phages were isolated in the first two 
weeks of the search, however A. xylosoxidans CF418 phages were isolated in six months. The 
prophage present in A. xylosoxidans CF418 could be providing superinfection exclusion 
agains invading phages, therefore the isolation of phages against this strain was challenging. 
In the Achromobacter spp. collection (n=23) used in this study, three bacteria strains couldn’t 
be infected by the tested lytic phages. Publicly available phage collections and cooperation 
among research groups are relevant resource for the advancement of the phage therapy field.   
Achromophages genomics 
Two distinctive clades were identified in the Achromophages Kumiai collection, this 
information may be usefull to design phage cocktails, since theoretically phages that are 
distantly related have a distinctive host range.  
Toxins characterization in phage genomes.  
Characterization of phage toxins based on genome sequencing is challenging 
(Philipson et al. 2018). A toxin motif was identified in A. phage tuull, therefore is not a 
suitable candidate for therapeutic use. No known toxins were identified in the rest of the 
Kumiai collection phages. Since most of phage proteins are annotated as hypotheticals, there 
is still a concern for the presence of uncharacterized toxins in phages intented for therapeutic 
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use. An alternative to evaluate their safety is to test the phage cytotoxicity in eukaryotic cell 
lines (Shan et al. 2018; Porayath et al. 2018) and their tolerance in animal models.   
Cryptic prophages induction  
During the isolation of lytyc phages, a cryptic prophage was induced from A. 
xylosoxidans CF418, wether this phage induction is promoting the expression of toxins is not 
known. Generalized transduction was observed in Prophage CF418-P1, since it packages 
pieces of the host genome in its viral capsids. This phenomenon has been observed in other 
Achromophages, such as Achromobacter phage α (Woods and Thomson 1975). Cryptic 
Achromobacter prophages induction mediated by superinfected by a related phage has been 
reported before (Thomson and Woods 1974).   
Endotoxin removal from phage lysates for therapeutic applications.  
The proposed method for endotoxin removal from phage lysates was succesfull in the 
number of phages recovered and the low amount of endotoxin in the prepatation. Phages for 
therapeutic applications are usually applied as a 1x109 PFU ml-1 solution. The phage stock 
presented in this work, when diluted to a concentration of 1x109 PFU ml-1 has a final 
concentration of 65 EU ml-1. The FDA recommended maximum amount of endotoxin units 
(EU) in an intravenous solution is 5 EU per kilogram of body weight per hour. Up to 6 ml of 
the phage stock of 1x109 PFU ml-1 which contains 65 EU ml-1 can be applied to a patient 
(average weight of 80 kg) every hour. Dosage of phage preparations is empirical and efforts 
towards understanding phage pharmacokinetics  are needed (Malik et al. 2017).  
 191 
A concern in the removal of endotoxin is the residual amount of 1-Octanol. It is 
important to note that 1-Octanil can be metabolized in the human body by class IV alcohol 
dehydrogenases (Danielsson et al. 1994; Satre, Žgombić-Knight, and Duester 1994; Jelski et 
al. 2006), which is an advantage of using 1-octanol for LPS removal, although other methods 
are available such as Hexafluoro isopropanol (McCord, Muddiman, and Khaledi 2017). 
Beyond phage hunting 
Alternative solutions to phage isolation are the engineering of phages to expand their 
host range (Lemire, Yehl, and Lu 2018); the use of phage tails to for therapeutic applications 
(Scholl 2017); or phage derived endolysins (Young and Gill 2015).  
Materials and methods  
 
Cystic fibrosis metagenomes 
Informed consent was obtained from patients CF116 and CF418. This study was 
approved by UCSD (HRPP 081510) and San Diego State University (IRB#1711018R). For 
patient CF116, a sputum sample was collected in a sterile cup after sputum induction. For 
patient CF418 a bronchioalveolar lavage sample (BAL) was collected. From BAL or sputum 
samples, 500 µl were transferred to a cryovial. The tube was submerged in a dry-ice and 
ethanol bath for 5 minutes, then transferred to a water bath at 100 ºC for 5 minutes, this 
process was repeated 3 times. The sample was transferred to the beads tube from Qiagen 
power soil DNA extraction kit (catalog number 12888-100) and homogenized by shaking for 
45 minutes. The rest of the Qiagen power soil DNA extraction kit protocol was followed. Ten 
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nanograms of DNA were used for Nextera library prep. Libraries were sequenced on the 
Illumina MiSeq platform.  
Achromobacter strains  
Achromobacter clinical isolates from patients CF116 and CF418 were phenotypically 
characterized by the UCSD clinical laboratory and grown in Remel blood agar. Both clinical 
isolates can grow in tryptone yeast extract glucose medium (TYG), supplemented brain heart 
infusion broth (BHIS) and lysogeny broth (LB). BHIS was supplemented with the following 
per liter: hemin 5 mg, menadione 1 mg, yeast extract 5 g, L-cysteine HCl 50 mg, MgSO4 120 
mg, and CaCl2 50 mg. Each clinical isolate was cultured in liquid LB media at 37 ºC for 16 
hours, cells were pelleted by centrifugation and resuspended in molecular grade water. Total 
DNA was extracted using Qiagen blood and tissue kit (Cat. No.  69504). 16S PCR was 
performed on each isolate using 27F and 1492R primers and ~1,500 bp amplicons 
sequenced by Sanger. Sanger sequences were compared to all NCBI using online megablast. 
The closest hit was to A. xylosoxidans for both isolates. In liquid culture, capsule formation 
was observed, characteristic of many pathogenic Achromobacter. A total of 400 nanograms of 
DNA were used for whole genome sequencing on the Nanopore platform. Whole genome 
analysis of both isolated determined the strains Achromobacter xylosoxidans CF418 and 
Achromobacter ruhlandii CF116.  
Phage hunting  
Aqueous samples (lake water, pond water, and fountain water) were collected and 
filtered with a 0.22 µm filter, and stored at 4 °C. Samples of influent from wastewater 
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treatment plants were stored at 4 ºC, then a 50 ml aliquot was centrifuged at 4000 RPM for 10 
minutes to pellet debris and the supernatant was filtered with a 0.45 µM filter. Chloroform 
was added to 5% v/v for long term storage at 4 ºC.  
Phage isolation for A. ruhlandii CF116 was performed based on PhagesDB (Russell 
and Hatfull 2017) protocols with the addition of 10 mM MgSO4 and 5 mM CaCl2 to bacterial 
cultures and top agar. Plates were incubated at 37 ºC overnight and examined for phage 
plaques. Individual plaques were streaked onto a top agar plate for phages purification, this 
procedure was repeated 3 times. After plaque purification, 3.5 ml of phage lysates were 
prepared by transferring a purified plaque into a growing bacteria culture, which was then 
incubated overnight at 37 ˚C. To prepare a stock of phage lysate (50 ml), previous 3.5 ml of 
phage lysate was used (Supplemental Table 5.3) 
A. xylosoxidans CF418 from frozen glycerol stocks was streaked onto BHIS plates and 
incubated at 37 °C for 24 hours in an anaerobic chamber. Individual colonies were then 
cultured at 37 °C for 24 hours in 3-5 ml BHIS broth. Phages were isolated from influent 
samples from 4 sewage treatment sites, ponds, fountains, and a lake. Four ml of BHIS top 
agar, 200 µl host overnight culture, and processed influent (0.1-1 ml) were combined and 
poured as top agar over BHIS plates. Individual plaques were then be selected by streak-
isolation with a toothpick to new top agar plate. The phages were passaged at least 3 times 
until only one phenotype was visible after last passage with individual plaques present. The 
phages library was preserved at 4 ºC and in glycerol stocks.  
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Phages Transmission Electron Microscopy (TEM)  
Phages were stained for transmission electron microscopy. Glow-discharged 300-mesh 
copper grids coated with carbon and formvar were overlaid with drops (30 µl) of purified 
phage samples for 3 minutes. Salts were removed from the buffer by rinsing the grids 3 times 
with drops of water (20 µl). Next, the grids were negatively stained with uranyl acetate (0.5 
%) for 15 seconds, dried, and examined using a FEI Tecnai T12 TEM (FEI, Hillsboro, OR) at 
the SDSU Electron Microscopy Facility, operating at 120 kV. Micrographs were taken with 
an AMT HX41 side mounted digital camera (Advanced Microscopy Technique, Woburn, 
MA) (Supplementa Figure 5.2). 
Phages genome size determination by Pulse Field Gel Electrophoresis (PFGE)  
Two hundred and fifty µL of pure phage resuspended in SM buffer were added to an 
equal volume of 1.6 % low melting (LM) agarose prepared in molecular grade 0.02 µm 
filtered water. Phage concentration in the starting suspensions are shown in Supplemental 
Figure 1-C.  Before mixing, the LM agarose was placed in 50 ºC water bath for 20 minutes to 
avoid heat damage to the phage particles. The mix was immediately distributed in individual 
75 µL wells of plug molds and allowed to solidify for 20 min at 4 ºC. A small suction bulb 
was used to pump the plugs out of the molds and place them in TE (10 mM Tris-HCl, 0.1 mM 
EDTA, pH 7.5) (always 2 ml of solution/3 plugs). Using flat bottom tubes avoid breaking the 
plugs during the procedure. Free DNA contamination was treated with DNase I by incubating 
the plugs in a solution containing 1 µg ml-1 of DNase and 1X DNase buffer in TE. Incubations 
were kept at 37 ºC for 1 hour. The liquid was removed, the plugs were transferred to a new 
tube containing ESP (0.5 M EDTA, pH 9, 1% N-laurylsarcosine, 1 mg ml-1 proteinase K), and 
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then incubated at 50 ºC overnight (ON). In order to inactivate the proteinase K, the plugs were 
transferred to a new tube containing PMSF solution (1 mM PMSF, 20 mM Tris-HCl, pH 8, 50 
mM EDTA). The incubation was carried out for 1 hour at room temperature (RT) on a tube 
rocker under gentle agitation. The plugs were washed six times with TE, but in the first wash 
the plugs were transferred to a new tube and left ON at RT under gentle agitation. The five 
following washes were performed for 30 minutes each and no tube exchange was needed. 
Using low EDTA TE (10 mM tris and 0.1 mM EDTA), six extra washes of 30 minutes each 
were performed at the same conditions of the previous ones. After this step, the plugs were 
maintained in low EDTA TE at 4 ºC until the Pulsed-field agarose gel was prepared. The 0.22 
filtered 0.5x TBE was kept in the PFGE machine until the temperature reached 14 ºC. After 
this step, the plugs were cut in half and placed in the wells of the 1% PFGE Agarose (Bio-rad) 
in the same filtered TBE. The wells were closed with melted agarose used to make the gel that 
was kept in a 50 oC water bath. The gel was left at room temperature for 5 minutes until the 
agarose polymerized and loaded. The electrophoresis conditions were automatically set by the 
instrument using the option “auto algorithm” and adding the range of the standard marker (in 
this case, from 15 Kb to 300 Kb). The gradient selected was 6 V/cm, the time 23:52 h, the 
included angle 120º, the initial switch time of 1.19 s and the ﬁnal switch times of 26.29s. The 
MidRange PFG marker (New England Biolabs) and T4 phage were used as size standards 
(Supplemental Figure 1-B).  
Phages host range determination 
Host range of isolated phages was tested in a collection of 22 Achromobacter strains 
isolated from sputum of cystic fibrosis patients at the UCSD CF clinic, and then in the 
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reference strain Achromobacter xylosoxidans HM-235. Host range was tested by spot test of 
10 µl of phage lysate in top agar of a lawn of the bacteria. Lysis was evaluated after 16 hours 
of incubation at 37 ºC.    
Phages DNA isolation for sequencing 
Fifty mililiters of phage lysate were produced without chloroform treatment to 
minimize the amount of free bacterial DNA. Phage DNA isolation protocol(Gill, n.d.) 
(Supplemental Figure 2) consists of phage lysate filtration through a 0.22 μm filter, followed 
by DNAse and RNAse treatment, PEG precipitation, DNAse and RNAse treatment, 
proteinase K treatment, and viral particles opening through resin from Promega Wizard DNA 
clean-up system (Cat. No. A7280). DNA was resuspended in molecular grade water 
(Supplemental Figure 5.6).  
Phages Illumina sequencing 
Ten nanograms of phage DNA were used for library preparation using Swift ACCEL-
NGS 1S PLUS (Cat. No. 10024) with 16 cycles of PCR amplification and an additional bead 
cleanup step (AMPure XP, Beckman-Coulter, Cat. No. A63881) with a proportion of 0.85X at 
the end of library prep to remove sequencing adapters. Libraries were pooled and sequenced 
in the Illumina platform MiSeq as pair end 300. The number of reads obtained per phage was 
between 400 and 5 million (Supplemental Table 5.1).   
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Phages Nanopore sequencing  
Three to 400 ng of phage DNA were used for Nanopore sequencing using barcoding 
and flow cell R9, between 200 to 5000 reads were obtained per phage (Supplemental Table 
5.2).  
Phages genome assembly  
Pair end reads were quality filtered using prinseq++ (Cantu, Sadural, and Edwards 
2019) (-lc_entropy=0.5 -trim_qual_right=15 -trim_qual_left=15 -trim_qual_type mean -
trim_qual_rule lt -trim_qual_window 2 -min_len 30 -min_qual_mean 20). A subsample with 
replacement of 50,000 and 100,000 reads per phage was obtained and used for denovo 
assembly with SPades(Bankevich et al. 2012) (--only-assembler). Attempts to assemble using 
all reads resulted in fragmented phage genomes. Assembly graphs (.fastg files) were inspected 
using BANDAGE(Wick et al. 2015), for some phages contigs were merged to obtain the 
complete genome, in most of the cases a complete genome was obtained in a single contig. 
Phage lysates propagated in Achromobacter CF418 had more than one phage in the assembled 
contigs, a common phage was identified in lysates LB5, LB7 and LB8 (Supplemental Figure 
2) and further identified as a temperate phage in Achromobacter CF418, this is 
Achromobacter prophage CF418-P1. Phage genomes were sorted by the terminase gene using 
circulaline.  
Phages genome annotation  
Phage genomes were annotated in PATRIC (Wattam et al. 2017) using optimized gene 
calling for phages, which uses PHANOTATE (McNair et al. 2019). Using this approach most 
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of the protein annotations were hypothetical. To improve annotations, the phage protein 
sequences were annotated using the conserved domains database (CDD) (Sayers et al. 2009), 
HMMER search (EBI, 2019), and ANNs for structural proteins(Cantú, 2019). Expert manual 
curation of each phage annotation was performed and genome maps were obtained using 
EasyFig (Sullivan, Petty, and Beatson 2011).  
Phages comparative genomics 
Available Achromobacter phage genomes (n=24) and phage genomes isolated in this 
study (n=13) were compared to the Phage Proteomic Tree (Rohwer and Edwards 2002) using 
VIPTree (Nishimura et al. 2017).  
High titer phage production and endotoxin removal and quantification 
One L of phage lysate (1x109 PFU ml-1) was produced in LB media supplemented 
with 10 mM MgSO4 and 5 mM CaCl2. Lysate was centrifuged to remove bacteria debris, 
filtered twice through a 0.22 µm filtering cup. Concentration was performed in a tangential 
flow filter (viva flow 200) to 55 ml, followed by filtration through a 0.22 µm filtering cup, 
phage titer after this step was 1x1010 PFU ml-1. A buffer exchange from LB to SM was 
performed in an Amicon filter (100 kDa), concentration volume was 10.6 ml and phage titer 
1x1011 PFU ml-1. Endotoxins (lipopolysaccharides) were removed with incubation of 10% 1-
Octanol, then it was removed by centrifugation followed by dialysis, volume after dialysis 
was 13 ml and phage titer of 1x1010 PFU ml-1 in a solution of 0.15 M NaCl. 
Lipopolysaccharides were quantified using a colorimetric essay (Biomerieux) and a total of 
6500 EU ml-1 were present in a 0.15 M NaCl solution with a phage titer of 1x1010 PFU ml-1. 
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This procedure is illustrated in Figure 5.6. Phage stock was stored at 4 ºC. This procedure was 
adapter from previous reports(Bonilla et al. 2016; Szermer-Olearnik and Boratyński 2015).  
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Appendix for Chapter 5 
 
Supplemental figures 
 
Supplemental Figure 5.1 Phages genome size by Pulse Field Gel Electrophoresis. A) 
Molecular size ladder B) Pulse Filed Gel Electrophoresis. C) Phages concentration used for 
Pulse Field Gel Electrophoresis plugs.  
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Supplemental Figure 5.2 Achromobacter phages transmission electron microscopy. 
Achromobacter phages ewii and Achromobacter phage maay were not imaged. 
Achromobacter phage ahaak and Achromobacter phage shaii were in a mixed lysate, imaging 
is not shown. Names etymology from the kumeyaai language spoken by native tribes of San 
Diego, CA.  
 
 
    
Achromobacter phage 
nyaak 
Achromobacter phage 
kewaak 
Achromobacter phage wiik Achromobacter phage tuull 
    
    
Achromobacter phage 
xasilly 
Achromobacter phage 
emuu 
Achromobacter phage 
nyashin 
Achromobacter phage kwar 
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Supplemental Figure 5.3 Prophage induced in Achromobacter CF418 when infected with 
additional lytic phages. Contigs assembled from each phage lysate using SPADES were 
visualized in BANDAGE. A) Assembly with 100,000 reads. One bacteriophage genome 
present. B) Assembly with 100,000 reads. Two bacteriophage genomes present, one with high 
coverage of 250X (light purple) and another one with low coverage 5X (dark purple). One 
Achromobacter element present (green) C) Assembly with 100,000 reads. Two bacteriophage 
genomes present, one with high coverage of 250X (light purple) and another one with low 
coverage 5X (dark purple). One Achromobacter element present (green) D) Assembly with 
100,000 reads. Two bacteriophage genomes present with similar coverage (dark purple). 
Achromobacter element present (green).  
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Supplemental Figure 5.4 Prophage induced in Achromobacter CF418 when infected with 
additional lytic phages. Genome coverage of bacteria reference genome. Region in red box is 
the prophage. 
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Supplemental Figure 5.5 Achromobacter prophage CF418-P1 and its closest phage relatives, 
genomes comparisons. 
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Supplemental Figure 5.6 Phages propagation and DNA extraction for genome sequencing.   
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Supplemental tables 
Supplemental Table 5.1 Achromobacter phages Illumina sequencing information.   
 
Phage 
lysate  
Illumina 
good quality 
reads 
Hits to 
A. 
ruhlandii 
NZ_CP0
17433.1 
Hits to A. 
xylosoxidans 
NZ_LN831029.1 
% 
Achromobacter 
reads 
Hits to 
human 
genome  
% 
Human 
genome 
reads 
TL2-B-
filtered 1,894,772 4 1 0.0003 3 0.0000 
TL3-C-
filtered 1,749,597 3 2 0.0003 0 0.0000 
LB1-D-
filtered 2,537,881 12 6 0.0007 1 0.0000 
LB2-E-
filtered 705 0 4 0.5674 0 0.0000 
LB3-F-
filtered 2,274,283 14 12 0.0011 0 0.0000 
LB4-G-
filtered 406 0 0 0.0000 0 0.0000 
TL1-M-
cscl 3,406,503 73 12 0.0025 10 0.0001 
TL4-U-
cscl 5,142,519 315 105 0.0082 35 0.0001 
LB5-V-
cscl 4,040,869 207 112,219 2.7822 0 0.0000 
LB6-T-
cscl 1,874,759 4 3,970 0.2120 0 0.0000 
LB7-W-
cscl 3,895,260 1,826 102,389 2.6754 145 0.0002 
LB8-X-
cscl 2,473,235 3,115 183,814 7.5581 23 0.0001 
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Supplemental Table 5.2 Achromobacter phages Nanopore sequencing information.   
 
Sample 
type 
Sample ID 
DNA amount 
(nanograms) 
BARCODE Reads 
% total 
reads 
Phage TL1 397.50 RB01 772 0.84 
Phage TL2 400.00 RB02 1867 2.04 
Phage TL3 400.00 RB03 1642 1.79 
Phage TL4 203.25 RB04 2700 2.95 
Phage LB4 60.75 RB05 5023 5.49 
Phage LB3 18.00 RB06 1127 1.23 
Phage LB7 10.50 RB09 585 0.64 
Phage LB8 3.26 RB10 231 0.25 
Bacteria 
Achromo 
CF418 213.75 RB12 21470 23.47 
      Unclassified 35399 38.70 
      Total  91482   
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Supplemental Table 5.3 Phage lysates and phage genomes names 
Isolation 
ID 
Sequencing 
ID 
Phage contig ID  Phage name Host  
Phage 
isolation 
source 
IS TL1 
Achromobacter 
phage nyaak TL1 
Achromobacter phage 
nyaak 
A. ruhlandii 
CF116 
Influent 
water 
sample 
pond TL2 
Achromobacter 
phage kewaak TL2 
Achromobacter phage 
kewaak 
A. ruhlandii 
CF116 
SDSU 
fishpond 
water 
LM TL4 
Achromobacter 
phage wiik TL4 
Achromobacter phage 
wiik 
A. ruhlandii 
CF116 
Lake 
Murray 
IS2 LB2 
Achromobacter 
phage tuull LB2 
Achromobacter phage 
tuull 
A. ruhlandii 
CF116 
Influent 
water site 2 
IS1 LB1 
Achromobacter 
phage maay LB1 
Achromobacter phage 
maay 
A. ruhlandii 
CF116 
Influent 
water site 1 
IS3 LB3 
Achromobacter 
phage xasilly LB3 
Achromobacter phage 
xasilly 
A. ruhlandii 
CF116 
Influent 
water site 3 
SA2 LB5 
Achromobacter 
phage LB5-A 
Achromobacter phage 
ahaak 
A.ruhlandii 
CF418 
Infuent 
water 
SA3 LB5 
Achromobacter 
phage LB5-B 
Achromobacter phage 
shaaii 
A.ruhlandii 
CF418 
Infuent 
water 
S315S LB7 
Achromobacter 
phage LB7-A 
Achromobacter phage 
emuu 
A.ruhlandii 
CF418 
Influent 
water 
S313L LB8 
Achromobacter 
phage LB8-B 
Achromobacter phage 
ewii 
A.ruhlandii 
CF418 
Influent 
water  
S2D 
LB6-
repeated 
Achromobacter 
phage nyashin LB6 
(repeated in 3 
samples) 
Achromobacter phage 
nyashin 
A.ruhlandii 
CF418 
Infuent 
water 
S313L 
LB8-
prophage 
Achromobacter 
prophage CF418-P1 
(prophage from 
CF418) 
Achromobacter 
prophage CF418-P1 
A.ruhlandii 
CF418 
Influent 
water  
IS4 LB4 
Achromobacter 
phage LB4 (partial 
genome ?) 
Achromobacter phage 
kwar 
A. ruhlandii 
CF116 
Influent 
water site 4 
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Supplemental Table 5.4 Lifestyle prediction for Achromobacter phages.  
Phage name Lifestyle  
probability 
of 
temperate 
lifestyle 
sd for 
temperate 
lifestyle  
probability 
of lytic 
lifestyle 
sd for 
lytic 
lifestyle 
Integrase 
in 
genome 
Achromobacter phage 
nyaak   0.514 0.041 0.486 0.041 0 
Achromobacter phage 
kewaak   0.512 0.040 0.488 0.040 0 
Achromobacter phage 
wiik   0.509 0.045 0.491 0.045 0 
Achromobacter phage 
tuull   0.504 0.043 0.496 0.043 0 
Achromobacter phage 
maay   0.517 0.042 0.483 0.042 0 
Achromobacter phage 
xasilly   0.509 0.041 0.491 0.041 0 
Achromobacter phage 
ahaak   0.486 0.043 0.514 0.043 0 
Achromobacter phage 
shaaii Lytic 0.468 0.039 0.532 0.039 0 
Achromobacter phage 
emuu   0.482 0.039 0.518 0.039 0 
Achromobacter phage 
ewii   0.505 0.043 0.495 0.043 0 
Achromobacter phage 
nyashin Lytic  0.461 0.039 0.539 0.039 0 
Achromobacter 
prophage CF418-P1 Temperate 0.526 0.040 0.474 0.040 1 
Achromobacter phage 
kwar   0.508 0.037 0.492 0.037 0 
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Supplemental Table 5.5 Isolated Achromobacter phages for broader host range.  
Phage 
ID 
Phage name 
Phage 
isolation host 
Phage isolation source 
Phage 
isolation 
source 
collection date 
M1 Achromobacter phage 
M1 
Achromobacter 
sp. VVP0357 
Vallecitos Wastewater 
District. (Meadowlark 
Water Reclamation 
Facility), Carlsbad, CA. 
2/20/2019 
M2 Achromobacter phage 
M2 
Achromobacter 
sp. VVP0357 
Vallecitos Wastewater 
District. (Meadowlark 
Water Reclamation 
Facility), Carlsbad, CA. 
2/20/2019 
ENA1 Achromobacter phage 
ENA1 
Achromobacter 
sp. VVP0357 
Encina Wastewater 
Authority, Carlsbad CA. 
92011 
2/20/2019 
MW2 Achromobacter phage 
MW2 
Achromobacter 
sp. VVP0426 
Vallecitos Wastewater 
District. (Meadowlark 
Water Reclamation 
Facility), Carlsbad, CA.  
2/20/2019 
SE2 Achromobacter phage 
SE2 
Achromobacter 
sp. VVP0426 
San Elijo Joint Powers 
Authority, Cardiff by the 
Sea, CA. 
4/16/2019 
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Chapter 6 : Synthesis 
 
In this dissertation the role of phages in an environmental and host-associated context 
was explored. Phages were studied at different scales, from a global environmental context 
(Chapter 1) to specific interactions in host-associated systems (Chapter 3 and Chapter 4). In 
addition, accurate methods to describe the effects of phages in microbiomes were developed 
(Chapter 2). 
Phages abundance, diversity and lifestyle.  
The most common mechanism by which phages influence microbial ecosystems is by 
controlling bacteria populations and therefore maintaining diversity. Phages exist as free viral 
particles (lytic phages) or inside bacteria genomes (lysogenic phages) and they can alternate 
between these two lifestyles. In host associated systems a third player is involved, the 
eukaryotic immune system. This tripartite association of host-bacteria-phage results in a more 
complex system.  
 Most phage particles on Earth are in soils and sediments (97%), these biomes have a 
high bacteria abundance and a virus to microbe ratio smaller than 10, which is indicative of a 
phage lysogenic lifestyle (Figure 6.1-A). The viral genetic diversity in soils and sediments is 
still underexplored. Since the publication of “Viruses as winners in the game of life” (Cobián 
Güemes et al. 2016), 35 new soils and sediment viromes have been published (Yoshida 2018; 
Bryson et al. 2015; Adriaenssens et al. 2017; Yu et al. 2019; Emerson et al. 2018; Trubl et al. 
2018; Han et al. 2017; Scola et al. 2018; Corinaldesi, Tangherlini, and Dell’Anno 2017).   
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Figure 6.1Virus to microbe ratio, microbial and viral abundance in Earth biomes and in Cystic 
Fibrosis (CF) stable and exacerbation respiratory tract samples. Aquatic, soil and sediments, 
and animal associated data points were compiled from the literature and published in Cobián 
2016 and Knowles and Silveira 2016. Cystic Fibrosis data points were obtained from Chapter 
4 of this dissertation. A) Microbes per milliliter and the virus to microbe ratio. B) Microbial 
and viral abundances. A virus to microbe ratio of 10 is presented for reference. 
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Host-associated environments present high bacteria abundances. The lungs of Cystic 
Fibrosis (CF) patients have between 108 and 1010 microbes per mililiter. In such high bacteria 
abundances, viral abundances do not scale linearly. This phenomenon is an indication of 
phages integrating in bacteria genomes, a mechanism described as Piggyback the winner 
(Knowles and Silveira et al. 2016). In periods of stability in the lungs of CF patients, a phage 
lysogenic lifestyle is predominant; in exacerbations, a phage lytic lifestyle is observed (Figure 
6.1-B). This finding suggests that phage inductions increase in exacerbation periods, an 
observation explored in Chapter 4. We predict that phage-pathogen intereactions are 
contributing to pathogenesis in the CF lung. Thus, characterization of bacterial and viral 
communities is needed to design effective therapeutic strategies during exacerbation events.  
Are phages hard to find? 
Phage identification in metagenomes and viromes is challenging since most phages are 
not characterized yet. In the exploration of the global virome, around 200,000 viral genotypes 
were identified, most of which represent new phages. To identify phages and mobile elements 
in CF metagenome assembled genomes (MAGs) an exact match strategy was developed 
(Chapter 2) and new phages were identified in every CF patient. This approach highlights the 
importance of accurate and detailed metagenomic studies. In this dissertation, methods to 
detect mobile elements in MAGs were developed and applied to successfully detect new 
phages and multispecies mobile elements.   
The personalized nature of Cystic Fibrosis exacerbations 
The CF lung is a harsh environment for microbes, nevertheless they colonize the 
mucosal surfaces persistently over the patient’s lifetime. During this time the microbial 
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community adapts to the CF lung through constant exposure to antibiotics and host immune 
responses. Thus, microbial species that inhabit the lungs of each CF patient have unique 
adaptations. In the case of Stenotrophomonas maltophilia, the same species dominated 
exacerbation periods of two CF patients; however, each S. maltophilia carried unique 
insertions that represented 3% of the genome. One of these insertions was a filamentous 
phage encoding zonula occludens toxin. This finding highlights the importance of accurate 
and detailed metagenomic analysis for the study of the CF lung and other polymicrobial 
infections. In Chapters 3 and 4 of this dissertation, I provided the methods to detect mobile 
elements and illustrated their importance in understanding their effect in host-pathogen-phage 
interactions.  
Model for Cystic Fibrosis acute exacerbations  
CF acute exacerbations in which the lung function declines rapidly and there is no 
improvement with treatment are identified by the clinicians as a danger signal for CF patients. 
To improve survival rates of these patients, a CF rapid response strategy was adopted. 
Lessons learned from these acute exacerbations include: 1) the microbial community exhibits 
low diversity, 2) the dominant microbes employ mechanisms to cause direct damage to the 
host epithelium and access oxygen and nutrients, 3) the dominant microbes appear to replicate 
rapidly, 4) these infections are not recurrent, and 5) the phages lytic lifestyle dominates the 
system. Examples of CF microbes associated with acute exacerbations that follow the 
described principles are: Achromobacter spp. which encode hemolysins that attack the host 
tissue in order to access nutrients and oxygen; Stenotrophomonas spp. carrying a filamentous 
phage encoding zonula occludens toxin; Escherichia coli carrying shigatoxin; as well as 
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Haemophilus spp., Staphylococccus spp. and Streptococcus spp. carrying several virulence 
factors (Figure 6.2).  
 
Figure 6.2 Model for Cystic Fibrosis acute exacerbations. 
 
The Chaotic Neutral Phage 
Phages are the winners in the game of life since they are the most abundant and 
diverse life form on Earth (Hendrix et al. 1999; Breitbart et al. 2002; Rohwer and Edwards 
2002; Edwards and Rohwer 2005; Cobián Güemes et al. 2016). How they maintain a total of 
6.03 x 1031 particles in the biosphere is still an open question, however we have some hints 
about their dominance strategies: 1) phages switch between a lytic and lysogenic lifestyle 
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which allow them to survive as free viral particles or in a latent state inside bacteria genomes 
(Ptashne 2004; Knowles et al. 2016; Zeng et al. 2010; Erez et al. 2017; Broussard et al. 2013); 
2) phages encode their genomic information in different kinds of genetic material, such as 
dsDNA, ssDNA, dsRNA and ssRNA (Koonin, Dolja, and Krupovic 2015; Ofir and Sorek 
2018), a feature that expands the genomic space they can explore and; 3) phages attack 
bacteria which leads to an arms race between them and allows for the development of 
multiple evasion and infection strategies (Benler et al. 2018, Lee et al. 2018, Rauch et al. 
2017). The diverse strategies phages employ seem chaotic (Cook, Tweet, and Williams 2003) 
in the sense that they do not follow a set of established rules, nor do we understand the extent 
of these rules yet. Phages seem to be neutral in the sense that their effect to their host is 
sometimes beneficial and sometimes detrimental, but they do not have an agenda (i.e. 
evolution is not intentional). The question of the nature of phages is still open, maybe they are 
lawful evil, and do abide by a strict set of rules to dominate the world.  
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